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Solo dopo aver conosciuto la superficie delle cose, - conclude -
ci si può spingere a cercare quel che c’è sotto.
Ma la superficie delle cose è inesauribile.
Italo Calvino, Palomar, 1983
Io penso che un uomo senza utopia, senza sogno, senza ideali,
vale a dire senza passioni e senza slanci
sarebbe un mostruoso animale fatto
semplicemente di istinto e di raziocinio,
una specie di cinghiale laureato in matematica pura
Fabrizio De André, intervista a Vicenzo Mollica
So... come up to the lab, and see what’s on the slab
I see you shiver with antici... pation
Dr. Frank N. Furter, The Rocky Horror Picture Show, 1975.
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Abstract
Hybrid diffuse optical devices allows for the non-invasive and continuous mon-
itoring of the cerebral haemodynamics and metabolism. Such devices can be
portable and are relatively inexpensive, therefore available at the bed- or cot-
side. These advantages make the technology appealing and useful for a variety
of applications. For my Ph.D. thesis, I have worked on the development of new
devices that integrate diffuse correlation (DCS) and time resolved near-infrared
spectroscopy (TRS) and on broadening their field of applications.
Preterm newborn infants are one of the target populations for such a neuro-
monitor. Premature newborns are at a risk of impaired neurodevelopment due
to brain lesions that can be developed during first hours and days of life. In
spite of the fact that these lesions are often due to episodes of abnormalities
of the cerebral haemodynamics, related to oxygen supply to the brain and its
consumption, these parameters are not currently monitored due to the lack of
an appropriate technology. In order to meet this need, the BabyLux project
aimed at developing a hybrid diffuse optical device that could be used to assess
the cerebral well-being of the premature newborn infants.
In the framework of this project, I have developed and built the Baby-
Lux device. Specifically, I have integrated DCS, to measure microvascular
blood flow, and TRS, to measure microvascular blood oxygenation, into a
user-friendly device, a prototype for a future medical grade device. In this
thesis I report results of tests in laboratory settings in order to assess the de-
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vice performance in best-case scenario. Furthermore, I explore the device’s
limits in precision and accuracy, through simulated DCS and TRS data with
realistic noise added, and I describe the influence of a variety of experimental
and analysis parameters. In addition, I demonstrate a high correlation between
cerebral blood flow (CBF) measurement performed by the BabyLux device and
by the gold standard positron emission tomography with 15O-labeled water on
a neonatal piglet model. This proves the robustness of the BabyLux solution
for blood flow measurement and provides a calibration formula to convert the
DCS-measured blood flow index into traditional flow units.
Finally, the device was tested in clinical settings, on healthy term newborns.
It allowed for following cerebral haemodynamics and metabolism during the
transition after birth. Reproducibility over probe replacement appeared im-
proved with respect to commercial oximeters for tissue blood oxygen saturation
and comparable to other technologies for the blood flow.
For an additional study on adult healthy volunteers, I have constructed a
hybrid device integrating a commercial DCS and a prototype for a TRS device.
This could serve as a neuro-monitor for following the cerebral response to tran-
scranial direct current stimulation. This is a non-invasive form of stimulating
the brain that has proven to be effective for cognitive augmentation and for
treating pathological conditions.
In conclusion, the work presented in this thesis paves the way to a new
generation of neonatal neuro-monitors that can be developed for extensive,
multi-center clinical testing and ultimately allow a robust and accurate assess-
ment of the cerebral well-being of the newborns. As far as the adult brain
is concerned, I have introduced a new method for monitoring the cerebral re-
sponse during transcranial direct current stimulation that can be exploited
for protocol and dosage definition and, eventually, for the on-line monitoring
of the cerebral response to the stimulation, tailoring the intervention to each
subject’s condition.
Resumen
Las tecnoloǵıas de óptica difusa permiten estimar de manera no invasiva y
continua la hemodinámica y el metabolismo cerebral a través de instrumen-
tos manejables, de coste relativamente bajo y disponibles al lado de la cama
o la cuna del paciente. En mi tesis doctoral he desarrollado un instrumento
que combina dos técnicas de óptica difusa: “diffuse correlation spectroscopy”
(DCS) y “time resolved near-infrared spectroscopy” (TRS). Además, he con-
tribuido a explorar nuevas aplicaciones para estas tecnoloǵıas.
Los prematuros recién nacidos son unas de las poblaciones objetivos para
este tipo de aparato de monitorización cerebral. El desarrollo cerebral de
los prematuros es más susceptible de lesiones cerebrales desarrolladas en las
primeras horas o d́ıas de vida. Aunque estas lesiones cerebrovasculares son
generalmente causadas por anomaĺıas en la hemodinámica cerebral, es decir
en el flujo sangúıneo hacia el cerebro o en el nivel de oxigenación del tejido
cerebral, estos parámetros no son monitorizados de forma continua porque no
existe una tecnoloǵıa que permita hacerlo. El proyecto BabyLux, en el que par-
ticipé activamente, teńıa el objetivo de desarrollar un instrumento que utilizara
óptica difusa para monitorizar el cerebro de los bebés prematuros.
Con el consorcio del proyecto BabyLux, he desarrollado y construido un
aparato que combina DCS, para medir el flujo sangúıneo microvascular, y TRS,
que mide la oxigenación del flujo microvascular, con el objetivo de que fuera
preciso, exacto y sólido como para poder utilizarse en aplicaciones cĺınicas. En
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esta tesis se exploran sus ĺımites de precisión y exactitud, simulando datos DCS
y TRS, y cómo estos se ven influenciados por varios parámetros experimentales
y de análisis. Además, se demuestra una fuerte correlación en lechones entre el
flujo sangúıneo medido por BabyLux y lo medido por tomograf́ıa por emisión
de positrones (PET) con 15O como radiofármaco, técnica de referencia para
medir el flujo sangúıneo cerebral. Esto demuestra la fiabilidad de la medida de
flujo de BabyLux y, además, permite calibrar el flujo sangúıneo medido por la
DCS y convertirlo en la unidad tradicional de medida de flujo.
Finalmente, el dispositivo fue ensayado en hospitales. La hemodinámica
cerebral fue monitorizada en los minutos posteriores al nacimiento de bebés
sanos. La reproducibilidad de las medidas de BabyLux demostró una calidad
superior respecto a los ox́ımetros cerebrales actuales y comparables a otras
tecnoloǵıas para medir el flujo cerebral.
Estudios adicionales han investigado la hemodinámica cerebral de voluntar-
ios adultos y sanos con otro aparato que he construido combinando una DCS
comercial y un prototipo para una TRS. He demostrado que este aparato puede
ser útil para investigar la respuesta cerebral a la estimulación eléctrica tran-
scraneal, una forma de estimulación no invasiva que ha dado buenos resultados
para tratar condiciones patológicas o para mejorar capacidades cognitivas.
En resumen, el trabajo presentado en esta tesis abre el camino hacia una
nueva generación de instrumentos capaces de monitorizar el cerebro de los
bebés prematuros, que puedan ser utilizados en ensayos cĺınicos en varios hos-
pitales y de forma extensiva. Además, he introducido una nueva técnica para
monitorizar la respuesta cerebral a la estimulación transcraneal que pueda ayu-
dar a la hora de definir protocolos y dosis de la estimulación y que permite
adaptar el protocolo a cada sujeto.
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Personalized medicine is an old concept currently gaining more and more pop-
ularity. Modern medicine is being nowadays pushed towards treatment and
intervention designed and optimized for each individual. This is today a con-
crete possibility thanks to the development of technologies that allow the pa-
tient to receive early diagnosis, risk assessment and to tailor the treatment to
each individual [218].
In order to put in practice such a clinical routine, diagnostics is fundamen-
tal. Information on the state and evolution of the patient must be acquired,
within time-scales that will depend on the specific condition and application.
This is believed to be particularly important for the clinical condition when the
brain is to be protected [208]. Specifically, the brain must be always correctly
perfused of oxygen in order to sustain its metabolic activity. The necessary
amount of oxygen to the brain must be provided and the sufficient level of
cerebral blood flow (CBF) maintained to meet the metabolic demand [198].
Pathological conditions arise from episodes of compromised cerebral haemody-
namics, referred to supply or consumption of oxygen by the brain.
Neuro-monitoring aims at preventing harmful pathological events by early
detection of abnormalities in brain haemodynamics [182]. An on-line feedback
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to treatment can be provided by monitoring the cerebral well-being continu-
ously and routinely. Guidelines should suggest how to maintain the CBF and
oxygenation of blood to the correct reference clinical values. The main purpose
of such a brain-oriented care should be prevention, to avoid irreversible dam-
age to the brain. Since such episodes may be unexpected and the condition of
the brain may change rapidly, such a neuro-monitor should run continuously
and be available at the bed- or cot-side. In addition it should be non-invasive,
to be applied to a variety of populations, and relatively inexpensive, to be
extensively available, ideally for each patients [182].
Preterm born infants are one target population which may benefit from
continuous neuro-monitoring. This condition is unfortunately not rare in our
society. Statistics reports a impressively large amount of infants born preterm
(24-32 weeks of gestational age). A report by World Health Organization
estimates fifteen millions of premature births worldwide every year and this
number is rising [146]. Prematurity is now the leading cause of death of chil-
dren under five years of age worldwide [142] and survivors often develop neu-
rodevelopmental impairments (cerebral palsy, mental retardation, and sensory
impairments) and dysfunction in other cognitive areas, such as attention, vi-
sual processing, academic progress, and executive function [193]. The high
number of preterm infants and high rate of bad outcome produce high medical
care costs, for the intensive care in the period after birth and for the life-time
assistance that survivors with disabling conditions need [146,193].
The neurodevelopment of preterm newborns can be negatively affected by
brain lesions developed especially during the first hours and days of life, when
preterm newborns often need intensive care due to the immaturity of the res-
piratory and cardiovascular system. The etiology of cerebral lesions is com-
plex but seems to be mainly related to hypoxia and poor cerebral perfusion
leading to hypoxia-ischemia [25]. Immaturity of the cardiovascular adaptive
system compromises the balance between oxygen demand and delivery [161].
The degree of maturity of cerebral autoregulation, which represents the abil-
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ity of maintaining CBF stable even when changes in blood pressure occur by
changing cerebrovascular resistance (i.e. diameters of the vessels), is not yet
understood in preterm infants [76]. The slope and limits in the CBF versus
arterial blood pressure curve seems to vary consistently among infants [25].
This picture suggests that intensive care should be brain oriented and
should adapt to the actual degree of development of each infant. This is cur-
rently not achieved because it is not possible to monitor at the cot-side the
perfusion and oxygenation of the newborn brain [138]. The currently available
technologies are not eligible for such a neuro-monitor. Whole-head haemody-
namic monitors such as positron emission tomography (PET) [87], single pho-
ton emission computed tomography (SPECT) [222] and magnetic resonance
imaging (MRI) based techniques [28] are bulky, expensive, need patient trans-
port and immobility. All these are fundamental drawbacks especially when
those technologies should be employed routinely in infants. While 133Xenon
clearance, an historically important methodology for measuring blood flow, re-
quires a radioactive tracer [166]. These days, doppler ultrasound is the only
method to monitor the brain haemodynamic widely exploited in the neona-
tology clinics [49]. It provides invaluable insight on the eventual pathological
cerebral events, but it is operator-dependent and it only provides a one-shot
picture of the cerebral haemodynamics of the infant. Due to this technology
deficiency and scarcity of clinical studies, no reference clinical values have been
defined for CBF and blood oxygenation in the brain [138]. Consequently, it
is absolutely not clear how a care intended to maintain the cerebral haemo-
dynamics parameter to a normal range would influence the rate of impaired
neurodevelopment and disabling conditions [25].
Monitoring the supply and consumption of oxygen by the brain can be
useful also for the adult population in a variety of conditions, involving the
necessity of intensive care [208]. In this thesis, I, instead, focus on monitoring
the evoked cerebral response to a stimulus. Specifically, monitoring cerebral
haemodynamics can be used to measure cerebral activity thanks to the prin-
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ciple of neurovascular coupling. When a brain region is activated and the rate
of oxygen consumption (CMRO2) in that region rises, the local cerebral blood
flow is increased to supply the metabolic demand [199]. The processes involved
in CBF recruitment are various, complex and not fully understood [185, 199]
but haemodynamic monitors are now heavily employed in functional studies.
Measuring cerebral evoked response is interesting for basic neuroscience knowl-
edge but it has also application in several pathological condition. For example
interest is growing on transcranial direct current stimulation (DC-tCS), a non-
invasive form of brain stimulation that applies weak direct electrical currents
from electrodes placed on the scalp [160, 179, 191]. It can have application
both in healthy subjects, for improvement of cognitive function, and for sev-
eral pathologic conditions [27]. Measuring cerebral response to the stimulation
has a two-fold interest. At this stage it is still not clear how the stimulation
works and what are the best protocols and dosages of application. Further-
more, it has been raised that the efficacy of the stimulation can be optimized
by a personalized protocol, for which it would be important to have an on-
line read-out of the effects of the stimulation, by measuring concurrently the
cerebral response [17].
I have here reported different conditions that solicit an enabling technology
that could provide continuous, non-invasive information of cerebral haemody-
namics at bed- or cot-side. In the following section I will explain how photons
of a selected range of the near-infrared can constitute “enabling” tools for
this purpose. This thesis is indeed focused on development and application of
diffuse optical technologies for monitoring brain haemodynamics, for clinical
purposes as well as for neuroscience.
1.1 Diffuse optics for haemodynamic monitoring
Biological tissue are relatively transparent to photons in a range of the near-
infrared (NIR) (between 650 and 950 nm) thanks to the low absorption of water
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Figure 1.1: Absorption coefficients in the NIR range of the main chromophores
(oxy- (HbO2) and deoxy-haemoglobin (HHb), water and lipids) at their typical
concentration values in tissue.
and blood [41]. This range is referred to as “physiological window” (figure 1.1).
In this wavelength range, biological tissues are diffusive media, photon prop-
agation is mainly ruled by scattering and several scattering events occur be-
fore photons are absorbed. Therefore photons propagate in a random-walk
and their propagation is described by a diffusion equation. In near infrared
spectroscopy (NIRS) absorption properties (figure 1.1) are characterized at
multiple wavelengths in order to retrieve information about oxy- (HbO2) and
deoxy-haemoglobin (HHb) concentration (cHbO2 and cHHb) [110].
The photon penetration depth depends on the experimental setup and on
the illumination but it is usually 1-1.5 cm. However, depth sensitivity can
be improved using short time pulses as the source and specific data analysis
methods [147]. It is therefore possible to use NIR light to probe relatively
deep tissue and, for example, reach the cerebral tissue by illuminating from
the surface of the head. Information retrieved with diffuse optics refer to the
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microvasculature of the tissue, because photons traveling in the arterial and
venous compartment are completely absorbed.
Different diffuse optical technologies are available, depending on the source
type [52]. Difficulties arise because, in order to obtain HHb and HbO2 con-
centration and consequently the tissue oxygen saturation (StO2=cHbO2/ctHb),
it is necessary to decouple the effect of scattering and the effect of absorption.
This requires to take advantage of more complex source of illumination.
In case a constant intensity light source is employed, only the light attenua-
tion after propagation in the tissue is detected. This is referred to as continuous
wave NIRS (CW-NIRS) and relates changes in attenuation to changes in HHb
and HbO2 concentration [41]. A single measurement does, therefore, not allow
an absolute estimation of the chromophore concentrations but only of changes.
Currently, various medical CW-NIRS devices are available, with the name of
oximeters [195]. Most of them infer the StO2 estimation from multi-distance
measurements.
More complex technologies that collect more information on the light prop-
agated into the tissue are necessary to solve both scattering and absorption
properties, hence to measure oxy- (HbO2) and deoxy-haemoglobin (HHb) in
their absolute concentrations. In frequency domain NIRS (FD-NIRS), inten-
sity modulated light is injected into the tissue and the amplitude and phase of
the emerging light measured. From multi-distance measurements it is possible
to retrieve absorption and scattering properties of the tissue [177, 224]. On
the other hand, in time resolved NIRS (TRS) [170], the light source is a short
pulsed laser whose shape after propagation into the tissue is studied. Differ-
ently from multi-distance FD-NIRS, from a single measurement it is possible
to obtain absorption and scattering properties of the tissue at the wavelength
used [35]. Moreover, the information in depth is naturally encoded in time
in a TRS pulse, since the photons arriving early have, on average, traveled
more shallow regions than photons arrived at later times. These are the ad-
vantages of TRS compared to FD-NIRS. Traditionally, FD-NIRS uses simpler
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and cheaper components, but research on TRS is pushing towards miniatur-
ization of components and improvement of cost-effectiveness [184]. Currently,
a FD-NIRS device is commercialized by ISS, USA (Imagent or MetaOx) not
as a medical but as a research device [29,210]. While a TRS device is commer-
cialized by Hamamatsu Photonics K.K., Japan (tNIRS-1) approved as medical
device only in Japan [69].
Dynamic properties of the tissue can also be studied with diffuse optics.
Moving scatterers, i.e. red blood cells, are present in the tissue and their
movement influence the coherence property of the emerging light. Diffuse cor-
relation spectroscopy (DCS) studies the electric field autocorrelation function
to retrieve information of the blood flow in the microvasculature of the tissue.
DCS has been commercialized by HemoPhotonics S.L., Spain (HemoFloMo)
and ISS, USA (MetaOx, integrated with a FD-NIRS device).
In the previous section I have highlighted how the current technologies
for measuring brain haemodynamics are not useful for monitoring the preterm
newborn brain, since they are either invasive or minimally invasive, not portable
and do not provide continuous measurements. Diffuse optical technologies can
overcome all these problems and the neonatology community has shown inter-
est since the early time of this technology [79]. The majority of commercial
cerebral oximeters (CW-NIRS devices) have indeed a version specific for neona-
tal and pediatric use and they can be found in selected neonatology units. In
addition, different randomized clinical trials have demonstrated that adding
cerebral oximetry to the standard clinical care can reduce the burden of cere-
bral hypoxia in preterm infants [96, 173]. In spite of this, currently available
monitors do not appear to be robust and accurate enough for accurately and
precisely monitor the oxygenation of the infant brain and neonatologist claim
that a further techology development is needed [78]. In addition these monitors
do not provide information on oxygen supply but only on the oxygenation, not
enough for characterizing some pathological conditions [21,25].
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1.2 Objectives
The present work of thesis is focused on the development of the integra-
tion of two diffuse optical technologies, diffuse correlation spectroscopy (DCS)
and time-resolved near-infrared spectroscopy (TRS), for concurrent continuous
monitoring of cerebral blood flow and oxygen consumption. This technological
development is focused towards hybrid device application in neuroscience and
in clinical monitoring of the premature newborn cerebral well-being.




• To develop a hybrid DCS and TRS device that could be used as a neuro-
monitor for term and premature newborns at the cot-side, being robust
and accurate
• To explore its limits of precision and accuracy through simulated data
with realistic noise
• To test the device in laboratory settings
Hybridization of a commercial DCS device and prototype for a
TRS device
• To develop the communication between the two devices in order to ac-
quire simultaneously with the two and minimize the cross-talk
• To test the hybrid device in laboratory settings
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Validation study of BabyLux device for CBF measurement
• To validate cerebral blood flow measurement by DCS with 15O-labeled
water positron emission tomography (PET) on a piglet model
Clinical studies to validate the BabyLux device in real-life settings
• To follow the cerebral haemodynamics during transition after birth in
healthy term newborns born by an elective cesarean section
• To assess the variability over replacement of the BabyLux probe in healthy
term newborns
Functional study
• To measure cerebral haemodynamics during and after transcranial direct
current stimulation of the frontal cortex
• To monitor concurrently cerebral haemodynamics and electroencephalog-
raphy (EEG) during and after transcranial direct current stimulation
1.3 Outline
This thesis is divided in three parts. The first part is dedicated to the the-
oretical and technical background. Chapter 2 explains the theory of photon
diffusion in biological tissue and how to derive a solution of the photon diffu-
sion equation. It also describes the theory for diffuse correlation spectroscopy.
Chapter 3 explains the basis for DCS and TRS instrumentation, how to sim-
ulate realistic data and how to perform DCS and TRS data analysis. The
second part of this thesis reports the work done in correlation with the Baby-
Lux project and with the BabyLux device. Chapter 4 describes the BabyLux
device and tests performed in laboratory settings, while chapter 5 explore the
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limits in accuracy and precision of the device through simulated data. Chap-
ter 6 reports the validation of CBF measurement by DCS towards 15O-labeled
PET on a piglet model, employing the BabyLux device. Chapter 7 shows re-
sults from the clinical studies run with the BabyLux device in two different
clinical centers. Specifically, cerebral haemodynamics has been monitored dur-
ing transition after birth in healthy term newborns. Another study aimed at
assessing the variability over replacement of the haemodynamic parameters on
the same population in the first day of life. The third and final part reports
the work done combining a commercial DCS device and a prototype of a TRS
device. In chapter 8 the development of the two device integration is explained
and results of test in laboratory settings shown. In chapter 9 results from
a study on healthy adult subjects is reported. Cerebral haemodynamics was
measured with the hybrid device, concurrently with EEG, during transcanial
direct current stimulation of the frontal cortex.
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Chapter 2
Interactions of light with
biological tissues
In this chapter I will describe the main physical processes that rule the prop-
agation of photons in turbid media within the realm of this thesis work, i.e.
absorption and scattering [148, 156, 221]. I will introduce the photon diffusion
equation and specify under which assumptions it can be used for photon prop-
agation in biological tissues. Afterwards, the photon diffusion equation will be
solved for the semi-infinite homogeneous medium and considering a short laser
light pulse as source type, this will be of interest for the experiments contained
in this thesis [148,170,211].
The last part of the chapter is focused on how dynamic properties can be
probed with diffuse optics by considering that part of the scatterers contained
in the tissue, the red blood cells, are moving. The diffusion equation for the
electric field autocorrelation function will be presented [19,20]. As before, it will
be solved for semi-infinite homogeneous medium but considering a steady-state
source [23, 52, 53]. This is the theoretical background for understanding time
resolved near infrared spectroscopy (TRS) and diffuse correlation spectroscopy
(DCS) that are the main technologies used in this thesis.
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2.1 Introduction
Two main processes interest the propagation of light in biological tissue, ab-
sorption and scattering. A molecule can absorb a photon and raise an electron
in an excited state. Consequently, the relaxation can happen with release of
heat, in a non-radiative process, or in a radiative process, emitting another
photon at a different wavelength. The former type of absorption event is what
interests the work presented in this thesis [148].
On the other hand, scattering refers to the elastic interaction of photon with
structural heterogeneities present into the tissue at the wavelength scale with
a different index of refraction than the propagation medium [156]. Scattering
events are associated to a change in direction of propagation.
The absorption coefficient describes the absorption property of the medium
and is defined as the probability of photon absorption in the medium per unit
infinitesimal path length [221]. Considering a medium with pure absorption,
attenuation of light with intensity I traveling in the z direction in the interval




By integrating the above equation Beer’s law is obtained for the transmittance
T (z)
T (z) ≡ I(z)
I0
= e−µaz (2.2)
Where I0 ≡ I(z = 0) is the incident light intensity. Typical biological tissue
value of µa is 0.1 cm
−1 in the range 650-950 nm.
Analogously, scattering coefficient µs is defined as the probability of photon
scattering in a medium per unit infinitesimal path length [221]. In a purely
scattering medium we can express the probability of no scattering events after
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which is also referred to as ballistic transmittance. Typical value for µs at the
wavelength typically used is 100 cm−1. In biological tissues, where photons
are both absorbed and scattered, we can define an extinction coefficient as
µt = µa + µs [156].
Biological tissues contain many scatterers randomly distributed in space,
therefore photons undergo multiple scattering events in their propagation.
Since the average distance between scatterers is large compared to the scat-
terer size and the wavelength used in diffuse optics, we can consider each of
the scattering event as independent [148]. Therefore, the optical properties of
the media are related to the optical properties of the single scattering particle,
described exactly by the Mie theory for spherical particles, or by the Rayleigh
theory if the spherical particles are far smaller than the wavelength [148].
The statistical meaning of the absorption and scattering coefficient ex-
plained above gives a set of useful typical length-scales that describes the prop-
agation of photon into the tissue. The reciprocal of the absorption coefficient is
the absorption length la, which is the mean length traveled by a photon before
being absorbed, while the reciprocal of the scattering coefficient, ls the scatter-
ing length, is the mean length traveled by a photon before being scattered. ls
is also referred to as mean free path. Referring to the typical values explained
above for µa and µs, la is typically 10 cm while ls is 0.01 cm.
In a medium where propagation of light is described by multiple scattering
events, photons accumulate change of direction in each of them up to a loss
of memory of the initial one. This defines another distance, the transport
mean free path ltr, which is the average distance traveled by photons before
their direction is completely randomized [164]. Its reciprocal is the reduced
scattering coefficient µ′s = (1 − g)µs, where g is the anisotropy factor and
represents the degree of forward scattering. In particular g = 0 defines the
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isotropic scattering, direction of propagation is randomized at each scattering
event, since ls = ltr. While g = 1 means that all the light is scattered in the
forward direction, the memory of the initial propagation direction is never lost
in this limit. Typical g values for biological tissue are approximately 0.9, quite
close to unity. Therefore ltr is typically 0.1 cm and its reciprocal µ
′
s is 10 cm
−1.
Figure 2.1: Schematic of fundamental length-scales of photon scattering into
a typical biological tissue. This refers to typical values for biological tissue of
µa=0.1 cm
−1, µ′s=10 cm
−1 and µs=100 cm
−1. After photon injection into the
tissue, the photon propagation regime is ballistic within a length of ls = 1/µs.
The direction of propagation will be completely randomized by several scatter-
ing events within a distance of ltr=1/µ
′
s. At this point photon propagation into
the tissue can be described as random walk. The third important length-scale
for photon propagation into the tissue is la=1/µa. This is not reported, being
typically 100 times greater than ltr and 1000 times larger than ls, i.e. 10 cm
in this example. All these values will depend on the specific tissue and on the
wavelength used. Figure inspired by Ref. [164].
The length-scales that describe the scattering properties of biological tis-
sue at the wavelength used in diffuse optics (650 nm-950 nm) are schematically
depicted in figure 2.1. Even if the scattering events are mainly in the forward
direction, the direction of propagation is ultimately lost, due to the accumula-
tion of several scattering events. This happens within a length of approximately
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0.1 cm and from this point photon propagation can be described as random
walk regime. Figure 2.1 omits the third important length-scale, i.e. the ab-
sorption length la. This is about 10 cm, therefore 100 times larger than ltr and
than the drawing reported.
2.2 Photon diffusion equation
In the section above the main processes that rule the photon propagation in
biological tissue are explained. An insight of the typical length-scale of this
propagation, when using photon in the range 650 nm-950 nm has been given,
highlighting that a random walk regime is reached after about 0.1 cm of prop-
agation. Since the typical length-scale for direction randomization (∼0.1 cm)
is much greater than the absorption length (∼10 cm), biological tissues are
diffusive media and photon propagation can be described as a diffusion process.
Two assumptions are necessary for using this formalism: 1) the radiance
(i.e. light power per unit area traveling in a certain direction) must be isotropic
and 2) the photon flux (i.e. a vector sum of the radiance emerging from
the infinitesimal volume) must vary slowly respect to the time scale 1/(vµ′s)
[148]. Both the requirements need the absorption to be small compared to the
scattering (µ′s  µa). In this way the propagation of photons is mainly affected
by the scattering and photons undergo long path-lengths and their direction
is randomized. In particular the mentioned time scale 1/(vµ′s) equals 0.004 ns
in a typical biological tissue (µ′s=10 cm
−1, index of refraction n=1.4). This
corresponds to a distance of 0.12 cm, far smaller than the absorption length
(typically 100 cm). Therefore photon flux is not expected to vary in such a
time scale.
We can thus write a diffusion equation for photon fluence rate Φ(r, t)(Wcm−2),
the total power per area going out from the infinitesimal value at position r
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and time t [221]:




here D(r) = v3(µ′s(r)+µa(r))
is the photon diffusion coefficient and v the velocity
of light in the medium. The photon diffusion equation (PDE), equation 2.4,
relates the time derivative of the photon fluence rate to the gradient of the
flux J(r, t) = D(r)∇Φ(r, t), the loss due to absorption and the gain due to
the source S(r, t). In homogeneous medium, where the diffusion coefficient is
space invariant, the PDE becomes




where D = v3(µ′s+µa)
. The photon diffusion coefficient is usually expressed
as absorption independent D ≈ v3µ′s using the assumption of µ
′
s  µa and
making the diffusion coefficient proportional to the transport mean free path
ltr [54,148]. In this way the effect of absorption in the PDE is purely expressed
in the loss term (−vµaΦ(r, t)).
2.3 Solution of the photon diffusion equation in time
domain for a semi-infinite homogeneous medium
In order to solve the PDE, the geometry of the source and the diffusive medium
must be defined. I will start considering a pulsed point source of unitary
strength at the origin of space and time, i.e. S(r, t) = δ(r)δ(t). Therefore
the solution found will be the Green’s function of the PDE. The most simple
geometry that can be imagined is a homogeneous infinite medium. In this case
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The homogeneous infinite medium is a geometry easy to solve but, unfor-
tunately, not usually applicable in real experiments, while the semi-infinite
homogeneous medium is a more realistic geometry. Here an infinite bound-
ary divides a diffusive from a non-diffusive medium. The boundary spreads to
infinite in the x-y plane while the diffusive medium spans from z = 0 to infi-
nite (figure 2.2). This is used when a large volume respect to source detector
separation is being probed and the photon launching and detector positions
are placed on the boundary of the medium. It must be noted that the source
is not isotropic but directional, being emitted from a fiber. This violates the
diffusion approximation since a directional source is not compatible with a
random walk type of propagation. Nonetheless, it has been proven that the
light source in this system can be approximated as an isotropic light source
emitting at a distance z+ = ltr = 1/µ
′
s from the boundary inside the diffu-
sive medium [59], provided that the source detector separation is large enough
respect to ltr (about 0.1 cm).
Boundary conditions must be defined to solve the PDE in this geometry.
The first boundary condition that will be here discussed is the partial cur-
rent boundary condition (PCBC) [84]. It considers the fact that photons that
emerge from the surface of the diffusive medium (Σ) do not enter back in the
medium. Therefore the light entering the medium at the boundary is only due
to the reflection of the radiance that emerges at the boundary into the non-
diffusing medium, which depends on the index of refraction mismatch of the
two media. It can be derived that in this case the following relation holds [148]:
[Φ(r, t)− 2AJ(r, t) · q̂]|r∈Σ = 0 (2.7)
where J(r, t) is the flux, q̂ the unit vector normal to the boundary surface Σ and
A = (1+Reff)/(1−Reff), Reff being the effective reflection coefficient to account
for the index mismatch between tissue and air. Its analytical expression is quite
complex but it can be derived through a linear least square fit. Its value for













Figure 2.2: Schematic of the extrapolated zero boundary condition for the semi-
infinite geometry. Here an infinite surface (Σ) separates a diffusive medium
(index of refraction ndiff) from a non-diffusive medium (n). Arrows indicate the
injection and detection point, separated by the distance ρ. The real source is
approximated by an isotropic source at a depth z+ = ltr. The horizontal dashed
line at −zb represent the extrapolated zero boundary surface. A negative source
is considered at z− = −2(zb + ltr). The solution of the PDE for this geometry
will be the sum of the contributions from the positive and the negative source.
an index of refraction of ndiff=1.4 for the turbid medium and n=1 for non-
diffusing medium is Reff=0.493 [84]. By using the Fick’s law that relates the
flux at the fluence rate, relation 2.7 becomes[







The PCBC is exact but difficult to use. For this reason an approxima-
tion has been introduced, called the extrapolated zero boundary condition
(EZBC) [52, 148, 170]. Assuming that the derivative of the fluence rate in the
non-diffusing medium remains constant at the value at the boundary, i.e. the
fluence rate is linear, the distance where the fluence rate is null can be extrap-
olated. This happens at a distance zb = 2AD from the surface. At this point
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the solution for the diffusion equation can be derived using the solution for the
infinite medium and the method of the imaginary point sources. The geometry
and the distance interesting for the problem are displayed in figure 2.2.
A solution for the fluence rate Φ(r, t) is found summing the contribution
of a positive source at distance z+ = ltr inside the diffusive medium and of
a negative source at a distance z− = −2zb − ltr in the non-diffusive medium.
Subsequently, Φ(r, t) is then inserted in the formula 2.7 to derive the reflectance





























The above equation represents the response of the system when a delta-shaped
pulse is injected in the tissue, i.e. the Green function of the system. However,
the real injected pulse has a finite width in time and this must be taken into
account. In this case the reflectance collected R̃(ρ, t) is the convolution of
the Green function with the real pulse shape, referred to as the instrument
response function IRF(t) [165].
R̃(ρ, t) = R(ρ, t)⊗ IRF(t) (2.10)
In the next chapter, I will show the shape of such curves and how they depend
on the tissue and experimental parameters (figure 3.1).
2.4 Diffusion equation for temporal correlation func-
tions
Photons diffusing in a turbid medium can also be used for probing the dynamics
properties of the medium itself, i.e. the movement of the scatterers. When a
laser beam of uniform intensity travels in a turbid medium, the intensity at
the surface is not uniform but presents regions of dark and bright spots [74].
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This is because photons have traveled different directions and path-lengths and
they can interfere constructively or destructively at the surface. The speckle
pattern emerging from biological tissue is not fixed in time, but the intensity
of each speckle fluctuates. These fluctuations are affected by the movement
of the scatterers, which, in biological tissue, is dominated by the movement of
red blood cells [158].
Probing the electric field emerging in a fixed point r, the electric field
autocorrelation function G1(r, τ) = 〈E∗(r, t)E∗(r, t+ τ)〉 can be calculated. It
gives a measurement of the loss of coherence between pairs of photons emerging
from the surface with a delay τ . The brackets in the G1(r, τ) formula refer
to the ensemble average for theory and to time average for experiments. This
equivalence requires the system to be ergodic, satisfied if only moving scatterers
are present in the probed region [19].
G1(r, τ) can be modeled as diffusing in the medium in a random walk man-
ner, like photons. It propagates ballistically until being scattered by a small
volume of sample and continues its ballistic propagation until being scattered
by another small volume of sample. All these scattering events contribute to
the correlation function and it itself depends on the movement of the scatterers
in all these single small volumes of sample. Therefore a diffusion equation can
be written for the electric field autocorrelation function G1(r, τ), analogously
to what I showed for the photon propagation in diffusive medium [20]. The
set of hypothesis is hence equivalent to what explained for the photon diffu-
sion equation (PDE). In particular photons must be diffusing and this is valid
when the mean free transport length ltr is smaller than the dimension of the
sample and the absorption length. The problem must be isotropic, therefore
the scatterers must be randomly oriented and their dynamics isotropic, like
in Brownian motion or random flow. The time assumption requires the cor-
relation time τ to be smaller than the time needed for a scatterer to move a
distance equal to a wavelength of light [19].
With this assumption the correlation diffusion equation (CDE) is the fol-










G1(r, τ) = −vS(r) (2.11)
D(r) is the photon diffusion coefficient previously seen; the square bracket
contains the gradient of the flux of the correlation and the loss of correlation
due to absorption and to the movement of the scatterers. α represents the
fraction of scattering events which occur from moving particles, k0 =
2π
λ , and
〈∆r2(τ)〉 is the mean square displacement of the scatterers. CW source and
steady state system are assumed, for this reason no temporal dependence is
expressed. In a infinite homogeneous medium and considering a delta-shape
















2.5 Solution of the diffusion correlation equation for
a semi-infinite homogeneous medium
The process to solve the CDE equation is equivalent to the PDE, but, differ-
ently to what has been done in section 2.3, a CW source is being considered.
Solution of equation 2.12 in an infinite homogeneous medium with a CW delta





As before, we consider a semi-infinite homogeneous medium and the extrap-
olated zero boundary condition (EZBC), as illustrated in figure 2.2. Summing
up contribution of a positive real source at position rs = (ρ = 0, 0, z = z+ = ltr)
and a negative source at position rs,− = (ρ = 0, 0, z = z− = −2zb − ltr) we















(z − ltr)2 + ρ2 as the distance between the detection point and
the positive source and r− =
√
(z + 2zb + ltr)2 + ρ2 as the distance between
the detection point and the negative source.
We have here an analytical solution for the electric field autocorrelation
function, however only the normalized intensity field autocorrelation function
g2(τ) = G2(τ)/G2(0) is measured experimentally, where G2(τ) = 〈I(t)I(t+τ)〉.
To link the intensity and the normalized electric field autocorrelation function
g1(τ) = G1(τ)/G1(0) we use the Siegert relation [132], valid for ergodic system
g2(τ) = 1 + β|g1(τ)|2 (2.15)
β is a parameter that depends on the number of speckles detected and the
injection and collection optics. β equals unity for an ideal experiment, while
β = 0.5 for ideal optics when using unpolarized light [230].
The shape of the g1(τ) and g2(τ) will be shown in the next chapter, as well
as their dependence on the tissue and experimental parameters (figure 3.3 and
3.4).
This chapter collected the basic theoretical background for DCS and TRS,
the two diffuse optical technologies exploited in this thesis’ work. The next
chapter will explain the experimental and data analysis strategies relevant for




The previous chapter focused on the basic theory of photon propagation into
biological tissue, while this chapter is focused on explaining how these models
can be used to extract interesting information about tissues.
In time resolved near infrared spectroscopy (TRS), biological tissues are
probed by injecting a short pulse of laser light and collecting it after few cen-
timeters of propagation into the tissue. The photon diffusion equation (PDE)
solution found in the previous chapter can be used to estimate the optical
properties of the tissue from the shape of the collected pulse. It is explained
here how to derive information on the oxygenation of the tissue by knowing the
absorption coefficient at different wavelengths. It will be also explained how, in
diffuse correlation spectroscopy (DCS), information about microvascular blood
flow is extracted by measuring the intensity fluctuations in the speckle pattern.
In this chapter, for each of the two technologies, the main requirements
for the instrumentation will be explained, while the instrument used in each
experiment will be described in details in the following parts of this thesis.
Furthermore, how to simulate DCS and TRS data with realistic noise will be
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illustrated as well as the data analysis methods used along the thesis.
3.1 Time resolved near infrared spectroscopy
In this technique short pulses of laser light are injected into the tissue. In the
experiments run through this thesis the pulse is then collected from the same
surface where the light is injected, in a reflectance geometry.
The reflectance (equation 2.9) measured at distance ρ from the source de-
pends on the optical properties and on the ρ itself [148,170]. Figure 3.1 shows
how the reflectance changes varying these three parameters. The increase of ρ
leads to a shift of the peak to the right and towards lower values, because pho-
tons have to travel more to reach the farther detector. An increase of µ′s has
the same effects on the peak, because it is associated to a decrease in the trans-
port mean free path ltr, hence to a increase in the path length traveled by the
photons. Increasing µa not only lowers the peak, because more photons are
absorbed, but it is also reflected in the tail of the curve.
The fact that µa and µ
′
s changes affect two different properties of the curve,
the tail and the center of mass respectively, suggests that from one single curve
acquired from a biological tissue we can estimate both µa and µ
′
s [35].
Estimation of the absorption coefficients at multiple wavelengths allows
for extraction of tissue chromophore concentrations [41]. To do so, the lin-






where ci is the concentration of each of the Nc chromophores and εi(λ) its
molar absorption coefficients.
It has been already mentioned that the relevant chromophores for wave-
lengths in the range 650 nm-950 nm are oxy- (HbO2), deoxy-haemoglobin
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Figure 3.1: Reflectance R(ρ, t) (given by equation 2.9) dependence on the
parameters ρ, µa and µ
′
s. The default value are ρ=3 cm, µa= 0.1 cm
−1 and
µ′s= 10 cm
−1. In the upper plot ρ varies between 2 cm and 5 cm by steps of
0.5 cm. In the bottom row, left figure, µa varies between 0.05 cm
−1 and 0.2
cm−1 with steps of 0.025 cm−1. While in the right figure µ′s varies between 4
cm−1 and 16 cm−1 with steps of 2 cm−1.
(HHb), water and lipids [41]. The number of wavelengths to be used must
equal at least the number of chromophores to be estimated. For brain appli-
cation, water concentration is assumed fixed and constant at literature values,
while lipids concentration is negligible. Three wavelengths are commonly used
to estimate HbO2 and HHb concentration, in order to have the system over-
estimated but still limit its complexity. Wavelengths must be chosen close
to the isosbestic point (800 nm) where effect of water and lipid is low and
HbO2 and HHb have a characteristic response (see figure 1) [52]. If water and
lipid content must be estimated, for example when the breast is the target
tissue, more wavelengths in a wider frequency range must be used [175].
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As suggested by equation 3.1 the molar absorption coefficients must be
known to estimate the chromophore concentrations. Table 3.1 reports the
molar absorption coefficients used in this thesis at the wavelengths of interest
[149,178].




685 6.36× 10−4 4.73× 10−3 4.72× 10−3
760 1.35× 10−3 3.57× 10−3 2.94× 10−2
785 1.70× 10−3 2.20× 10−3 2.50× 10−2
820 2.11× 10−3 1.60× 10−3 2.41× 10−2
Table 3.1: Molar absorption coefficients of HbO2, HHb [178] and absorption
coefficient per volume fraction of water [149] at the wavelengths (λ) of interest.
HbO2 and HHb concentration (cHbO2 and cHHb) allows for determination of
blood volume, i.e. concentration of total haemoglobin (tHb) and of oxygen sat-
uration StO2=cHbO2/ctHb. The t subscript refers to tissue oxygen saturation,
i.e. blood oxygen saturation in the microvasculature of the tissue.
3.1.1 Basic instrumentation
Here, I will describe the basic principle of the instrumentation used for a TRS
experiment. Light sources employed are near-infrared pulsed lasers, with a
full width half maximum (FWHM) of few hundreds of ps [211]. As previously
mentioned, three wavelength are used in order to be able to estimate concen-
tration of two chromophores (HHb and HbO2). Optical fibers in contact with
the tissue deliver the laser light from the device to the tissue of interest. Few
cm away from the injection fiber another fiber collects the light that has prop-
agated into the tissue. This is detected by a photon detector, traditionally a
photocathode-based device [174]. The detector’s output is a voltage pulse that
marks the arrival time of each photon. This information is fed to a time cor-
related single photon counting (TCSPC) board that builds the distribution of
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time of flight of photons (DTOF), i.e. the histogram of arrival time of photons
with respect to the injection time of the pulse.
It was previously explained that the instrument response function IRF(t)
must be known to do the convolution with the response to a delta-shaped
pulse (equation 2.10). The IRF(t) is generally obtained by acquiring a TRS
measurement facing the injection and the detector fibers. Therefore it depends
not only on the laser source but also on the detection system [202].
3.1.2 Curve simulation with realistic noise
The analytical formulas derived in chapter 2 can be used to simulate TRS data,
to which realistic noise can be added. A schematic of the simulation process to
obtain simulated TRS curves is depicted in the upper row of figure 3.2, going
from left to right.
First of all HbO2 and HHb concentration values (cHbO2 and cHHb) and per-
centage of water with respect to the total chromophores concentration (c′H2O)
are defined. This allows to calculate the absorption coefficients, at each wave-
length of interest, through equation 3.1:





where εHbO2 , εHHb and ε
′
H2O
are reported in table 3.1. On the other hand,
scattering properties are derived from Mie theory, which defines how µ′s(λ)







where λ0 is a reference wavelength set to 600 nm and a and b are parameters
that depend on the tissue [153,157].
At this point, the reflectance in time resolved regime R(t) is derived ex-
ploiting equation 2.9, and convoluted with the Instrument Response Function
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Figure 3.2: Schematic of the flow for TRS (top row) and DCS (bottom row)
curve simulation (from left to right). After definition of HbO2 and HHb con-
centrations and a and b parameters to obtain µa(λ) and µ
′
s(λ), reflectance
R(λ, t) in time domain is calculated and convoluted with the instrument re-
sponse function IRF(t). Noise is added and the curve is eventually shifted by
t0 to obtain R
sim(λ, t). In order to simulate DCS curves, a BFI level is chosen
and the normalized electric field autocorrelation curve gmodel1 (τ) calculated.
Afterwards, the Siegert relation is used and noise is added to derive gsim2 (τ).
IRF(t) of the system to obtain Rmodel(t). Next step requires to add realis-
tic noise to obtain the simulated time-resolved curve Rsim(t). This technique
is essentially affected by Poisson noise, being the measured light intensity at
a certain time determined by counting the photons having the same time of
flight [16]. Finally, the simulated curve could eventually be shifted by t0 in
order to simulate instability in the temporal TRS laser position. One curve for
each wavelength of interest is generated.
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3.1.3 Data analysis
Along the thesis, multiple TRS data analysis methods are used. All of them
will be described in this section and for each experiment the method used will
be explicitly reported.
To start with, experimental and simulated TRS data can be analyzed fol-
lowing the flow presented in figure 3.2 in the opposite direction (from right to
left) respect to the simulation process. The DTOF curve simulated or mea-
sured is compared to the model Rmodel(t) obtained from equation 2.10 by a
Levenberg-Marquardt procedure that minimized the least square error between
the two [202]. The fitting range includes all points with a number of counts
higher than 90% of the peak value on the rising edge of the curve and 1% on
the falling edge. The absorption, the reduced scattering coefficient and t0, the
shift of the TRS laser peak, could be considered as fitting parameters [35].
Usually t0 is kept fixed in the analysis since there is not enough power to esti-
mate three parameters, especially if count rate is not considerably high. This
choice will be described for each experiment presented along the thesis. This
type of analysis allows for estimation of absolute values of optical properties at
three wavelengths. Thanks to this, the absolute concentrations of HbO2, HHb
and tHb and the oxygen saturation StO2 can be calculated.
TRS data can be analyzed using purely the information about the intensity
of the collected pulse and its change during time, that can be related to the
change in time of chromophore concentrations. This is a way to simulate what
a single-distance CW-NIRS device would measure and it will be referred to
as DPF analysis [52]. First, the quantity optical density OD is introduced as
OD ≡ −ln(I(rd, t)/I(rs)), where I refers to the intensity and rs and rd to the
source and detection position, respectively. I(rs) is thus the intensity injected.
The quantity measured is the change in the optical density at time t respect
to baseline
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∆OD(λ, ρ, t) = −ln
(
I(rd, t)
I(rd, t = 0)
)
where ρ is the distance between rs and rd.
Assuming that the changes in the optical properties (∆µa and ∆µ
′
s) are small
compared to their baseline values (µ0a and µ
′0
s ), the optical density expression
can be truncated at the first order of the Taylor expansion [52]











Subsequently, the change in µa can be expressed as a function of the change in
chromophore concentrations. Assuming that the scattering is unchanged and
defining da ≡ ∂OD(µ0a, µ′0s , ρ)/∂µa, we have




Usually it is assumed that da(ρ, λ) = DPF(λ)ρ, where DPF(λ) is a differential
path-length factor not dependent on ρ [51]. Thanks to equation 3.5, changes in
OD at multiple λ can be used to obtain changes in chromophores concentration,
specifically HHb and HbO2.
The last method here explained has been developed in order to improve
the sensitivity of TRS measurement to the deeper layers of the probed tissue
(e.g. the cerebral cortex when measuring the brain) and reduce the influence of
the contribution of the more superficial layers (e.g. the extra-cerebral tissue).
Different moments of the DTOF are considered to extract this information






When considering an experimental DTOF the integral is substituted by a fi-
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nite summation over the time channels [135]. Therefore, the 0th moment cor-
responds to the total counts of the DTOF
m0 = NTOT =
∑
Ni





The variance of the DTOF V is defined as the second centralized moment [136]




The relationship between these three moments and the changes in absorption
can be considered linear, provided that the changes are small.
The different moments are used to retrieve absorption changes from differ-
ent layers of probed tissue, if TRS data are acquired at different source detector
separations and if the thickness of each layer is known [136,137]. In this thesis
this method is used considering the probed tissue and the absorption change
as homogeneous and considering the linear relation between the absorption
change and the change in variance
∆V = VSF∆µa (3.7)
where VSF is the sensitivity matrix, usually obtained by Monte Carlo simu-
lation. In this way, the only improvement in sensitivity to the deeper layer
respect to the traditional analysis is purely due to the sensitivity of each mo-
ment to the different layers. Interestingly, the variance has found to be more
sensitive than the attenuation to the deeper layers respect to the superficial lay-
ers [135]. Therefore, this method, even if applied to an homogeneous medium
assuming homogeneous change, is more sensitive to changes in the deeper layer
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than the DPF analysis, which uses the 0th moment [108].

















Figure 3.3: Example of electric field autocorrelation function g1(τ) (left side)
and intensity field autocorrelation function g2(τ) (right side). The horizontal
dashed line represent the value of g2(τ = 0) = 1 + β.
The diffusion theory for the normalized electric field autocorrelation func-
tion g1(τ) was explained in the previous chapter, as well as the derivation
of the analytical solution in a semi-infinite homogeneous medium [23, 52].
Figure 3.3 reports an example of g1(τ) (equation 2.14) and of the intensity
field autocorrelation function g2(τ), which are linked by the Siegert relation
(g2(τ) = 1 + β|g1(τ)|2) [132]. The decay rate of the g1(τ) curve depends on
the mean square displacement of the scatterer particles 〈∆r2(τ)〉 [20]. It has
been shown that the Brownian model is the best choice to describe diffusion
of red blood cells in the microvasculature, therefore 〈∆r2(τ)〉 = 6DBτ where
DB is the particle diffusion coefficient [22, 52]. The parameter extracted from
analysis of DCS curve is the blood flow index BFI= αDB, where α is the
ratio of moving scatterers over the total scatterers (see equation 2.14). BFI
is proportional to the blood flow and it has units of cm2/s, being a diffusion
coefficient [22]. The dependence of the electric field autocorrelation function
g1(τ) on the BFI is depicted in figure 3.4 together with the dependence on the



































Figure 3.4: Dependence of the electric field autocorrelation function g1(τ) given
by equation 2.14 on the parameters BFI,ρ, µa, µ
′
s. The default value are BFI
= 1 × 10−8cm2/s, ρ = 3 cm, µa= 0.1 cm−1, and µ′s= 10 cm−1. In the upper
row, graph on the left, BFI varies between 0.4 ×10−8cm2/s and 1.6×10−8cm2/s
by steps of 0.2× 10−8cm2/s. While, in the right figure, ρ varies between 2 cm
and 5 cm by steps of 0.5 cm. In the bottom row, left figure, µa varies between
0.05 cm−1 and 0.2 cm−1 with steps of 0.025 cm−1. While in the right figure
µ′s varies between 4 cm
−1 and 16 cm−1 with steps of 2 cm−1.
source detector distance ρ and on the optical properties. The higher the blood
flow, the higher the BFI and the curve decays faster. The effect is similar for
the µ′s, as can be expected from equation 2.14, where the BFI and the square
of µ′s are coupled.
3.2.1 Basic instrumentation
DCS uses a long coherence length laser as the injection source [53]. This
property is necessary in order to not influence the coherence of the emerging
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photons. In general the coherence length must be larger than the longest path-
length traveled by the photons in the tissue. Laser light is coupled to the tissue
with a multi-mode optical fiber. Collection is done preferably with a single
mode fiber in order to collect the intensity from a single speckle and not lower
the beta, to not compromise the signal-to-noise ratio (SNR), as suggested by
figure 3.3. The collection fiber is connected to a single photon counting detec-
tor, usually a single photon avalanche photodiode (SPAD) [29]. The detector
output is a TTL marking the arrival time of each photon. This signal is fed to
a hardware correlator, which uses the difference of time of arrival of all pairs
of photons to build the intensity autocorrelation function g2(τ). The τ is dis-
cretized in the hardware correlator by defining time windows, referred to as
bins, being τ the center of each bin. The definition of the time bins depend on
the correlator design.
3.2.2 Curve simulation with realistic noise
Simulation process for DCS curves is explained in the bottom row of figure 3.2.
Analytic expression for the gmodel1 (τ), as expressed in equation 2.14 [20, 52], is
calculated using the desired BFI value. Once defined the value for β and em-
ploying the Siegert relation (equation 2.15), gmodel2 (τ) is calculated. Afterwards
noise is added to obtain gsim2 (τ).
An analytic expression for DCS noise is calculated in [231] and gives the






(1 + e−2ΓTm)(1 + e−2Γτ + 2m(1− e−2Γτ )e−2Γτ )
(1− e−2ΓT )
+
2〈nm〉−1β(1 + e−2Γτ ) + 〈nm〉−2(1 + βe−Γτ ]1/2 (3.8)
Here Tm is the correlator bin time interval of the m
th bin, tav is the averaging
time and 〈nm〉 is the average number of photons within the bin time Tm and
it can be expressed as 〈nm〉 = ITm, with I the measured photon count rate.
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Lastly, Γ is the decay rate of g1(τ) and it is obtained by fitting the electric field
autocorrelation curve with an exponential decay model, as g1(τ) = e
−Γτ .
3.2.3 Data analysis
Simulated and experimental DCS curves are analyzed following the reverse of
the simulation process. From g2(τ), g1(τ) is obtained through the reverse of the
Siegert relation by estimating β from a weighted average of the first three points
of the g2(τ) curve or assuming a fixed value for it. The retrieved g
sim
1 (τ) is then
compared to the model, with BFI as the fitting parameter, using as a fitting
range the τ where g1(τ) < 0.5. Optical properties are introduced as input
parameters of the analysis process, because it is not possible to accurately
extract, from a single DCS curves, both the optical properties and the BFI
[48]. Multi-distance or multi-wavelength measurements are necessary for this
[61,207].
In the experiments reported in this thesis, concurrent DCS and TRS mea-
surements are available, therefore optical properties measured by TRS are used
in DCS analysis. In principle, this helps the accuracy of BFI estimation com-
pared to using literature values for optical properties.





BabyLux device and its test
in laboratory settings
The second part of this thesis reports the work done in relation with the Baby-
Lux project (January 2014 - April 2017, http://www.babylux-project.eu/),
whose aim was the development of a robust and accurate device based on diffuse
optical technology that could be employed as a neuro-monitor for the prema-
ture newborns. In this chapter, the device which integrates DCS and TRS is
described, reporting in details the hardware, the software and the probe. Re-
sults of tests in laboratory settings, both on phantoms and in vivo, developed
in order to test the accuracy, precision and stability of the device, are shown.
The device was developed in a collaboration among the technical partners
of the project, which defined the task to be developed by each of them. Specif-
ically, PicoQuant GmbH (Berlin, Germany) has provided most of the photonic
components for the device. On the other hand, Loop-Competitive Design Net-
work (Sant Cugat del Vallès, Barcelona) has designed and built the external
chassis of the device, while Fraunhofer Institute for Production Technology
IPT (Aachen, Germany) has designed and built the probe. The main partners
involved in the device development were ICFO (Barcelona, Spain), Diparti-
42 BabyLux device and its test in laboratory settings
mento di Fisica of Politecnico di Milano (Milano, Italy), and HemoPhotonics
(Castelldefels, Spain). In particular, ICFO was in charge of the DCS module,
while Politecnico di Milano of the TRS module. On the other hand, HemoPho-
tonics main role was to develop the integration of the two modules into one
device. Since my PhD was co-supervised by ICFO and HemoPhotonics, I have
worked in the tasks assigned to the two institutions. In addition, I have fol-
lowed closely the tasks of the other technical partners, in order to make sure
that all the different parts were developed considering the final, integrated
device. Finally, once the module components were chosen and the chassis de-
veloped, I have built the device under the supervision of HemoPhotonics and
I have coordinated and performed the tests in laboratory settings.
The results reported in this chapter are contained in the manuscript Gio-
vannella, M., Contini, D., Pagliazzi, M., Pifferi, A., Spinelli, L., Erdmann, R.,
Donat, R., Rocchetti, I., Rehberger, M., König, N., Schmitt, R., Torricelli,
A., Durduran, T., Weigel, U. M. (2019). “BabyLux device: a diffuse optical
system integrating diffuse correlation spectroscopy (DCS) and time resolved
near infra-red spectroscopy (TR-NIRS) for neuro-monitoring of the premature
newborn brain.”, Neurophotonics, submitted.
4.1 The device
The BabyLux device can be used in two different configurations. Figure 4.1(a)
shows the main unit which contains the optical and electronic components
and the screen in its desktop configuration. In addition, the main case can be
supported by a custom cart as depicted in figure 4.1(b). The cart consists of an
upper drawer for storage purposes and a bottom drawer for an uninterruptible
power source (UPS) battery (HAT 1101S, Hectronica, Spain) and for a medical
grade isolator transformer (REO España 2002 S.A.). Wheels make the device
portable.
A schematic of the main optical and electronics components of the DCS
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(a) (b)
Figure 4.1: The BabyLux device in its desktop configuration (a) and on its
custom cart (b).
and TRS module are presented in figure 4.2. The TRS module uses three
pulsed laser diodes heads at 685 nm, 760 nm and 820 nm (PicoQuant GmbH,
Germany, pulse duration < 100 ps and average power < 1 mW), driven by a
compact pulse driver at 20 MHz (PicoQuant GmbH, Germany). The electri-
cal connection between the pulse driver and the laser heads have a different
length for each of the three lasers in order to introduce different temporal de-
lays between the pulses. Each branch of pulsed light is divided by a 96%/4%
fiber splitter (OZ Optics LTD., Canada). The 4% branch of the splitter is
attenuated (OZ Optics LTD., Canada), combined into a single fiber connector
(Lightech SRL, Italy) and sent directly to the detector (PicoQuant, Germany)
(dashed red lines in figure 4.2) to monitor the temporal drift of the TRS lasers.










































Figure 4.2: Schematic of the principal optical and electronic components of
the BabyLux device. Red lines represent optical fibers while black lines are
electronic connections.
The 96 % branch is directed to motorized software-controlled attenuators (OZ
Optics LTD., Canada) and then, to the front panel of the device. At the de-
tection side, the light is collected by an optical coupler and delivered to the
detector (PicoQuant, Germany). The optical coupler combines the signal and
the reference branches and contains a triple band pass filter (AHF Analysen-
technik AG, Germany) to reduce the detection of the ambient light and the
cross talk by the DCS signal. The output of the photon counting detector is fed
into the time correlated single photon counting (TCSPC) board (PicoQuant
GmbH, Germany) to reconstruct the distribution of time of flight (DTOF) of
the detected photons.
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Figure 4.3: Screen-shot of the home window of the device during a cuff occlu-
sion of an adult arm. Time series of the oxygen saturation (top) and relative
BFI (bottom) are reported in the time plot. Color dots on the right top corner
represent the optical quality of the data collected and the attachment of the
probe as monitored by a capacitive sensor placed on the probe.
DCS module employs a long coherence length continuous wave laser at 785
nm at the source side. The laser light passes through a band pass optical
filter centred at 780 nm and with 20 nm of band-width (Semrock Inc., U.S.A.)
before being connected to the front panel. The filter’s purpose is to cut the
tails in the spectrum of DCS light, in order to have it fully blocked by the band
pass filter in front of the TRS detector. A manual attenuator is adjusted in
order to reach a power of approximately 20 mW at the probe head. Two single
photon avalanche detectors are used at the detector side (PicoQuant GmbH,
Germany). Their input FC/PC connectors are directly placed in the front panel
of the device. The detectors’ output is a train of TTL pulses marking the arrival
46 BabyLux device and its test in laboratory settings
time of each photon. This is fed into a two-channel autocorrelation board
(HemoPhotonics S.L., Spain) which calculates the intensity autocorrelation
function of each signal.
The device is powered by two power supplies. An advanced technology
extended (ATX) medical grade power supply, which provides 180 W, in voltage
lines at 3.3 V, 5 V and 12 V, and a 24 V, 3.5 A power supply.
4.1.1 Software
A software developed by HemoPhotonics S.L. (Castelldefels, Spain) is used for
the acquisition of both DCS and TRS measurements and for the communication
with all the optical and electronic components of the device. The software,
written in C++ language and running in Linux (Kubuntu 14.04) environment,
was designed in order to be user-friendly. A normal user has access to the
home window displayed in figure 4.3. The quality of optical data (for example
the signal-to-noise ratio, stability, various parameters) is assessed on-line and
is shown to the user with a color code (green for good, orange for intermediate
and red for low quality) in the top right corner. The on-line analysis of the
data is performed by procedures provided by ICFO for DCS and Politecnico
di Milano for TRS and the results of all the hemodynamic parameters and
a plot following their time evolution are shown in real-time. An example is
given in figure 4.3 from the occlusion of an adult arm. Advanced users can
use windows where raw DCS and TRS data curves are shown, whose screen-
shots are displayed in figure 4.4. The intensity autocorrelation curve is shown
for DCS (figure 4.4(a)) together with a time line of the relative BFI. In TRS
data windows (figure 4.4(b)), both the reference and the DTOF peaks are
shown for the three wavelengths. The IRF, measured usually before the actual
measurement, is also displayed. In the bottom part of the window, results for
the optical properties are shown on-line, while in the right side of the screen
the DTOF statistic parameters (position of the peak, width, total counts) are
reported. From these windows, available for advance users, acquisition and
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(a)
(b)
Figure 4.4: Windows for the advanced users of the BabyLux device software.
(a) Intensity autocorrelation curve and the on-line results for the relative BFI
are shown for DCS. (b) DTOF and reference peak for each of the three wave-
lengths are shown for TRS, together with results for the optical properties.
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analysis parameters can be changed.
All the measurements reported in this thesis are acquired with 1 s of aver-
aging/accumulation time.
4.1.2 Probe
Type core NA Provider
DCS
source MM 400 µm 0.39 Thorlabs, Germany
detector SM 4.4 µm 0.13 Thorlabs, Germany
TRS
source MM, GIF 62.5 µm 0.21 Thorlabs, Germany
detector MM, GIF, POF 1 mm 0.3 FIBERFINN, US
Table 4.1: Launching and detection fibers used in BabyLux probe, both for
DCS and TRS. Abbreviations: NA, numerical aperture; MM, multi-mode;
SM, single-mode; GIF, graded-index fiber; POF, plastic optical fiber.
Table 4.1 reports the details of the fiber used for light launching and de-
tection in the BabyLux probe. Four fibers are used for light launching, one for
DCS and three for TRS, one each wavelength, that shine in the same position.
Two single mode fibers are used as the detection fibers for DCS, one for each
detector, and one for TRS.
A monolithic small and lightweight probe has been built by Fraunhofer
Institute for Production Technology (IPT, Aachen, Germany) to encase all the
seven fibers. A picture of the probe is presented in figure 4.5 with a schematic
of the source and detector fiber positions. Prisms are used to deflect the light
in the perpendicular direction with respect to the surface of the probe which
is sealed by sapphire windows to protect fiber tips and prisms. For both DCS
and TRS, the distance between source and detector is 15 mm. A second DCS
detector is placed at 5 mm distance from the DCS source to follow changes in
the superficial extracerebral tissue.
A capacitive sensor is implemented in the probe in order to check whether
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this is in contact with the skin. The state of the capacitive sensor is displayed
in the home window, as shown in figure 4.3, with green and red to indicate
attachment and displacement of the probe, respectively. This is also utilized
for laser safety purposes.
The instrument response function (IRF) is measured by placing the probe
over a reflective surface. A dedicated case to hold the probe in this position












Figure 4.5: On the left side a picture of the head of the probe is shown. On the
right side a schematic highlights the positions of the fibers and the distances
between the pairs of source and detector fibers. A schematic explaining the
mounting of the fibers and the prisms is also presented.
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4.2.1 Methods
Phantom tests
MEDPHOT protocol [176] was applied to assess the performance of the TRS
module using a phantom kit of twenty-four solid phantoms, with three different
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µ′s (nominal values 5, 10, 15 cm
−1 at 660 nm) and eight different µa (nominal
values from 0 cm−1 to 0.49 cm−1 in 0.07 cm−1 steps at 660 nm).
This protocol is divided in five assays, a sixth one was added since relevant
for the clinical measurement planned with the BabyLux device. The six assays
are the following:
1. Accuracy: This test is designed to quantify the error made by the
device on the optical property estimation. The error was defined as
ε = 100× (xmeas−xconv)/xconv, where xmeas was the quantity measured
by the BabyLux device and xconv the conventionally true value, obtained
by measuring each phantom with a broadband TRS system with high
temporal resolution.
2. Linearity in µa and µ
′
s: Measured µa values were plotted versus the
conventionally true ones. In this case the measurements should ideally
lie in a line passing trough zero with 45◦ slope. On the other hand, the
measured µ′s were plotted versus the conventionally true values of µa.
Therefore, they should ideally lie in three horizontal lines corresponding
to the three conventionally true values of µ′s.
3. Noise (or precision): Thirty continuous measurements were acquired on
one phantom with nominal optical properties of 10 cm−1 for µ′s (690 nm)and
0.1 cm−1 for µa (690 nm) at different count level, in the range 10
3-108. In
order to quantify the precision, we used the coefficient of variation (CV)
over the thirty measurements x = [x1, ..., x30], i.e. CV= 100× σ(x)/〈x〉,
where σ(x) is the standard deviation and 〈x〉 the averaged value.
4. Stability: The same phantom used in the previous point was measured
for approximately 10 hours after the device had been switched on. The
time series of the derived optical properties was plotted to check the
time necessary for reaching their final values, i.e. the warming up of the
device, and to check the eventual presence of drifts or fluctuations.
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5. Reproducibility: The same phantom was measured over five different
days, at the same experimental conditions. Averaged value of optical
properties over all the five days was calculated as well as the percentage
deviation on each day with respect to them.
6. Reproducibility over probe replacement: The same phantom was mea-
sured over five different days, at the same experimental conditions. The
probe was placed on the phantom, thirty measurements were acquired,
then the probe was lifted, placed back on the phantom surface and other
thirty acquisitions run. This was done until six sets of measurement were
acquired. The coefficient of variation (CV) over the six replacements was
calculated for each of the five days.
All the described measurements were acquired collecting 105 photon/s, if
reachable, apart from point (3).
In order to test the DCS module, a liquid phantom provided by HemoPho-
tonics S.L., Spain [169] was employed in the last three points of the above
protocol (stability, reproducibility and reproducibility over probe replacement
). This phantom had nominal optical properties of 0.17 cm−1 and 7 cm−1 at
785 nm and a nominal particle diffusion coefficient of 1×10−8cm2/s.
Finally, to quantify possible mutual cross-talk between TRS and DCS, we
have acquired thirty TRS and DCS measurements on a same phantom both
simultaneously (i.e. DCS on and TRS on) and independently (i.e. DCS on
and TRS off, or vice versa). Optical and dynamic properties are estimated in
the two modes and mean and standard deviation of the thirty measurements
calculated.
In vivo protocol
A protocol for arterial cuff occlusion of the arm was implemented on healthy
adult volunteers to test the device in relevant settings closer to the operational
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ones. This test was previously proposed as a controlled and easy to repeat test
to check the in vivo performance of cerebral oximeters [97].
The studies were approved by the ethical committee of the Hospital Clinic
Barcelona. Each subject signed an informed consent and the study was con-
ducted according to the principles of the Declaration of Helsinki. The inclusion
criteria was a skin-fold thickness of less than 8 mm as measured by a skin cal-
iber. The probe was placed on the upper part of the flexor muscle of the lower
arm. After two minutes of rest, arterial cuff occlusion at 230 mmHg was main-
tained for six minutes. The cuff was deflated and seven more minutes were
recorded. This protocol was repeated three times sequentially for each subject
in the same session.
Data analysis
In the following section, results from off-line data analysis are explained. The
fitting procedure explained in chapter 3 was implemented both for TRS and
DCS. Few words must be spent on t0, the shift of the TRS laser peaks. The
time t= 0 ps represents the photon launching time and it is considered as
the peak of the IRF in the realistic case when the injected pulse is not a
delta pulse. This holds true if IRF is measured by directly facing the source
and detector fibers [165]. Since we have measured the IRF in a reflectance
geometry, with some distance from the reflecting surface, a shift of the peak
t0 must be considered. This parameter was calibrated by measuring a solid
phantom with known optical properties. We have used the model explained
above for the fitting procedure and a spectral fit was performed by defining a
spectral constraint for the reduced scattering coefficient according to the Mie
theory. Specifically, µ′s(λ) = a(λ/λ0)
−b [105, 153, 157] where λ0 is a reference
wavelength and a and b are parameters that depend on the scatterers size
and density. Curves at the three wavelengths were then fitted simultaneously
considering µa(λ), a, b and t0 as fitting parameters in order to define the best
value for t0.
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Once t0 was obtained for this system, the measured DTOF could be shifted
with respect to the IRF and analyzed by fitting the DTOF with the model R̃(t).
An estimation of optical properties (µa(λ) and µ
′
s(λ)) for each wavelength was
derived.
The same procedure was implemented in the on-line data analysis. There-
fore the same results would have been obtained, provided that the same pa-
rameters were selected in the software.
As for the in vivo measurement, the response in each of the three occlusions
was characterized by extracting the level of BFI and StO2 reached during
occlusion and after releasing the cuff. In order to test whether the response
differed over multiple occlusions, a linear mixed effects (LME) model for those
two variables was built with number of occlusion as fixed effect and subject as
random effect.
4.2.2 Results and discussion
Figure 4.6 shows examples of IRFs and DTOFs acquired at the three wave-
lengths with the BabyLux device from a solid phantom. The curves resulted
from the analysis are also shown and the vertical bars highlight the range used
for the analysis. Analogously, g2 measured from a liquid phantom by the DCS
module is also shown, together with the results of the fit analysis and the range
used for the analysis.
Phantom tests
As explained in the Methods section, the MEDPHOT protocol [176] was ap-
plied to assess performance of the TRS module. I will start explaining results
of the five assays of this protocol, plus the one added specifically for this device.
1. Accuracy. Tables 4.2 and 4.3 report the error in optical properties esti-
mation with respect to the conventionally true values. Value of interest
for application in infant neuro-monitoring is 0.2 cm−1 for µa and 7 cm
−1
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Figure 4.6: IRF and example of DTOF (collected from a solid phantom) are
shown for the three wavelengths (a) 685 nm, (b) 760 nm, (c) 820 nm. The
solid line represent the results of the fitting procedure. In (d), a DCS measured
normalized, intensity auto-correlation curve collected from a liquid phantom is
depicted, together with the results of the model, solid line. The black vertical
lines highlight the region used for the fitting procedure.
for µ′s [39]. Focusing on the phantom with optical properties of this
range we find an accuracy of around 6-8% for µa at 685 nm and 760 nm
and of about 8% at 830 nm. While the deviation for µ′s is around 10%
at the three wavelengths. This is comparable with other TRS devices
performance [176] and with the intrinsic limits of employing the photon
diffuse equation [35, 202]. It was fundamental to assess the accuracy in
estimation of the optical properties for different reasons. Firstly, the ab-
solute measurement of HHb and HbO2 concentrations and consequently
of StO2 depends on the possibility to measure the absolute values of the
optical properties of the tissue, in other words, on decoupling µa and
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µ′s. In addition, the optical property values are needed for the blood
flow index estimation, since they are the input parameters of DCS anal-
ysis. It must be highlighted that the accuracy is tested not towards
the true optical properties but towards the conventionally true values.
This is motivated by the fact that assessing the true optical properties is
particularly challenging, mainly because the accurate characterization of
optical properties of the individual constituents of the phantoms is not
feasible [176]. The conventionally true values have been obtained mea-
suring the phantoms with a tunable multi-wavelength system. Optical
properties were estimated with a resolution of 5 nm and using a spectral
fit and measurements over several months have been averaged. In spite
of this, the conventionally true values cannot still be considered as the
true optical properties, therefore the MEDPHOT protocol tests a device
accuracy towards the state-of-the-art and not the true values [176]. In
addition, the accuracy in in vivo measurements is a different and more
complicated issue. This can be assessed by testing the device against
gold-standards (chapter 6 for the DCS) or checking the performances in
clinical settings (chapter 7).
2. Linearity in µa and µ
′
s. Left column of figure 4.7 shows the linearity
of the system for absorption measurement by showing the behavior of
µa estimation with respect to the conventionally true values for µa. The
black line represents the expected values, therefore the distance of each
point from this line gives an additional indication of the accuracy of the
estimation. The right column of the same figure (figure 4.7) reports the
measured µ′s with respect to the conventionally true values for µa in
order to show the coupling of µ′s to µa. The horizontal lines represent
the expected values for µ′s. Linearity is good for low values of µa, while a
coupling between µa and µ
′
s affect results at higher values of absorption.




µa conventionally true 5.9 cm
−1 10.7 cm−1 14.2 cm−1
0.01 cm−1 -42% -2% -5%
0.07 cm−1 -6% -5% -5%
0.14 cm−1 -9% -10% -13%
0.20 cm−1 -4% -6% -8%
0.27 cm−1 -6% -8% -10%
0.33 cm−1 0% -10% -13%
0.40 cm−1 -4% -8% -13%
0.46 cm−1 0% -2% -11%
760 nm
µ′s conventionally true
µa conventionally true 5.20 cm
−1 9.50 cm−1 12.70 cm−1
0.01 cm−1 -44% -29% 33%
0.07 cm−1 -13% -6% -8%
0.13 cm−1 -10% -8% -9%
0.19 cm−1 -7% -8% -7%
0.25 cm−1 -8% -6% -8%
0.29 cm−1 1% -4% -7%
0.36 cm−1 -1% -3% -8%
0.42 cm−1 -1% -2% -8%
820 nm
µ′s conventionally true
µa conventionally true 4.70 cm
−1 8.70 cm−1 11.70 cm−1
0.01 cm−1 -88% -1% 7%
0.07 cm−1 -26% -16% -16%
0.12 cm−1 -16% -12% -12%
0.18 cm−1 -16% -12% -12%
0.23 cm−1 -11% -9% -9%
0.28 cm−1 -5% -10% -11%
0.34 cm−1 -6% -10% -10%
0.39 cm−1 -5% -3% -9%
Table 4.2: Error in µa estimation from BabyLux device compared to conven-
tionally true values of the twenty-four solid phantoms measured.




µa conventionally true 5.9 cm
−1 10.7 cm−1 14.2 cm−1
0.01 cm−1 -17% -21% 0%
0.07 cm−1 -9% -7% -6%
0.14 cm−1 0% -5% -3%
0.20 cm−1 5% -8% -5%
0.27 cm−1 5% -5% -7%
0.33 cm−1 11% -1% -11%
0.40 cm−1 17% -4% -14%
0.46 cm−1 26% -1% -13%
760 nm
µ′s conventionally true
µa conventionally true 5.20 cm
−1 9.50 cm−1 12.70 cm−1
0.01 cm−1 -17% -21% 2%
0.07 cm−1 -9% -8% -8%
0.13 cm−1 -1% -6% -3%
0.19 cm−1 5% -9% -5%
0.25 cm−1 3% -6% -7%
0.29 cm−1 7% -2% -10%
0.36 cm−1 19% -3% -12%
0.42 cm−1 24% -3% -10%
820 nm
µ′s conventionally true
µa conventionally true 4.70 cm
−1 8.70 cm−1 11.70 cm−1
0.01 cm−1 -15% -19% -1%
0.07 cm−1 -12% -10% -7%
0.12 cm−1 -4% -9% -5%
0.18 cm−1 -3% -10% -7%
0.23 cm−1 -3% -10% -8%
0.28 cm−1 1% -5% -9%
0.34 cm−1 9% -10% -13%
0.39 cm−1 14% -6% -12%
Table 4.3: Error in µ′s estimation from BabyLux device compared to conven-
tionally true values of the twenty-four solid phantoms measured.
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3. Noise (or precision). The coefficient of variation (CV) of optical prop-
erty measurement at different count levels in a logarithmic scale are re-
ported in the top row of figure 4.8. A value of 1% is reached with 5×105
counts. Due to the Poisson nature of the photon noise, the CV is ex-
pected to decrease as the square root of the counts. In order to test this,
the logarithmic transformation of CV versus the counts, as plotted in
figure 4.8 was tested for linear regression. For each wavelength and for
both µa and µ
′
s, the 95% confidence interval of the slope contains -0.5,
i.e. a square-root dependence, as expected.
4. Stability. Optical properties estimated from eight hours of measurement
right after the starting of the device are reported in the bottom row of
figure 4.8. The horizontal lines represent a range of ±3% with respect to
the average values calculated in the last hour of measurement. A warm
up period of one hour is thus identified. After the warm up period no
shifts or deviations are detected in the results.
5. Reproducibility. Table 4.4 reports results of the repeatability assay
over different days, where the same solid phantom was measured under
the same experimental condition. The deviation between different days
of measurement is low, with a maximum value of 5% reached only in one
day.
6. Reproducibility over probe replacement. Table 4.4 reports results
for repeatability over replacements of the probe as well. This test was
motivated by the fact that poor reproducibility in this scenario is a major
drawback of current NIRS technologies. CV over replacements is always
less than 2.5%.
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Figure 4.7: Optical properties retrieved from a series of twenty-four solid phan-
toms, built with three different levels of reduced scattering coefficient and eight
levels for absorption are shown. Each row represents one wavelength (λ). In
the left column the measured µa are plotted versus the conventionally true µa,
different colors correspond to the different level of µ′s. The black line represents
the expected values. The right column reports the measured µ′s with respect to
the conventionally true µa. The horizontal lines represent the conventionally
true µ′s.


































































































































































































































































































































































































































































































































































































































































































Figure 4.8: Top row reports the CV of µa and µ
′
s estimation over thirty con-
tinuous measurements at different count levels. Both axis are in logarithmic
scale, dashed lines represent the linear regression, whose slope is -0.5 for all of
them, as expected by Poisson photon noise. 1% stability level is reached at
5×105 counts for the µa and already at 105 counts for the µ′s. The bottom row
reports results of µa and µ
′
s over eight hours after turning on the device for
the three wavelengths. The dashed horizontal lines represent the ±3% range of
the average value obtained from the last hour of measurement, that is reached
after one hour of measurement.
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Absorption coefficient µa



















































Table 4.4: The same solid phantom was measured on five different days, ac-
quiring six measurements per day replacing each time the probe on the surface
of the phantom. In the table, for each wavelength and each day, the average
value of optical properties is presented, together with the percentage deviation
from the average values and the coefficient of variation (CV) over replacement.
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A standard procedure to assess the accuracy of the DCS measurement does
not exist, mainly due to the complexity of making a stable liquid phantom. A
mixture of water, ink and lipid emulsions is usually used. Few techniques have
been considered to change the particle diffusion coefficient in a controlled way,
from changing the viscosity of the medium, its temperature or adding forced
motion by pumps [23, 34, 70, 120, 140]. However the phantoms for dynamic
properties are still to be improved. Therefore only stability and reproducibility
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(b)
Figure 4.9: BFI measurement of a liquid phantom by DCS over hours (a) and
its histogram (b). The red continuous line indicates the average value, while
the dashed line represent the ±3% range.
• Stability. The results of measurement on a liquid phantom over five
hours are reported in figure 4.9. Retrieved BFI values show no trend
over time and the coefficient of variation over the whole period is 1.5%.
• Reproducibility. The deviation from average value of BFI between
days is reported in table 4.5. This is larger than those for optical prop-
erties, reaching 8%. It must be noted that variability of liquid phantom
conditions plays an important role in dynamic property measurement,
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mainly because the measured diffusion coefficient depends on the envi-
ronmental conditions such as the temperature [55].
• Reproducibility over probe replacement. Results for CV of BFI
over replacements, reported in table 4.5, are very good and similar to
those obtained for TRS.
BFI
average Day deviation CV







Table 4.5: The same liquid phantom was measured on five different days, ac-
quiring six measurements per day replacing each time the probe on the surface
of the phantom. The table reports the average value obtained for BFI and, for
each day, the deviation from the average value and the CV over replacement.
The final test performed on phantoms was aimed at assessing whether each
module influences the other, to evaluate potential cross-talk, since DCS and
TRS measurement are acquired simultaneously. Table 4.6 compares the results
of DCS measurements on the same liquid phantom both in presence of TRS
light shining from the probe and without TRS light. Intensity, β parameter
and BFI are equivalent in the two configurations, within the standard deviation
of the measurement. This is also confirmed for TRS. Table 4.7 shows the
equivalent results for optical properties measured by TRS with and without
DCS light shining from the probe. The results in the two modes correspond
to each other within the standard deviation of the thirty measurements. The
increase of background must be related to the counts in all the 2048 channel,
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i.e. an increase of only 2 counts per channel on average, which does not affect
the measurement.
TRS light BFI × 10−8 β Intensity (kHz)
OFF 1.95 (0.09) 0.50 (0.01) 153 (2)
ON 1.90 (0.08) 0.49 (0.01) 154 (1)
Table 4.6: The same liquid phantom was measured with and without TRS
laser light shining from the probe, acquiring thirty curves. The table reports
the mean BFI, β and intensity with the standard deviation (in brackets) over
the thirty measurements. This shows that TRS light does not affect DCS
measurements.
λ DCS light µa (cm
−1) µ′s (cm
−1) Total background counts
685 nm
OFF 0.243 (0.002) 9.49 (0.06) 6144
ON 0.242 (0.002) 9.42 (0.09) 8192
760 nm
OFF 0.232 (0.002) 8.38 (0.06) 4096
ON 0.232 (0.003) 8.35 (0.09) 8192
820 nm
OFF 0.215 (0.002) 7.55 (0.05) 4096
ON 0.214 (0.002) 7.49 (0.07) 8192
Table 4.7: Thirty TRS curves were acquired from a solid phantom with nominal
properties of µa=0.27 cm
−1 and µ′s=10 cm
−1 at 660 nm with and without DCS
laser light shining from the probe. The table reports the mean optical prop-
erties with the standard deviation (in brackets) over the thirty measurements,
as well as the total background noise, registered in all the 2048 channels.
In vivo protocol
Six subjects (three females, aged 23 to 29 years) were recruited for the cuff
occlusion protocol of adult arm, designed in order to test the device during in
vivo measurement and its performance when blood flow and saturation levels
vary over a dynamic and wide range. The skinfold thickness of the overlying




















































Figure 4.10: Time series of changes of HHb, HbO2, StO2 and rBFI during the
cuff occlusion protocol. Curves are reported for each subject, who are color
coded. Legend identifies the thickness for the superficial layer for each subject.
tissue ranged from 2 mm to 4 mm. The each repetition of occlusion did not
differ from the others, as confirmed by the LME model (p>0.05). For this
reason, the three repetitions of the protocol were averaged for each subject.
Figure 4.10 reports the haemodynamic time series during the protocol for the
six subjects, each of them represented by a different color. The legend re-
ports the superficial layer thickness as assessed by the skinfold thickness. The
deoxy-hemoglobin (HHb) concentration increased during the arterial occlusion,
with a median increase over the population at the end of occlusion period of
32.4 µM (14.1 µM, 37.6 µM). Here the numbers in brackets are the I and III
interquantile. This notation will be kept for the other parameters in this sec-
tion. On the other hand, the oxy-hemoglobin (HbO2) concentration decreased
during the occlusion by -24.0 µM (-31.0 µM and -8.9 µM) as the median over
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the population at the end of the occlusion period. These changes resulted in a
decrease of StO2 of -28.2% (-31.6%,-14.7%). Concurrently, the percent change
of BFI (∆rBFI) at the end of the occlusion was 85% (79%,89%) as the median
over the population.
After releasing the cuff, HHb changed by -8.9 µM (-15.1 µM, -7.6 µM)
and HbO2 by 20.4 µM (12.1 µM,30.9 µM) with respect to the initial value.
Consequently, StO2 increased with respect to the initial value by a median
value of 12.9% (11.9%, 16.6%) within 30 s after the release of the occlusion,
this was followed by a recovery to baseline. Blood flow increased releasing
the cuff, reaching a percentage change of 490% (380%, 510%) as the median
over the sample population with respect to the initial baseline value. All these
values tended towards recovery within two minutes after the release of the cuff.
Overall, the hemodynamic parameters changed in the expected manner.
Within all the subjects, a wide range of level for StO2 was reached during the
occlusion period reflecting, presumably, differences in the oxygen metabolism
of the muscles of those subjects. Furthermore, the decrease of StO2 was de-
pendent on the measured thickness of the superficial layer, which is not sur-
prising since the source detector separation is optimized for probing relatively
shallow regions, such as the infant brain. During the occlusion the reduction
of StO2 was larger in subjects with thinner superficial layer, since the active
muscle tissue occupied a larger percentage of the probed volume respect to
subjects with thicker superficial layer. StO2 decrease reached 40% in the sub-
ject with a skin and adipose tissue layer of 2 mm. It has been proven that
for thin superficial layer (7 mm for a source detector separation of 20 mm),
the absorption properties retrieved using the model for homogeneous level are
independent on the changes of the upper layer [72]. Even if this holds true,
StO2 changes depend on the amount of muscle tissue probed by the optics,
which consumes more oxygen respect to the skin and adipose tissue, as it was
demonstrated in a previous work changing the source detector separation on
the same subjects [226].
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In our case, for the blood flow we did not distinguish levels reached at the
cuff release in the different subjects, the response during the hyperaemia was
indeed homogeneous within the subjects. It increased by 490% as the median
over the sample population with a narrow interquartile range of (380%, 510%).
In the previously cited work, the blood flow level of hyperaemia was actually
dependent on the source detector separation [226]. It must be noted that the
occlusion in the mentioned work was kept for less time (3 minutes instead of
6 minutes) and the blood flow increase was far lower than in our protocol (3-
fold increase instead of 5-fold). Different durations of occlusion may be the
source of the discrepancy and the fact that the hypoxia here was more extreme
due to the longer occlusion may be the cause of the response which was not
dependent on the superficial layer thickness. Since it has been proven that the
depth sensitivity of DCS is higher than CW-NIRS and the contrast to noise
ratio of the deeper layer change equivalent [196], we do not expect DCS to be
less sensitive to the muscle haemodynamics than TRS in this measurement.
4.3 Conclusions and outlook
The work presented in this chapter demonstrates that the BabyLux device
can be a good candidate for monitoring cerebral haemodynamics in the infant
brain for two reasons. First, by using DCS, it has a direct measurement of
the blood flow to the cerebral tissue. Instead of having information only on
the consumption of oxygen, as done by NIRS that measures blood oxygen
saturation, the BabyLux device provides a direct independent measurement of
the supply of oxygen. Secondly, TRS allows for the absolute measurement of
the optical properties and, consequently, of HHb and HbO2 concentrations and
StO2.
The laboratory tests showed good performance of the BabyLux device.
The estimation of optical properties was accurate and precise. The results
were stable over several hours of functioning and they were repeatable within
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days and replacement of the probe. Good performance in the dynamic range
and in vivo measurement has been proved by an arterial cuff occlusion of the
adult forearm.
In the future, technological development can be pushed forward and more
laboratory tests can be thought. For example the layered structure of the head
can be considered as well as the role of the cerebral spinal fluid (CSF) with
quite different optical properties from the tissue ones. This is currently not
trivial and efforts are being done by the diffuse optical community to develop
new realistic phantoms [44]. In addition, more distances between source and
detector fibers could be considered. It is not straightforward to define the best
distance to choose, considering the trade-off between reaching deeper regions
and the signal to noise ratio or geometry of the head. Furthermore, studies
are still ongoing regarding the sensitivity to the brain, which seems to be
dependent on the specific method used [26,147,196]. Nonetheless the BabyLux
consortium aimed at developing a prototype for a medical device, based on the
start of the art of DCS and TRS technology. The device’s performance was
tested considering one of the current available protocols for TRS devices and
translating this to DCS. Surely these tests assess the device performances in
a controlled and ideal scenario and set the realistic limits to be expected from
more complex clinical studies. However, this is only a starting point and more
work has been developed within this thesis work to test the device. Firstly, the
device precision and accuracy limits were investigated at different experimental
and analysis configuration through realistic simulated data (chapter 5). Then,
the cerebral blood flow measurement were validated towards 15O - water PET
in a piglet model (chapter 6). Finally, the device was tested in a more realistic
scenario, performing measurement on infants over a dynamic range and to
assess the variability over replacement of the probe (chapter 7).
Chapter 5
Precision and accuracy limits
of the BabyLux device
In the introduction of this thesis it was highlighted that one of the objectives of
the BabyLux project was to improve the precision and accuracy of the state-of-
the-art. This chapter is focused on exploring the limit in precision and accuracy
of the BabyLux device. For this purpose, DCS and TRS data with added
realistic noise have been simulated with the procedure explained in chapter 3.
The role of different experimental parameters is investigated by generating data
at different settings. Analogously, different choices for the analysis as well as
different settings for input analysis parameters are implemented to individuate
the role of each of them. Throughout the chapter, the results in terms of
precision and accuracy described for each simulation and analysis setting are
reported. To conclude with, experiments have been performed on phantoms
and on a piglet model to verify the performance of the system on precision of
results.
These results are reported in Giovannella, M., Spinelli, L., Pagliazzi, M.,
Contini, D., Greisen, G., Weigel, U. M., Torricelli A., Durduran, T. (2019).
“The accuracy and precision of tissue optical properties and haemodynamic
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parameters estimated by the BabyLux device: a hybrid time-resolved near-
infrared and diffuse correlation spectroscopy neuro-monitor.”, Biomedical Op-
tics Express, submitted.
5.1 Curve simulation and analysis process
The procedure used for curve simulation and analysis was explained in chap-
ter 3. Specifically, in figure 3.2 the process implemented for the generation of
DCS and TRS curves with realistic noise was depicted.
Briefly, starting with TRS, the desired level of HHb and HbO2 concentra-
tion are converted into µa for the wavelengths of interest. Once the µ
′
s values
are also chosen, the analytical solution of the photon diffusion equation (PDE)
for semi-infinite homogeneous medium is convoluted with a typical instrument
response function IRF(t). Afterwards the curve is adjusted to the desired count
level and Poisson noise is added. This is done for all the wavelengths of in-
terest. These curves are analyzed as explained in section 3.1.3, in particular
using the fit analysis to retrieve optical properties from each generated curve.
This is equivalent to reverse the process depicted in figure 3.2.
Analogously to TRS curves, diffusion approximation is exploited for DCS
data generation. As depicted in figure 3.2, normalized electric field autocorre-
lation function is derived from the solution of the correlation diffusion equation
(CDE). Realistic noise is added using the method and formula explained in sec-
tion 3.2.2. Again, the reverse process is used for DCS data analysis, by fitting
the simulated curve with the solution of the CDE.
It must be pointed out that using the same modeling for curve generation
and analysis allows for understanding the lower limits for precision and accu-
racy due to photon noise and how this changes with different experimental and
analysis settings. This procedure excludes the error due to the limits of the
diffusion approximation.
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5.1.1 Parameters for simulation and analysis
Experimental parameters
TRS DCS
λ 685 nm, 760 nm, 820 nm λ 785 nm
ρ 15 mm ρ 15 mm
Counts 105
Count rate 100 kHz






685 nm 0.178 cm−1 8.21 cm−1
760 nm 0.175 cm−1 6.86 cm−1
785 nm 0.201 cm−1 6.47 cm−1





concentration water 90 %
StO2 62 %
BFI 10−8 cm2/s
Table 5.1: Experimental parameters and tissue properties as defined for DCS
and TRS curve simulation, unless differently specified.
In order to generate and analyze simulated data, various parameters must
be defined in their values. Table 5.1 reports the default values for experimen-
tal and tissue properties used for data generation, if not differently stated.
The experimental parameters were chosen accordingly to the BabyLux device
(chapter 4). While the tissue properties are comparable to what measured in
newborns with the BabyLux device (chapter 7).
Since the purpose of this chapter is to understand the contribution of each
parameter in precision and accuracy of the retrieved values, I have simulated
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Is precision and accuracy influenced by:




the instability of the TRS laser
pulse peak position?
analysis input parameters?
How is a physiological variability
propagated?
counts: 104 , 105, 2 x 105, 5 x 105,
106,107 
tHb= 80 μM
StO2 = 5% -> 80% by 5%
σ(t0)= 5 ps, 10 ps, 15 ps
water content: 70% -> 100% by 5%
count rate: 20 kHz, 40 kHz, 60 kHz, 
80 kHz, 100 kHz, 120 kHz
averaging time: 1 s, 2 s, 3 s, 4 s, 5 s
BFI : [0.025, 0.05, 0.1, 0.25, 0.5,
1, 2.5, 5] x 10-8 cm2/s
CV optical properties: 0% -> 16%
by 2% 
CV BFI= [1%, 3%, 7%, 10%]
CV HbO2= 7%, CV HHb = 3%
CV a = 3 %, CV b = 3%
Curve simulation Curve analysis
• t0 = 0 ps
• t0 fit parameter
water content = 90%
• β= 0.45 -> 0.5 by 0.01
• β estimated from g2(τ) curve
optical properties fixed
β= 0.48
Figure 5.1: The left column lists the questions raised to characterize the in-
fluence of various parameters on the accuracy and the precision of optical and
haemodynamic parameters. The central column explains how the settings for
curve simulation were defined in order to answer those questions. Finally, the
right column focuses on the settings for analysis input parameters.
different sets of data and varied the values of the parameters necessary for
data simulation and analysis. Each sets of data consisted of thirty independent
curves, generated keeping fixed all the parameters necessary for the simulation
or assuming an a priori variability for some of them. This was defined by
selecting a value for its coefficient of variation CV = σy/y, where y is the mean
value of an input parameter and σy is its standard deviation. Thirty values
were randomly generated from a normal distribution centered at y and with a
width of σy. Each of those thirty values was used for generating each of the
thirty simulated curves.
In order to have some statistics in the variability and the error of the
simulated data, this process was run ten times to generate ten sets of thirty
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curves for each configuration.
Let me proceed by explaining how each set of data was generated. This is
summarized in figure 5.1, that reports the values selected for each parameter
either in the simulation (central column) or the analysis process (right column)
in order to identify the contribution of each of them in precision and accuracy.
• Parameters for TRS
To start with, DTOF curves were simulated changing the number of
total collected photons from 104 photons to 107 photons. Afterwards,
different absolute levels of StO2 were considered, from a minimum of 5%
to a maximum of 80%, with tHb concentration fixed at 80 µM. Then, an
instability in TRS laser peak positions was simulated. TRS curves were
shifted by t0, generated from a normal distribution with a mean at 0 ps
and a standard deviation (σt0) of 5, 10 and 15 ps. In the analysis process,
t0 was either kept fixed or treated as a fitting parameters. Furthermore,
an error in the water content estimation was introduced in the analysis.
Data were simulated with a water content varying from 70% to 100%
of the total chromophore concentration and analyzed considering it as
90% of the total chromophore concentration. Lastly, I have assumed a
variability for HbO2 concentration (7% of CV), HHb concentration (3%
of CV) and for the Mie parameters a and b (3% of CV each) in the data
simulation process.
• Parameters for DCS
Figure 5.1 suggests how the same kind of effects were considered in DCS
data simulation and analysis process as was done for TRS. As a first step,
count rate was increased from 20 kHz to 120 kHz while the averaging
time from 1 s to 5 s. In order to consider different BFI absolute values,
this varied from 0.025×10−8cm2/s to 5×10−8cm2/s. Afterwards, DCS
data were simulated considering a variability for the optical properties
(from 0.01% to 16% of CV). The same data were analyzed considering
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the optical properties fixed at the mean of the thirty values used in the
simulation. The other input analysis parameter is β, always considered
fixed at 0.48 in the simulation, but either estimated from the g2(τ) curve
or varied from 0.45 to 0.5 in the analysis. Lastly, curves were generated
with a BFI variability from 1% to 10% to check how the CV for BFI
increased due to noise and analysis process.
5.2 Experimental measurements
All the measurements contained in this chapter have been performed with the
BabyLux device, the hybrid DCS and TRS system described in chapter 4. In
particular, the BabyLux probe was used, with a distance of 15 mm between the
source and the detector fiber. This very same probe could be used on piglets
because the extra-cerebral tissue thickness is comparable to the infant one.
5.2.1 Phantom measurement
Phantoms were measured to test the precision of the device over multiple con-
tinuous measurements for both TRS and DCS. A solid phantom made by epoxy
resin as solid matrix, TiO2 particles as scatterers and ink powder as absorber
was measured by TRS. It was made with nominal optical properties of µa = 0.1
cm−1 and µ′s = 10 cm
−1 at 690 nm [176].
On the other hand, a liquid phantom, provided by HemoPhotonics S.L.
(Castelldefels, Spain) [169], was employed for DCS, since this technique probes
moving scatterers. The count rate for this measurement was 150 kHz.
Each set of phantom measurement, either solid or liquid, consisted of 30
curves.
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5.2.2 Piglet model
The permit to perform the animal experimentation was obtained from the Dan-
ish animal experiments inspectorate (license no. 2016-15-0201-01021). Precau-
tions were taken to reduce any animal suffering to a minimum. Anesthesia was
induced shortly after arrival to our facility and sustained throughout prepa-
ration and experimentation until termination of the animal. Newborn piglets
(Danish landrace) were delivered on the day of the experiment and rapidly
anesthetized by intramuscular injection of Zoletil (xylazine 2 mg/kg, ketamine
10 mg/kg, methadone 1 mg/kg and butorphanol 1 mg/kg; Virbac, Denmark),
intubated and put on a ventilator (Dameca, Denmark). Once the piglet was
stable, the BabyLux probe was placed on the piglet head and 30 curves at
1 s time resolution were acquired. After the completion of the protocol of
the main study, whose results are described in chapter 6, the piglets were eu-
thanized with an overdose of intravenous pentobarbital 150mg/kg. Cerebral
haemodynamics was continuously monitored with the BabyLux device during
the euthanasia.
5.2.3 Analysis of experimental curves
Experimental curves were analyzed using the same flow explained for analysis
of simulated curves (figure 3.2 from right to left). As explained in chapter 4
the shift of the TRS lasers was monitored independently from the TRS mea-
surement. The measured shift was used to correct the position of the Rexp(t).
Afterwards, in the fitting procedure only optical properties were used as fitting
parameters, while t0 was kept fixed at 0 ps.
As previously mentioned, different options are available for DCS input anal-
ysis parameters. The time average of the optical properties measured by TRS
for each experimental set was used for DCS analysis. This means that they
were kept constant over the whole set of measurements. An exception was
made for the liquid phantom, where, in order to highlight the effect of the
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variability of the estimates of the optical properties, they were inserted in the
analysis by defining an a priori CV for them. The other input parameter for
DCS analysis is β which was estimated from each experimental gexp2 (τ) curve.
5.3 Estimation of precision and accuracy
The precision over the 30 simulated or experimental curves was quantified
considering either the standard deviation σ(X), where X = [x1, x2, ..., x30]
with xi as each of the values obtained from the analysis, or as the coefficient of
variation (CV). CV was defined as the ratio between the standard deviation and
the mean value CV= σ(X)/〈X〉. For the simulations, a relative error was also
calculated to quantify the accuracy, defined as ε = (〈X〉 − xtrue)/xtrue, where
xtrue is the parameter value used for the simulation. As mentioned before, for
the simulated curves, the generation of ten data sets of thirty curves for each
setting allowed us to have a standard deviation of the variability (σ(X) or CV)
and of the relative error (ε).
5.4 Results and Discussion
Figure 5.2 shows example of DCS and TRS curves generated in the simulation
process, both the model curve and the simulated ones with realistic noise are
reported. Values used for simulating those data were the default ones reported
in table 5.1.
5.4.1 Variability and error in simulated TRS curves
Figure 5.3 shows how CV of optical (a) and haemodynamic properties (b)
decreases drastically with increasing total photon counts. Relative error de-
creases with increasing counts as well, but it is notably low (below 5%) for all
the count levels considered. Increasing the count level from 105 photons, as
used in the BabyLux device, to 106 would lead to a substantial improvement
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Figure 5.2: Right side, example of IRF(t), Rmodel(t) and of the thirty Rsim(t)
generated at 760 nm. Left side, example of gmodel2 (τ) and g
model
1 (τ) and the
thirty gsim2 (τ) and g
sim
1 (τ) generated in the simulation process. The dashed
vertical lines highlight the fitting range.
in precision. This is crucial to improve the variability of current commercial
cerebral oximeters, judged to be too high for clinical purpose [200].
The variability (CV) of StO2 depends not only on the count level but also
on its own absolute level. Specifically, CV and standard deviation decrease
with increasing StO2 level (figure 5.4). It was previously noted that accuracy
in determination of optical properties by TRS depends on their absolute values
[165,202]. Better performance could be achieved with samples of high reduced
scattering and low absorption coefficient. Those works simulated data with
a method similar to the one used in this chapter, therefore their results did
not depend on the limits of the diffusion approximation but on the shape
of the collected curves. I have here shown that precision is dependent on
the tissue properties as well. Nonetheless, it must be highlighted that the
standard deviation of StO2 does not vary as much as CV with the absolute
StO2 level. The high CV values at low StO2 are mainly due to the fact that
the denominator in the CV calculation is small.































































































Figure 5.3: CV and relative error of the fitted absorption µa and reduced
scattering coefficient µ′s at 760 nm (a) and haemodynamics parameters (b)
within thirty simulated curves at different counts levels. For optical properties,
behavior of the other two wavelengths is equivalent. Error bars refer to the
standard deviation over the ten sets of simulated data.















































Figure 5.4: Standard deviation and CV of estimated StO2 at different StO2 lev-
els within thirty simulated curves. Error bars refer to the standard deviation
over the ten sets of simulated data.



















































































































































Figure 5.5: CV of absorption coefficient µa (top row) reduced scattering coef-
ficient µ′s (middle row) at 760 nm and oxygen saturation StO2 (bottom row)
at different counts level, when a variability in t0 is considered in the TRS data
simulation (standard deviation according to the legend). t0 is either kept fixed
in the analysis (left column) or treated as fit parameter (right column). Error
bars refer to the standard deviation over the ten sets of simulated data.
























































Figure 5.6: CV and relative error in oxygen saturation StO2 when water content
is either under- or over-estimated by the analysis (90%) compared to the value
used for the simulation (according to the x axis). The dashed vertical black
line indicates the only case where the true value is considered in the analysis.
Results for only two count levels are shown. Error bars refer to the standard
deviation over the ten sets of simulated data.





















































Figure 5.7: CV and relative error in haemodynamic parameters obtained by
simulated data when an a priori physiological variability is considered, at dif-
ferent count levels. In particular a CV of 7% is assumed for HbO2 concentration
(red horizontal dashed line) and of 3% for HHb concentration (blue horizontal
dashed line). Error bars refer to the standard deviation over the ten sets of
simulated data.
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Figure 5.5 summarizes how precision varies if considering the different avail-
able choices for t0 determination in the fitting process, if an instability in the
TRS peaks was simulated. The uncertainty in t0 influences more drastically
the µ′s estimation than the µa, as expected. Two different behaviors arise
increasing the count levels if two different approaches of the analysis are con-
sidered. If no correction for t0 variability is considered (figure 5.5, left column)
and if t0 has a non zero standard deviation, CV of optical and haemodynamic
properties is high even for high count levels. On the other hand, considering
t0 as a fitting parameter (figure 5.5, right column) leads to high CV for low
counts level but provide a good correction and low CV for high count levels.
In Ref. [165] it was demonstrated that an uncorrected shift of the peak of the
spectrum resulted in large errors in the determination of the optical properties.
For example, errors of 5% and 10% for µa and µ
′
s were obtained with a shift
of 20 ps. Such a large shifts were not considered in this simulation, since the
Babylux device allows for monitoring the position of the TRS peaks concur-
rently to the measurement, as explained in chapter 4. The reference branch
method works well for large and sudden change of the laser pulse but even the
corrected peak position has a certain noise, that was simulated in this work.
I have here shown that this kind of instability compromises the precision of
results if no correction is applied, even at high count levels. Considering t0 as a
fitting parameter is a good method and gives good results only for high (> 105)
count levels.
Water content is assumed fixed and estimated from literature values in
TRS analysis for the BabyLux device, as done generally from TRS devices
developed for neuro-monitoring. Figure 5.6 shows how StO2 variability is sta-
ble if the water content is either over- or under-estimated, while the error in
StO2 increases.
Last simulation of TRS data focused on considering an a priori estimation
of the physiological variability for haemodynamics. Figure 5.7 reports that at
about 105 counts, the results for CV in the haemodynamic parameters already
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match the input values.
5.4.2 Variability and error in simulated DCS curves
As expected, CV and relative error for BFI decrease increasing the averaging
time and the count rate (figure 5.8). The improvement over the averaging time
is not as drastic as shown for TRS, especially for high count rates. This is due
to the fact that probability to detect pairs of photons within each bin time of
the correlator does not increase linearly by increasing the averaging time [230].
Changing the absolute level of BFI leads to an increase in the standard
deviation and a decrease in the CV at high BFI values (figure 5.9 for 100 kHz
of count rate and 1 s of averaging time). This may be due to the higher noise
registered in the (smaller) earlier delay times of the correlator [231], compared
to the later ones, since DCS curves with higher BFI decay faster and are pushed
towards the smaller delay times. This can be improved increasing the count
rate and optimizing the correlator design.
The next point is about the effects of the input parameters in the DCS
analysis, starting with the optical properties. They were considered as vari-
able a priori in the data generation and figure 5.10 shows how CV of input
µ′s is drastically reflected in CV of the BFI, while the effect of a variability in
µa is smaller. On the other hand the effect on the relative error is minimal.
The drastic influence of µ′s is explained by eqn. (2.14) that shows the coupling
between BFI and µ′s
2 in the decay rate of the auto-correlation curve. Luckily,
a change of µ′s is not expected during haemodynamic changes. Since red blood
cells account only for a tiny amount of the total scatterers, a change in their
volume does not influence bulk scattering properties of the tissue. For this rea-
son µ′s is usually kept constant over measurements in DCS analysis. Moreover,
the changes in µ′s detected by TRS are often usually due to cross talk between
µa and µ
′
s in TRS analysis.
Proceeding with the input parameter for the analysis, the role of β was
considered. If this is kept fixed, its under- or over-estimation did not compro-
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mise CV of BFI while it did for the relative error of BFI (figure 5.11). On the
other hand, estimating it from each curve lead to higher CV and relative error
for low count rates, i.e. less than 50 kHz (table 5.2). We can conclude that for
such low count rate is not convenient to estimate β from the first part of each
single curve, since this is compromised by the noise. It is reasonable to keep β
constant for an experiment as long as the laser source is known to be stable in
coherence and that there is no significant leakage of external light.
To conclude with, a simulated a priori physiological variability for BFI
was reflected in a comparable value in the CV of the estimated BFI at count
rates larger than 50 kHz, while it was not reflected on the relative error, which














































Figure 5.8: CV and relative error in BFI estimation from simulated curves at
different count rate and averaging time.











































Figure 5.9: Standard deviation and CV of BFI estimation from simulated
curves at different BFI levels. Error bars refer to the standard deviation over














































Figure 5.10: CV and relative error of BFI estimation from simulated data
generated considering a certain CV for the optical properties in the data sim-
ulation, accordingly to the x and y axis. Count rate is 100 kHz and averaging
time 1 s.
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Figure 5.11: CV and relative error of BFI estimation from simulated data, at
different count rate, when the value of β used for simulation (β=0.48) and the
one used as input in the analysis (according to the x axis) do not coincide. The
vertical dashed black line highlights the point when the two coincide. Error
bars refer to the standard deviation over the ten sets of simulated data.
Count rate CV BFI error BFI
25 kHz 22% (5%) 3% (5%)
50 kHz 10% (2%) 0% (2%)
75 kHz 7% (1%) -1% (1%)
100 kHz 5.4% (0.7%) -1% (1%)
125 kHz 4.6% (0.6%) -0.4% (0.7%)
800 kH 2.0% (0.2%) -1.1% (0.3%)
Table 5.2: CV and relative error in BFI estimation from simulated data when β
is estimated from each correlation curve, at different intensity levels. Standard
deviation over the ten sets of data generation shown in brackets.



























































Figure 5.12: CV and relative error of BFI estimation from simulated data when
a physiological variability is assumed for BFI, according to y axis, at different
intensity levels, according to x axis.
5.4.3 Variability in experimental TRS and DCS curves
As described above, tissue simulating phantoms were measured by the BabyLux
device to estimate the variability.
Thirty TRS measurements were acquired on a solid phantom at the three
wavelengths at approximately 105 total photon counts to calculate its optical
properties and their CV, shown in table 5.3. Results for the latter are compa-
rable to those obtained from the simulated data. This is an indication of the
good quality of the BabyLux device in terms of precision for optical proper-
ties. It must be noted that the solid phantom used for this measurement has
different optical properties compared to the ones chosen for simulation (5.1).
This phantom has been made specifically for the BabyLux device and it is
kept in its drawer. It is measured every time the device is used and allows
for monitoring the performance of the device during time. Therefore it is use-
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ful to report performances on this phantom for future references. However, a
phantom with optical properties closer to the values used for simulation can be
considered. Among the solid phantoms used in the previous chapter, the one
with µa(760 nm) of 0.19 cm
−1 and µ′s(760 nm) of 5.2 cm
−1 has comparable
CV over 30 s of continuous measurement as the one reported in table 5.3.
Analogously, thirty DCS measurements were acquired from a liquid phan-
tom, with µa of 0.17 cm
−1 and a µ′s of 7 cm
−1, as measured by the TRS, with
a count rate of 150 kHz. They were analyzed considering different levels of
CV for input optical properties. The estimated BFI values are consistently
increasing in variability with increasing variability of the input optical prop-
erties (table 5.4). Focusing on results considering no variability for optical
properties, CV of DCS results from the liquid phantom is higher compared to
the simulated data. The intrinsic variability of the liquid phantom can also
influence this result.
In the experiments involving the piglet model, thirteen (N=13) piglets with
a median weight of 3.25 kg (range 3.1 - 3.3 kg) and median age of 11 days (range
10 - 12 days) were measured. All TRS measurements were acquired at 105
counts in a approximately 1 s integration time. On the other hand, different
count rates for DCS were collected from each piglet, since the output power
for DCS light is constant. The median of the count rate was 150 kHz, with a
minimum value of 100 kHz and a maximum value of 200 kHz. The optical and
haemodynamic properties, and their CV, were retrieved and averaged over
the sample population and reported in table 5.5 and table 5.6. Results for
optical property and saturation variability are comparable to those obtained
from simulated and phantom data, considering the absolute value of StO2,
lower than what was previously measured in infants [60] probably because the
piglets were anesthetized. CV for BFI is slightly larger than in simulated data
and comparable to phantom data.
The last experiment focused on registering the variability over a range of
values changing dynamically in time by following changes after the euthanasia
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of the piglets. This measurement was performed for eleven (N=11) piglets.
In order to quantify the variability during these dynamic changes, ten second
windows of measurements taken at one second resolution, i.e. ten data points,
were selected instead of thirty as was done with the simulations. I have opted
for this because choosing thirty second time windows with thirty data points
would have resulted in a too variable of haemodynamics in each time window
due to the rapid changes following euthanasia. The CV for BFI and StO2 over
ten seconds of measurement during the euthanasia decreased with increasing
BFI and StO2 absolute values (figure 5.13). Measurements over wide ranges of
physiological values have to face this limit. This needs to be further explored
and accurate confidence intervals must be established when reporting values in
the ultimate clinical use.
λ µa (cm




685 nm 0.070 (0.002) 2.3% 9.4 (0.2) 1.8%
760 nm 0.070 (0.001) 1.9% 7.7 (0.1) 1.6%
820 nm 0.066 (0.001) 1.7% 7.0 (0.1) 1.7%
Table 5.3: Optical properties estimation (with standard deviation in brackets)
and their CV for thirty TRS measurements on solid phantom at the three
wavelengths (λ) employed in the BabyLux device.
CV optical properties BFI ×10−8 (cm2/s) CV BFI
0% 1.62 (0.08) 4.7%
3% 1.61 (0.09) 5.8%
7% 1.55 (0.15) 9.5%
Table 5.4: BFI, with standard deviation in brackets, and its CV as obtained
from thirty DCS measurements on a liquid phantom. Different CV of optical
properties are assumed in the analysis, as indicated by the first column.




685 nm 0.18 (0.15, 0.33) 2.3% (1.7%, 3.6%)
760 nm 0.16 (0.14, 0.31) 2.2% (1.6%, 3.6%)




685 nm 10.3 (7.8, 11.9) 2.0% (1.6%, 3.4%)
760 nm 9.9 (7.4, 11.3) 2.1% (1.5%,3.6%)
820 nm 9.2 (6.9, 10.8) 1.8% (1.4%, 2.4%)
Table 5.5: Optical properties and their CV obtained from 30 s measurement
at 1 s time resolution on a piglet head. N=13 piglets were measured, median
(minimum, maximum) values over the population are reported.
Variable Value CV
HbO2 25(18, 67) µM 7.3% (5.9%, 12.2%)
HHb 28 (23,50) µM 3.1% (2.4%, 5.9%)
StO2 48% (37%, 60%) 5.3% (3.8%, 9.7%)
BFI 2.0 (0.7, 3.3) ×10−8 (cm2/s) 4.5% (3.4%, 11.3%)
Table 5.6: Haemodynamic properties and their CV obtained from 30 s mea-
surement at 1 s time resolution on a piglet head. N=13 piglets were measured,
median (minimum, maximum) values over the population are reported.









































































































































































































































































































































































































































































































































































Figure 5.13: Variability of continuous DCS and TRS measurement on a piglet
model during euthanasia. CV of StO2 (a) and BFI (b) over 10 s measurement,
at 1 s time resolution, is shown as a function of the mean absolute value in the
10 s bin. Color codes represent the different N=11 piglets.
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5.5 Conclusion
Overall, these results define a lower value for CV and error for the BabyLux
data, valid in the ideal scenario, considering the experimental parameters used
for the real measurements (count rate, averaging time, temporal instabilities
of TRS lasers, etc...). In addition, these results can be a guidance on how to
choose parameters in the analysis process in order to maximize precision and
accuracy. Surely, the picture here drawn is incomplete, since the error due to
employing the diffusion approximation has not been considered. Nonetheless,
this would minimally influence the precision of DCS and TRS measurements,
while it would be more heavily reflected in accuracy. In spite of this, the
conclusion on how to set the analysis process and how to select experimental
parameters in order to obtain the best results are valid.
Good results were obtained for the precision of the optical property esti-
mates from the phantom and piglet model which were equivalent to the sim-
ulation results. This proved good performance in terms of precision of optical
properties of the BabyLux device. This was true also for the tissue oxygen
saturation, while blood flow index variability in phantom and piglet resulted
slightly higher than in simulations.
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Chapter 6
Validation of CBF
measurement by DCS with
15O - water PET
This chapter is dedicated to the validation of cerebral blood flow measurement
by the BabyLux device. As explained in Part 1 of this thesis, DCS assesses
locally the microvascular blood flow in units of cm2/s. This measurement is
here validated on a piglet model towards the gold standard positron emission
tomography (PET) using 15O-labeled water as the tracer. I also provide a
calibration formula to convert BFI measurement in flow units (ml/100g/min).
These results are reported in the manuscript Giovannella, M., Andresen,
B., Andersen, J. B., El-Mahdaoui, S., Contini, D., Spinelli, L., Torricelli, A.,
Greisen, G., Durduran, T., Weigel, U. M., Law, I. (2019). “Validation of
diffuse correlation spectroscopy against 15O-water PET for regional cerebral
blood flow measurement in neonatal piglets.”, Journal of cerebral blood flow
and metabolism, submitted.
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6.1 Background
Positron emission tomography (PET) using 15O-labeled water (H152 O) as a free
diffusible tracer is the gold standard for measuring regional cerebral blood flow
(rCBF) [87, 181]. This technology measures rCBF distribution with a time
sampling of few minutes, since the tracer has a relatively short half-life (two
minutes). Spacial resolution is limited to about 5 mm because of the high
positron energy of the 15O decay and the noise limitation. This technique is
not a routine clinical modality, especially due to the short half-time of the
tracer that requires it to be produced on-line and makes it costly. Only few
centers around the world have it available.
Even when available, it cannot be extensively used on infants. One reason is
that it requires patient transport out of the intensive care unit and stabilization
for a prolonged period of time. Most importantly, it requires the patient to be
exposed to a relatively high doses of ionizing radiation. Effort has been made
to improve this and to develop methods to quantitatively measure rCBF by
PET in neonates with a small injected H152 O dose [6]. In spite of this, PET
with 15O-labeled water is still far to be used as a neuro-monitor in the clinical
routine and most probably it will never be.
DCS, the technology implemented in the BabyLux device, offers an appeal-
ing opportunity to overcome the major drawbacks of 15O - water PET listed
above. As already explained along this thesis, it allows to continuously and at
the cot-side monitor cerebral blood flow (CBF), being completely non-invasive
and implemented in optical devices.
This chapter presents a study conducted on a piglet model that aims at
validating DCS against the gold standard 15O - water PET. rCBF was con-
currently measured by DCS (the BabyLux device) and by 15O - water PET
during a protocol with acetazolamide injection and hypoxic challenges in order
to explore a range of CBF values. I have investigated whether the BFI by
DCS was correlated with rCBF and global CBF (gCBF) measured by 15O -
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water PET. In addition, I have calculated a conversion formula and its limit
of agreement to turn BFI into flow units ml/100g/min. I have applied it to
baseline haemodynamic measurements of another group of piglets, measured
by the BabyLux device as well, and to measurements in infants (see chapter
7).
6.2 Methods
All animal procedures were approved by the Danish animal experiments in-
spectorate (license no. 2016-15-0201-01021). Precautions were taken to reduce
any animal suffering to a minimum. Anesthesia was induced shortly after ar-
rival to our facility and sustained throughout preparation and experimentation
until the termination of the animal.
6.2.1 Animal model and preparation
Seventeen newborn piglets (Sus scrofa domesticus, Danish landrace) with a
median weight of 3.2 kg (range 3.0 - 3.4 kg) and median age of 11 days (range
10 - 12 days) were included in this study. Two different protocols were applied.
Group 1 involved six piglets, while the other eleven were included in Group 2.
The animal preparation explained in this section is relevant for both groups,
unless further specified.
The piglet was delivered on the day of the experiment and anesthetized
by intramuscular injection of Zoletil (xylazine 2 mg/kg, ketamine 10 mg/kg,
methadone 1 mg/kg and butorphanol 1 mg/kg; Virbac, Denmark), intubated
and put on a ventilator (Dameca, Denmark).
During the protocol, electrocardiography was performed and pulse oximetry
was measured continuously. In addition continuous monitors of rectal tempera-
ture (IntelliVue MP70, Philips, The Netherlands) and end-tidal carbon dioxide
(Secma, Skævinge, Denmark) were established. Analgesia and anesthesia were
sustained with intravenous fentanyl 10 µg/kg/h and propofol 20 mg/kg/h in
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an ear vein using an infusion pump (B.Braun, Melsungen, Germany). Intra-
venous catheters were placed in the femoral arteries and veins bilaterally. An
arteriovenous shunt was meant to continuously monitor the tracer activity in
the blood (left femoral artery to left femoral vein). While the other was for
monitoring arterial blood pressure (right femoral artery) and for fast adminis-
tration of the tracer (right femoral vein). For Group 2 only the one relevant
for arterial blood pressure was used. Additionally, an intravenous catheter was
placed in the superior sagittal sinus through a craniotomy for cortical venous
blood samples. All these monitors and measurements allowed for acquiring a
complete picture on the physiology of the animal.
All catheters were flushed with heparinized saline every hour during prepa-
ration and subsequent stabilization. Intravenous antibiotics (ampicillin 200 mg/kg
and gentamicin 4 mg/kg) were administered as sepsis prophylaxis, and, in-
travenous heparin (100 IE/kg; LEO Pharma, Ballerup, Denmark) to prevent
blood clotting. A continuous infusion of isotonic glucose (15-20 ml/kg/h) com-
pensated for fluid losses and maintained blood glucose levels.
6.2.2 PET measurements
The PET scans were performed on a high resolution research tomograph (HRRT,
Siemens, Erlangen, Germany) with the piglet in prone position supported by
a vacuum pillow. Only the head and neck were inserted in the scanner, which
had 25 cm of axial field of view. First, a transmission scan using a Cesium-137
(137Cs) point source was performed for attenuation correction. Afterwards, for
each measurement, dynamic scans were started approximately 30 seconds be-
fore injecting a bolus of 100 MBq 15O - water in the right femoral vein, which
was subsequently flushed by heparinized saline. After the injection, data was
collected for seven minutes in list mode. During this time, tracer activity in the
blood was continuously measured every half second using the shunt between
the left femoral artery and vein driven by a peristaltic pump (Allogg ABSS,
Mariefred, Sweden) with a flow of 4 ml/min.
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Transmission list mode data were histogrammed with emission contamina-
tion correction, and the transmission scan was reconstructed using the HRRT
maximum a posteriori for transmission (MAP-TR) method [114]. The data
were sorted as 1x25 seconds, 15x2 seconds, 11x5 seconds, 4x10 seconds, 9x30
seconds with a fast implementation [90] of the software OP-OSEM 3D (10 iter-
ations, 16 subsets) including point spread function modeling [205], attenuation,
random scatter and decay correction. The image size was 256 x 256 x 207 vox-
els with a 1.22 x 1.22 x 1.22 mm voxel size. Image frames were preprocessed
using a 5 mm 3D Gaussian filter. A minimum time of 10 minutes (5 half-lives)
between the scans was kept to allow for decay of the tracer.
PET image analysis
All quantitative PET image analyses were performed in PMOD v3.3 (PMOD
Technologies, Zürich, Switzerland). Results from two volumes of interest (VOIs)
were calculated. One contained the cortex of both hemispheres and I will re-
fer at this result as regional CBF (rCBF). Then the global CBF (gCBF) was
calculated by considering the whole brain. Time activity curves were gener-
ated for the VOI for kinetic modeling using a single tissue compartment model
adapted for 15O - water tracer studies by applying the equation
CPET (t) = vBCa(t)+(1−vB)
(







where CPET (t) is brain tissue activity at the time t (count/s/ml), τ is
dispersion of the tracer (s), k1 is the unidirectional blood to brain clearance of
the tracer (CBF; ml/min/100ml tissue), k2 is the efflux rate constant (1/min),
Ca(t) is the arterial input function (counts/s/ml) and vB is the arterial blood
volume fraction. Parameters k1, k2 and the tracer arrival time delay was fitted
simultaneously by the Meyers method [152]. Dispersion was set to 3 seconds
based on prior experience [5]. The arterial input function was derived from
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the automated sampling from the femoral shunt. The measured activity was
corrected for decay and was aligned with the start time of the scan. Only
the first 3 minutes of the dynamic scan was used for kinetic modeling. rCBF
and gCBF in ml/min/100ml as derived from the kinetic model was converted
to the usual units of ml/100g/min by dividing for the brain tissue density
1.05 g/ml [125].
6.2.3 Optical measurement
The BabyLux device described in chapter 4 was used for the piglet measure-
ment.
Data analysis
BabyLux measurement were analyzed off-line as explained in chapter 3. Some
additional settings specifically chosen for these measurements will be here ex-
plained.
Specifically, baseline DTOF were fitted with both absorption (µa) and re-
duced scattering coefficient (µ′s) as fitting parameters in order to retrieve the
baseline optical properties. Subsequently, the whole measurement was fitted
fixing the µ′s value at baseline and allowing for free shift of the temporary
position of the IRF as previously explained [35]. Scattering properties are in-
deed expected not to change during haemodynamic changes and this improves
the stability of the estimated µa. From the retrieved values of µaat the three
wavelengths, concentration of oxy- (HbO2) and deoxy-haemoglobin (HHb) can
be calculated. Water content was fixed at the 85% of the total chromophore
concentration [89].
Few words must be spent on how the optical properties measured by TRS
were used in DCS analysis. µa concurrently measured by TRS was used in
the DCS analysis, while µ′s was kept fixed during the protocol at the baseline
value, as was done for TRS analysis. A second choice was made to define µ′s to
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be used in DCS analysis in order to reduce the effects of the variability of µ′s on
the DCS signal. First, a individual µ′s for each piglet, as measured by TRS,
was introduced in the DCS equation. Then a sample average of baseline µ′s was
calculated and DCS analysis was repeated using this value for all the piglets.
This choice was reasonable since the piglets were of all the same breed, similar
age and weight and were raised in a controlled manner.
6.2.4 Experimental protocol
After the preparation of the animal (described above), piglets of Group 1 were
allowed to stabilize for at least 30 minutes before transport to the PET facility.
Heating bags, blankets and manual ventilation were used to keep the animal
stable for the duration of the transport.
Once in the PET facility, and after assuring that the piglet was still stable
after transport, the BabyLux probe was placed over the left hemisphere of the
piglet head using an auto-adherent bandage. 30 s of measurement was acquired
and, subsequently, the bandage was released and the probe was placed again
in approximately the same spot. An other measurement was run for 30 s and
this was repeated until six sets of measurement were acquired. This protocol
allowed us to define the variability within replacement of the probe. It was
added on a later stage of measurement, therefore it was not available for all
piglets. Afterwards, the probe was kept in place for the remaining protocol and
acquisition run continuously. BabyLux device concurrently measured DCS and
TRS with a sampling time of 1 s.
A series of ten PET scans were planned for each piglet, including three
scans during baseline, three scans after a dose of acetazolamide (ACZ) and
four scans during two levels of hypoxia. ACZ inhibits the carbonic anhydrase
enzyme in red blood cells, which leads to an accumulation of carbon dioxide
in the blood stream [130]. Since carbon dioxide is a potent vasodilator of cere-
bral arterioles and arteries, cerebral blood flow is increased [219]. Likewise,
hypoxia is matched by an increase in cerebral blood flow to try to meet the
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nutrient and oxygen demands of the metabolic processes [115, 216]. After the
baseline scans 10 mg/kg acetazolamide (ACZ, Mercury Pharmaceuticals, Croy-
don, Great Britain) was administered intravenously and after 15-20 minutes to
produce the increase in blood flow three new scans were acquired. Thereafter,
hypoxia was induced by lowering the inspired oxygen and adding nitrogen try-
ing to target a SpO2 of 85% (Hypoxia A) for the next two scans and a SpO2 of
50% (Hypoxia B) for the last two scans. Respiratory rate and tidal volume
was adjusted to target an EtCO2 near 5.5 kPa during baseline and below 8.5
kPa after ACZ injection. Upon completion of the protocol, or if humane end-
points were reached, piglets were euthanized by an overdose of Pentobarbital
150 mg/kg.
Piglets of Group 2 were not transported to the PET facility. After prepara-
tion and stabilization of the animal, the same replacement protocol of BabyLux
probe was performed as in Group 1 above. It was again used for defining vari-
ability of DCS measurement but also for measuring baseline cerebral haemody-
namics. A separate experimental protocol followed as the animals were being
prepared for another study, but, since it was not object of the present study,
it not reported in details.
6.2.5 Statistical data analysis
Statistical data analysis was performed through R [209] and threshold for sig-
nificance for p-values was defined as 0.05. Firstly, I calculated the variability
of BFI over replacements of the optical probe. For each of the six replacements
BFI was averaged over the thirty seconds of continuous measurement. Vari-
ability was quantified as the coefficient of variation (CV) defined as the ratio
of the standard deviation and the mean over the six replacements. As far as
PET method is concerned, CV over the three baseline scans is calculated for
its variability. Mean and standard deviation over the population of the CV for
the two methods were considered.
In order to compare BFI obtained by DCS measurement with rCBF and
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gCBF results from the PET scans, DCS measurement acquired in the three
minutes after each 15O - water injection was averaged and considered as cor-
responding to the concurrent scan. A visual check was performed for each
scan to ensure that BFI did not vary considerably during the three minutes of
averaging.
For each scans, a paired Wilcoxon signed rank text was performed to check
whether the haemodynamic (BFI, rCBF and gCBF) and arterial blood gas
parameters (partial pressure of carbon dioxide PaCO2, of oxygen (PaO2), sat-
uration (SaO2), haemoglobin concentration (Hb) and pH) changed respect to
baseline in Group 1. Mean and standard deviation over the population of those
parameters are reported.
The first hypothesis to be tested was whether BFI was correlated with
rCBF and gCBF. For this purpose the Pearson correlation coefficient (R) was
calculated. In order to estimate the slope and intercept between the two meth-
ods Deming regression was used [141]. This kind of regression is preferable
when the reference method cannot be considered as without error. The sam-
ple average CV over the three baseline scans was computed and used as the
error for PET and the sample average variability in replacement protocol was
defined as the error for DCS. The Deming regression was performed with the
R package mcr [145].
Subsequently, I have tested the hypothesis that the two methods were in
agreement in rCBF measurement. Since they measure two different physical
quantities, each of them with different units, I have converted the two into
a unitless measure of rCBF (nrCBF) by diving each value calculated by one
method by the average value of all the measurements performed by the method
itself. First, a Bland-Altman plot was built by plotting the difference of the two
methods versus the average. In case of heteroscedasticity, i.e. different variance
for different values of nrCBF, a logarithmic transformation is performed.
In order to calculate the limits of agreement, the fact that measurements
were repeated in each animal had to be taken into account through the pro-
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cedure explained in [30]. In case of repeated (replicated) measurements, an
error due to the interaction between animal and replicate, independent from
the method, must be considered, together with the error due to the interaction
between animal and method, independent from the replicate. Ultimately, a
measurement variation is also due to the interaction between animal, method
and replicate. To estimate the variance corresponding to these effects and
their interaction, a linear mixed effect model was built and those errors are
considered as random effects. The model gives the estimates of the variance
for each random effect, which are squared summed for calculating the limits of
agreement [30].
This method allowed for retrieving a conversion formula (and its limits
of agreement) from BFI to rCBF to be used for single BFI measurements
conversion. Therefore it was employed to convert each BFI measurements of
the Group 2 piglets into flow units. A Wilcoxon signed rank text was used
to check whether the measured rCBF in Group 1 was different from the BFI-
derived rCBF in Group 2. This is different from comparing the BFI from the
two groups because I convert individually each BFI from Group 2 instead of
using a group conversion.
6.3 Results
Let me start with the optical property estimation for the piglets brain. The
average µa and its standard deviation (SD) measured in the whole population
of piglets (N=17) at 760 nm was 0.18(SD 0.06) cm−1 while µ′s was 9.8(SD
0.8) cm−1. I report results only for 760 nm since this is the closest wavelength
to what used for DCS (785 nm).
A recording from one piglet of Group 1 is shown in figure 6.1 that also helps
visualizing the protocol. BFI was measured by DCS with 1 s sampling time,




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6.1: Example of the recording of rCBF and gCBF by PET and BFI by
DCS during the whole protocol in a piglet of Group 1. Red dots represent the
time series of BFI with 1 s time resolution. Light grey line shows rCBF values
while dark grey line gCBF as measured by PET in each scan, synchronized with
the DCS acquisition. After a period of baseline where three PET scans were
performed, acetazolamide (ACZ) was injected, followed by three PET scans.
Hypoxia was subsequently induced aiming at a SpO2 level of 85% (Hypoxia A)
and at a SpO2 level of 50% (Hypoxia B).
An abrupt decrease of BFI was measured in this piglet at the end of Hypoxia
A, as shown in figure 6.1. This happened simultaneously to a decrease in
mean arterial pressure (not shown). This suggests a pressure-passive BFI, that
might be due to the fact that, after ACZ injection and hypoxia, the cerebral
artery system is already maximally dilated. PET measurement appears to
be not equally sensitive because it happened in the last period of the about












































































































































































Figure 6.2: The white boxplots collects rCBF and gCBF measurements resulted
from all the sixty-two PET scans performed in the six piglets. Grey boxplots
refer to the BFI measurements by DCS corresponding to the PET scans by
using an individual µ′s for DCS analysis and a common µ
′
s for all the piglets.
Individual piglets are coded in different colors. The horizontal dashed line
highlights the limit of 8 ml/100g/min.
three minutes of tracer activity, which weights less in PET signal. It must be
noted that, in addition, DCS is sensitive to the extra-cerebral perfusion. This
particular piglet showed an increase both in BFI and CBF at the beginning of
the protocol, before ACZ injection. This may suggest that the piglet was not
stable enough at the beginning of the protocol, even if, after the preparation
of the animal, some time was considered to stabilize it. The measurements are
still valid for our purpose, since BFI and CBF were measured concurrently.
Two of the six piglets of Group 1 had one additional scan (one after ACZ
injection and the other during Hypoxia A). Therefore a total of 62 scans are
available in Group 1 of piglets (figure 6.2). Some of those scans, corresponding
to the hypoxic challenge, resulted in a very low rCBF value (<8 ml/100g/min).
This was concurrent to a bradycardia (reduction in heart rate of 50% from
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baseline) and to very low mean arterial pressure, below 20 mmHg. This value
corresponds to a region where CBF is pressure-passive. This picture represents
a pathological condition for the brain.
Baseline BFI values were available for both groups of piglets. Averaging
over Group 1, baseline BFI resulted to be 25(SD 7)×10−9 cm2/s as mean
(standard deviation) if an individual µ′s was used for the analysis while 23(SD
5)×10−9 cm2/s if a common µ′s was considered. On the other hand, for Group 2,
it was 24(SD 7)×10−9 cm2/s and 24(SD 5)×10−9 cm2/s, if µ′s was inserted
in the analysis as individual or common value, respectively. Baseline PET
measurements resulted in a rCBF of 18(SD 3) ml/100g/min and a gCBF of
18(SD 4) ml/100g/min as averaged in Group 1.
The variability over DCS and PET measurement was quantified in this
protocol. For the former, a replacement protocol was applied to thirteen out
of the seventeen piglets (four of Group 1 and nine of Group 2). It gave a
coefficient of variation (CV) of 7% (SD 3%) as mean (standard deviation) of
the thirteen piglets. On the other hand, CV over the three baseline PET scans
resulted to be 18%(SD 12%) as averaged over the population for rCBF and
18%(SD 12%) for gCBF.
Blood gas and haemodynamic parameters were averaged in Group 1 over
the different challenges (table 6.1 and 6.2, respectively). ACZ challenge pro-
voked an increase in CBF and a small increase in PaCO2, while PaO2 and
SaO2 stay constant. The statistical test confirms a small decrease in pH af-
ter ACZ injection compared to baseline. Hypoxic state was demonstrated by
the decrease in PaO2 and of SaO2. This did not provoke a concurrent change
in rCBF and gCBF relative to baseline, if the whole piglet population was
considered.
BFI and rCBF resulted to be highly correlated using both the DCS analysis
configuration of µ′s (R>0.9, p<0.0001) (figure 6.3). The Deming regression
resulted in 1.34 (confidence interval (CI) 1.16, 1.55) (cm2/s)/(ml/100g/min)
and -4.43 (CI -9.79,-0.01) (cm2/s) for slope and intercept respectively if DCS
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Event PaCO2 PaO2 SaO2 Hb pH
(kPa) (kPa) (%) (mmol/l)
Baseline 6.6 (0.9) 21.6 (3.5) 99.8 (0.9) 4.4 (1.5) 7.29 (0.08)
ACZ1 7.4 (0.7) 22.4 (2.6) 100.0 (0.3) 4.1 (1.2) 7.23 (0.06)*
ACZ2 7.7 (0.9)* 22.3 (2.5) 100.0 (0.2) 4.0 (1.1) 7.20 (0.06)*
ACZ3 8.0 (0.8)* 21.4 (2.5) 100.0 (0.3) 3.9 (1.1) 7.19 (0.06)*
Hypoxia1-A 8.3 (0.8)* 6.4 (1.8)* 61.6 (17.8)* 4.0 (1.1) 7.17 (0.06)*
Hypoxia2-A 8.3 (0.8)* 7.1 (1.2)* 68.3 (10.9)* 3.9 (1.0) 7.15 (0.08)*
Hypoxia3-B 8.3 (1.0)* 6.0 (1.5)* 53.2 (15.4)* 4.0 (1.0) 7.1 (0.1)*
Hypoxia4-B 8.5 (1.2) 5.7 (1.9)* 47.1 (18.2)* 4.1 (1.2) 7.1 (0.1)*
Table 6.1: Mean (standard deviation) of parameters estimated by blood gas
analysis at baseline, after acetazolamide (ACZ) injection and during the two
hypoxic challenges (Hypoxia A and B). Each event corresponds to a PET scan.
Arterial partial pressure of carbon dioxide (PaCO2) and of oxygen (PaO2), ar-
terial saturation (SaO2), arterial haemoglobin concentration (Hb) and arterial
pH are presented. * highlights statistically significant difference from baseline
as confirmed by a paired Wilcoxon signed rank test (p<0.05)
analysis was performed with a individual µ′s for each piglet, and, in 1.15 (CI
1.05, 1.27) (cm2/s)/(ml/100g/min) and -1.54 (CI -4.88, 1.47) (cm2/s) if DCS
analysis was performed with a common µ′s for all the piglets.
Interestingly, high correlation was also obtained between gCBF and BFI
(R>0.9, p<0.0001) (figure 6.4). Linear regression by Deming method resulted
in a slope of of 1.35 (CI 1.21, 1.45) (cm2/s)/(ml/100g/min) and intercept of
-5.08 (CI -8.64,-1.75) (cm2/s), considering a common µ′s in DCS analysis.
Apart for testing the correlation, I have also checked the agreement be-
tween the two using a untiless rCBF (nrCBF), calculated by dividing each
value obtained by the two methods with the average of all the sixty-two
measurements. This resulted to be 30 ml/100g/min for rCBF and 34×10−9
cm2/s for BFI. In order to build the Bland-Altman plot (figure 6.5), a loga-
rithmic transformation of nrCBF was performed to avoid heteroscedasticity.
The variance component model estimated a bias of 0.004, practically zero,
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Event BFI BFI rCBF gCBF
individual µ′s common µ
′
s
(×10−9 cm2/s) (×10−9 cm2/s) (ml/100g/min) (ml/100g/min)
Baseline 24.8 (7.1) 22.7 (5.1) 17.5 (4.4) 17.9 (4.5)
ACZ1 34.9 (14.2)* 31.9 (10.5)* 30.6 (9.1)* 29.8 (7.7)*
ACZ2 36.3 (14.1)* 33.4 (10.9)* 32.6 (8.0)* 31.5 (7.2)*
ACZ3 40.4 (17.4)* 37.0 (13.7)* 35.0 (8.5)* 33.4 (7.7)*
Hypoxia1-A 45.0 (25.5) 41.3 (21.5) 39.1 (16.6) 36.5 (14.0)
Hypoxia2-A 40.2 (24.2) 37.0 (21.1) 34.0 (17.7) 32.3 (15.9)
Hypoxia3-B 42.1 (27.9) 38.7 (25.2) 37.4 (22.9) 34.6 (20.4)
Hypoxia4-B 46.4 (34.5) 42.7 (31.7) 39.0 (28.9) 36.4 (25.4)
Table 6.2: Mean (standard deviation) of cerebral blood flow (CBF) at base-
line, after acetazolamide (ACZ) injection and during the two hypoxic challenges
(Hypoxia A and B). Each event corresponds to a PET scan. Blood flow index
(BFI) measured by DCS and derived either using an individual µ′s for each
piglets and a common µ′s is presented. Regional CBF (rCBF) and global CBF
(gCBF) as obtained from the PET scans are also reported. * highlights statis-
tically significant difference from baseline as confirmed by a paired Wilcoxon
signed rank test (p<0.05)
considering the range in the y axis, as expected from the normalized mea-
surement, with a standard deviation of 0.224, corresponding to (-0.445,0.452)
as the limits of agreement. The bias in the logarithmic could be translated as
nrCBFPET=1.004×nrCBFDCS . By re-introducing the units for the two, a con-
version factor can be calculated as rCBF=0.89 (ml/100g/min)/(cm2/s)×109×
BFI, with (0.56, 1.39) (ml/100g/min)/(cm2/s) as the corresponding limits of
agreement.
Baseline BFI measurement of Group 2 of piglets were converted to rCBF
in flow units. No statistical significant difference was detected between the two
groups by a Wilcoxon signed rank test (p=0.06).



















































































































(b) common µ′s for population
Figure 6.3: BFI by DCS plotted against rCBF as measured by PET.
Pearson coefficient (R) with its p-value is shown, while the line was ob-
tained by the Deming regression. This has a slope and intercept of 1.34
(1.16,1.55) (cm2/s)/(ml/100g/min) and -4.43 (-9.79,-0.01) (cm2/s) respectively
if DCS analysis was performed with a individual µ′s for each piglet (a) and
of 1.15 (1.05, 1.27) (cm2/s)/(ml/100g/min) and -1.54 (-4.88, 1.47) (cm2/s) if
DCS analysis was performed with common µ′s for all the piglets (b). Numbers
in brackets represent the 95% confidence interval (CI). Colours code individ-
ual piglets (N=6). The grey circles highlight the scans which resulted in a
rCBF<8 ml/100g/min
6.4 Discussion
This chapter presents the validation of DCS towards the gold standard 15O
- water PET for measurement of rCBF on piglets. Such an animal model is


























































Figure 6.4: BFI by DCS (common µ′s analysis) is plotted against global
CBF (gCBF) as measured by PET. Pearson coefficient (R) with its p-value
is shown, while the line was obtained by the Deming regression. This has
a slope and intercept of 1.35 (1.21,1.45) (cm2/s)/(ml/100g/min) and -5.08 (-
8.64,-1.75) (cm2/s) respectively. Numbers in brackets represent the 95% confi-
dence interval (CI). Colours code the individual piglets (N=6). The grey circles
highlight the scans which resulted in a rCBF<8 ml/100g/min.
6.4.1 Haemodynamic and blood gas parameters at baseline and
during challenges
I will start comparing the CBF and BFI values found in our experiment with
the literature. The same PET scanner was used in a previous study with
older piglets (22 days instead of 11 days) [4]. They measured a higher base-
line gCBF (median 26 ml/100g/min, in a range between 16 ml/100g/min and
38 ml/100g/min), but the divergence in age could explain the difference.
As far as BFI is concerned, values presented here were lower that what
reported in another study using DCS on piglets [45,215]. Again, the comparison
is not straightforward, since they used a different anaesthesia and CBF, hence










































































Figure 6.5: Bland-Altman plot for the logarithmic transformation of nr-
CBF. The calculated bias is 0.004 and is shown by the black thick
line. The standard deviation estimated by the model is 0.224, which
results in the limit of agreement highlighted by horizontal dashed lines
(-0.445,0.452). The bias in the logarithmic could be translated as
nrCBFPET=1.004×nrCBFDCS . By re-introducing the units for the two, we
have rCBF=0.89(0.56, 1.39) (ml/100g/min)/(cm2/s)×109× BFI as the con-
version factor and the corresponding limits of agreement in brackets. Colours
code the individual piglets (N=6). The grey circles highlight the scans which
resulted in a rCBF<8 ml/100g/min.
BFI, depends on the anesthesia [215].
Evolution of blood gas parameters and cerebral haemodynamics was fol-
lowed throughout the protocol. In particular, ACZ injection caused an increase
in PaCO2 and CBF, as expected [219]. The hypoxic challenge was confirmed
by the decrease of PaO2 and SaO2, however the expected CBF increase was
not significant considering the whole group of piglets. This was due to a very
diverse response among different piglets. Bradycardia was observed and mean
arterial blood pressure decreased drastically in some of them and this caused a
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decrease in CBF, suggesting compromised autoregulation capacity. Nonethe-
less, these measurements were still useful for the purpose of the study, since
PET and DCS measurements were always acquired simultaneously.
6.4.2 µ′s in DCS analysis
In chapter 5 of this thesis and in various pieces of literature [48, 100], it was
reported how an accurate measurement of µ′s is fundamental to assure accuracy
in BFI estimation and how error and poor precision in µ′s is propagated in BFI
value.
For this reason, even when optical properties are measured concurrently,
a population average of µ′s is usually used in DCS analysis [60, 139], in order
to not propagate in DCS the error of µ′s. It must be noted that here the
distribution of BFI values did not considerably differ if a common value of
µ′s was used compared to using an individual estimation of µ
′
s, except from one
piglet. µ′s estimated value in this piglet, encoded with red dots in figure 6.2,
was the only one notably different from the average.
I have opted for presenting the complete results only using a common µ′s.
However, results would not have notably changed with the other analysis con-
figuration, as demonstrated from the correlation results.
Chapter 7 discusses results related to the different choices for µ′s in DCS
analysis when measurements are performed on infants.
6.4.3 Correlation between BFI and rCBF or gCBF
Correlation between absolute BFI values and rCBF was strong (R>0.9) with
high significance (p<0.0001) for both configurations of µ′s evaluation. The cor-
relation coefficient was slightly higher if using a common µ′s for all piglets. In
any case, the confidence intervals for slope and intercept estimated by the Dem-
ing regression overlapped in the two configurations. Notably, the confidence
interval of the intercept did not contain zero in the individual µ′s configuration
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and this was not expected, given the proportionality between BFI and rCBF.
One reason for this may be the increased, false, variability or a bias due to the
µ′s estimates.
It is of high interest that the BFI values highly correlated with the gCBF.
It means that the local measurement of perfusion by DCS is, in this protocol,
representative of the global CBF.
It has been highlighted that four PET scans resulted in a very low rCBF
(<8 ml/100g/min) due to a low mean arterial pressure and heart rate. Those
measurement were kept in the analysis and marked in the figures 6.3, 6.4, 6.5.
The fact that the correlation between BFI and rCBF or gCBF holds even with
these very low CBF measurements is a positive results. They surely emerge
in the Bland-Altman plot (figure 6.5), due to the low mean. In spite of this,
the difference between the methods is comparable to the range of all the other
measurements for three of them.
6.4.4 Calibration formula
The bias in the Bland-Altman plot built with the logarithm of the normalized
rCBF is practically zero (0.004), as expected from this normalization. For this
reason the scaling factor is approximately the ratio of the normalization factors.
Notably, it was comparable to the slope found with the Deming regression.
Thanks to the method used, limits of agreement were defined for the scaling
factor. Those are useful for conversion of single BFI measurements. The range
defined by the limits of agreement was surely quite wide (approximately the
90% of the scaling factor) and this limits the reliability of this calibration for
clinical purpose, for which it is necessary to have high confidence in a single
absolute value. Another limitation is due to the fact that the whole cerebral
cortex is used as the VOI to represent rCBF. It was not possible to consider
a smaller volume, close to the BabyLux probe, because of high noise in small
VOI that would have compromised the comparison between methods.
I have used the calibration formula to derive rCBF by single DCS mea-
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surements on second group (Group 2) of piglets, with the same age and weight
and prepared and monitored with the same protocol. Satisfactorily, converted
rCBF in Group 2 is not statistically significantly different to rCBF of Group 1
by PET (p=0.06). They lied in a quite wide range due to the limits of agree-
ment of the conversion formula. This procedure is not equivalent of comparing
BFI from the two groups because the conversion formula is derived from all
the measurements of Group 1 while rCBF in Group 2 is obtained by single BFI
measurements.
Our formula can be compared with the few previous studies that investi-
gated a calibration of the absolute BFI values in different population, such as
piglets, infants and adults [45,85,106]. It must be noted that these works used
different methods (phase contrast MRI and a combination of time-resolved dy-
namic contrast-enhanced near-infrared spectroscopy (DCE-NIRS) and DCS)
and estimation of absolute CBF may not be consistent among them, thus the
conversion formula may be dependent on the method.
The same piglet model was measured using DCE-NIRS, i.e. a flow tracer,
and DCS. They report a slightly higher scaling factor (1.14 (ml/100g/min)/(cm2/s))
than ours but still inside our limits of agreement [45]. This factor was con-
firmed by another recent calibration study employing the same method on
adults [85]. On the other hand, the work measuring gCBF with phase contrast
MRI on 4 days neonates with congenital heart disease reported a smaller factor
of 0.4 (ml/100g/min)/(cm2/s) [106]. This may be expected since it has been
suggested that phase contrast MRI measures usually larger gCBF values then
PET [180,217].
6.5 Conclusion
The study presented in this chapter validated regional CBF measurement by
DCS against the gold standard 15O - water PET in piglets. DCS measurements
were highly correlated with regional CBF and with global CBF. A conversion
116 Validation of CBF measurement by DCS with 15O - water PET
formula for this population was derived for obtaining rCBF in flow units by
single BFI measurement. The limits of agreement of the scaling factor are too
wide for a clinical use that would require high confidence in each single CBF
value.
Chapter 7
Clinical studies on infants
In the previous chapters I described the BabyLux device, explored its limits in
precision and accuracy and reported validation measurements of CBF towards
the gold standard positron emission tomography with 15O - water PET as a
tracer. After this, performance of the device in real clinical settings and on the
target population can be explored. This chapter is dedicated to the clinical
studies performed with the BabyLux device in two different neonatology units.
First of all, cerebral haemodynamics in healthy term newborns was measured
right after birth. In addition, a probe replacement protocol was implemented
to assess measurement reproducibility. Results from the measurement of the
transition at birth are reported in the manuscript: De Carli, A., Andresen,
B., Giovannella, M., Durduran, T., Contini, D., Spinelli, L., Weigel, U. M.,
Passera, S., Pesenti, N., Mosca, F., Torricelli, A., Fumagalli, M., Greisen, G.
(2019). “Cerebral oxygenation and blood flow in term infants during postnatal
transition: the BabyLux project”, ADC Fetal Neonatal Edition, submitted.
In the framework of the BabyLux project I was involved in the study design,
data acquisition and data analysis and interpretation. I acknowledge Bjørn An-
dresen and Gorm Greisen for conducting the study in Copenhagen and Agnese
de Carli and Monica Fumagalli for conducting the study in Milan, finalizing
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the statistical data analysis and writing the manuscript for the delivery room
protocol.
7.1 Background
The BabyLux project aimed at proposing a diffuse optical device that could
be a neuro-monitor for the preterm infant. As explained in chapter 1, this was
motivated by the current lack of a technology that can assess non-invasively and
continuously the cerebral haemodynamics at the cot-side. The BabyLux device
would allow to monitor the cerebral well-being of these infants that may suffer
cerebrovascular lesions during the first hours and days of life [25, 138, 193].
Continuous monitoring at the cot-side of brain haemodynamics could help
defining real-time clinical reference values to develop a brain-oriented clinical
care for the preterm newborns [25].
As explained in the previous chapters, the BabyLux device was developed
integrating time resolved near infrared spectroscopy (TRS), to measure blood
oxygenation in the microvasculature of the tissue, and diffuse correlation spec-
troscopy (DCS), to measure microvascular cerebral blood flow (CBF). The de-
vice was tested in laboratory settings and the regional CBF measurement was
validated towards gold standard positron emission tomography. Ultimately,
two devices were built and translated into two different neonatology units,
one in Rigshospitalet in Copenhagen, Denmark and the other in Fondazione
IRCCS Ca Granda, Ospedale Maggiore Policlinico in Milan, Italy. Clinical
studies involving healthy newborns were designed in order to test the device
performance and feasibility in clinical settings.
To start with, we tested the performance of the device by measuring cere-
bral haemodynamics right after birth on healthy term newborns delivered by
an uncomplicated elective cesarean section. First of all this was intended to
assess whether the BabyLux device could measure in a complicated environ-
ment such as the delivery room and fast enough to catch the response in
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the first minutes of life. BabyLux measurement of StO2 were intended to
be compared with previous works that employed commercial cerebral oxime-
ters [3, 11, 62, 102, 172, 213, 214]. Moreover this study added information on
CBF and cerebral metabolism, by measuring concurrently with DCS. These
two parameters had not been measured before due to the lack of technologies
to measure non-invasively CBF in the delivery room, right after birth.
The second study objective was to assess the variability of the BabyLux
measurement over probe replacement. This is interesting because poor pre-
cision over different replacements of the probe is an issue in the commercial
cerebral oximeters [78]. A replacement protocol on a healthy newborn head,
during its first days of life, was implemented.
7.2 Methods
The study was conducted according to ISO 14155:2011 with external moni-
toring. Local research ethics committees approved the same study protocol in
two centers (Rigshospitalet, Copenhagen, Denmark and Fondazione IRCCS Ca
Granda, Ospedale Maggiore Policlinico, Milan, Italy). The protocol is regis-
tered at ClinicalTrials.gov, identifier NCT02815618. Written informed consent
was obtained from parents or legal guardian prior to inclusion. The clini-
cal investigation has been monitored by external consultants according to ISO
14155:2011 “Clinical investigation of medical devices for human subjects- Good
clinical practice”.
7.2.1 Measurement protocol
Infants with gestational age of at least 37 weeks were included in the study
if planned to be delivered by an uncomplicated elective cesarean section. Ex-
clusion criteria were congenital malformation apparent at birth, need for any
additional assistance immediately following delivery and need for resuscitation
or supplementary oxygen during the first 10 minutes after birth. Parental
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consent was obtained before the elective cesarean section.
The protocol consisted of two phases, the first one took place immedi-
ately after birth and the other the following day. After birth the infant was
wrapped in warm towels and the head and right hand or wrist were cleaned
to remove vernix and amniotic fluid, to ensure good probe attachment. After-
wards the BabyLux probe was positioned in the fronto-parietal region, while
a pulse oximetry was placed in the right hand or wrist, to measure peripheral
saturation (SpO2) and pulse rate. Both probes were held by a self-adherent
bandage. The measurement were started as soon as the probe was in place and
it lasted for at least 10 minutes, while standard neonatal care was provided.
The same infant was measured on the following day in a protocol aimed
at assessing the repeatability of measurements. The probe was placed on the
fronto-parietal region with the infant at rest, maintained by a self-adherent
bandage, and 30 s of measurement acquired. Subsequently the bandage was
lifted and the probe released and put back on approximately the same position.
This was repeated until 6 sets of 30 s of measurement were acquired.
7.2.2 Data analysis
The BabyLux measurement were analyzed off-line, with the same procedure
explained in chapter 3 optimizing parameters for the infant measurement. In
particular, water content was assumed to be 90% [46]. DCS measurements
from all the infants were analyzed with the same µ′s, averaged from the whole
sample population.
Technical exclusion criteria were established for both DCS and TRS results.
A threshold was defined for the count level of each DTOF curve (1000 counts)
and for count rate registered by DCS detector during correlation curve acqui-
sition (10 kHz). Once performed the fit analysis, the mean of the residuals for
each data point were calculated and points where it exceeded 2 standard devi-
ation from the mean of the whole measurement in the infants were excluded.
The continuous data acquired in the delivery room by the BabyLux device
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were aligned with the pulse oximetry measurements. BFI and StO2 were aver-
aged in 10 s time windows as well as SpO2 from pulse-oximetry. Tissue oxygen
extraction was calculated as TOE=SpO2-StO2 and cerebral metabolic rate of
oxygen extraction index as CMRO2I=TOE × BFI.
Data from the replacement protocol were further cleaned. Specifically, the
30 s blocks with less than 50% of valid measurements were discarded. Only
the infants with 6 valid repetitions for DCS and for TRS, independently, were
further considered in the analysis.
7.2.3 Statistical data analysis
The relationship between each variable and time during the first 10 minutes
of life was studied with linear mixed effect (LME) models, with time as fixed
effect and subject as random effect. BFI and CMRO2I were previously log-
transformed to adjust their right-skewed distribution. BFI and StO2 values
were extracted for each infant averaging data from 10 minutes after birth until
completing the acquisition.
Data from replacement protocol were analyzed in order to define baseline
optical and haemodynamics properties. Mean and standard deviation (SD)
over the population were calculated, as well as median and I and III inter-
quartile. From the same protocol, the coefficient of variation (CV) of BFI and
StO2 during 30 s of continuous measurement and within replacement of the
probe was obtained. CV is defined as the ratio between the standard deviation
and the mean value.
BFI and StO2 measured in the delivery room after 10 minutes of life were
compared with the baseline values measured during the replacement protocol
by a paired Wilcoxon signed-rank test. Infants with successful measurement
for both protocols were selected for this purpose.
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7.3 Results
7.3.1 Study population
Thirty infants were enrolled. Four of them were excluded: one because needed
resuscitation at birth, two due to parental consent withdrawn and the last one
because of a software crash of the BabyLux device. Mean (SD) gestational age
was 38.4 (0.7) weeks; mean (SD) birthweight was 3258g (393g); male were 13
(50%); median (range) Apgar 1’ was 10 (8-10); median (range) Apgar 5’ was
10 (9-10).
After validity check of data, the final number of accepted infants measure-
ments from the delivery room protocol were 23 for SpO2, 23 for StO2 (TRS),
25 for BFI (DCS) and 20 for calculated TOE and CMRO2I. As far as the
replacement protocol is concerned, the number of infants with six repetitions
was 21 for StO2 (TRS) and 20 for BFI (DCS).
7.3.2 Baseline values
Table 7.1 reports the baseline values for optical properties and haemodynamic
parameters as measured in the first day of life during the replacement pro-
tocol. BFI and StO2 measured after birth, right after transition, were calcu-
lated for each infant averaging measurements from minute 10 after birth until
completing the protocol. These values were compared to the baseline mea-
surement performed during the first day of life, considering only the infant
with available measurements for both the protocols. DCS measurement from
N=18 infants were therefore available, median (I-III inter-quartile) for BFI
was 23 (19, 28)×10−9cm2/s as measured in the delivery room while 28 (23,
39)×10−9cm2/s as measured during the replacement protocol. No statistical
difference is registered between the two days by a paired Wilcoxon sign-rank
test. StO2 measurements were available from N=19 infants. 65% (59%, 70%)
is the median (I-III inter-quartile) measured in the delivery room, while 61%
(57%, 66%) what measured in the replacement protocol on the following day.
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Optical properties
mean (SD) median(I, III interquartile)
µa (cm
−1)
685 nm 0.18 (0.03) 0.183(0.166, 0.194)
760 nm 0.19 (0.03) 0.194(0.170, 0.218)
N=21 820 nm 0.19 (0.04) 0.192(0.151, 0.209)
µ′s (cm
−1)
685 nm 8 (2) 8.52(7.54, 9.53)
760 nm 7 (2) 7.01(5.54, 8.16)





HHb (µM) 29 (4) 30.3(28.0, 32.4)
StO2 60% (6%) 60.7 %(57.7%, 65.5%)
BFI (×10−9cm2/s) N=20 31 (11) 28.8(23.1, 38.7)
Table 7.1: Baseline values for optical and haemodynamic properties in healthy
term newborns as measured by the BabyLux device in the first day of life.
Mean, standard deviation (SD), median and I and III inter-quartile range are
reported.
No statistical difference between the two days is found.
7.3.3 Cerebral haemodynamics after birth
The average starting time for the measurement after birth was 3.5 min (stan-
dard deviation of 1.5 min). Only measurements from minute 3 were considered.
Figure 7.1 reports measurements acquired from all the infants for StO2, SpO2,
BFI, OE and CMRO2I. Black lines referred to the results of the LME model,
a change over time was found to be significant for all the variables in the first
ten minutes after birth. Specifically SpO2 increased over time (estimate 3.05
%/min; CI: 2.78, 3.31 %/min; p<0.001) as well as StO2 (estimate 3.95 %/min;
CI: 3.63, 4.27 %/min; p<0.001), whereas BFI (estimate -2.84×10−9cm2/s/min;
CI: -2.50×10−9, -3.24×10−9cm2/s; p<0.001) and TOE (estimate -0.78%/min;
CI: -1.12, -0.45 %/min; p<0.001) decreased. Analogously CMRO2I decreased
(estimate -7.94 10-8/min; CI: -6.2610-8, -9.6210-8 /min; p<0.001).
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Figure 7.1: Peripheral arterial saturation (SpO2) (a), tissue oxygen saturation
(StO2) (b), tissue oxygen extraction (TOE) (c), blood flow index (BFI) (d)
and cerebral metabolic rate of oxygen extraction index (CMRO2I) (e) in the
minutes after birth measured in all the infants. Black lines indicate the results
of the LME model.
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7.3.4 Variability over replacement
Figure 7.2 shows the six measurements of StO2 and BFI acquired on each
infant included in the study. StO2 results to have a mean CV of 4.3% within
30 s of continuous measurement and 5.2% over the six replacements. On the
other hand BFI has a mean CV of 11% and 21,6% within 30 s of continuous
measurement and over the six replacements, respectively (table 7.2).











median 3.1 (2.1,4.1) (×10−9cm2/s)
CV30s
mean 11.0%
median 9.5% (8.0%, 12.9%)




median 2.6% (1.8%, 4.0%)
CVrepl
mean 5.2%




median 5.6 (3.9, 8.4) (×10−9cm2/s)
CVrepl
mean 21.6%
median 21.5% (15.0%, 23.5%)
Table 7.2: Standard deviation (SD) and coefficient of variation (CV) over 30 s
of continuous measurement and over six replacements of the probe for StO2 and
BFI. Mean and median (I, III interquartile) over the population are presented.










































































































































































































































Figure 7.2: BFI (a) and StO2 (b) measurement over the six replacements of
the probe for each infant.
7.4 Discussion
7.4.1 Baseline parameters
I reported baseline optical and haemodynamic properties as measured by the
BabyLux device in 21 healthy newborns (20 for BFI). Values we found for
optical properties are in the quite wide range reported in previous literature,
considering both FD-NIRS and TRS [43,60,98,203,228].
Analogously, reported absolute values of StO2 are not uniform within differ-
ent studies and different devices. Our values are comparable to what measured
by FD-NIRS on healthy infants [42,60], but slightly lower than what measured
previously with TRS [203] and much smaller than measurement with pediatric
or neonatal sensor of commercial cerebral oximeters [12, 18]. It has been ob-
served that cerebral oximetry devices with neonatal sensor display higher value
than the adult device and in general measurement over different commercial
sensors are not comparable [50,122]. This considerable variability between in-
strumentations is an issue when a threshold for normal StO2 values must be
defined, as done in guidelines for ongoing clinical trials [96]. This must be im-
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proved, on one side, working on standardization procedure and better protocols
for assessing accuracy and precision. From the other side, more multi-center
clinical studies enrolling a large number of infants should be run. Focusing
on inter subject variability, our results are comparable to what measured with
CW-NIRS [12, 18] and equal or lower with what measured with FD-NIRS or
TRS [42,60,203].
BFI absolute measurements on infants have also been previously reported.
An average BFI value (standard deviation) of 21 (8) ×10−9 cm2/s has been
recently measured in a group of 30 healthy term infants [60]. Nonetheless, a
higher value (35 ×10−9 cm2/s with a inter-subject coefficient of variation of
30%) has been measured in a control group of 13 healthy infants [40]. Our
measurements lie between these two results. Variability among subjects is also
comparable between our study and those previous works [40,60], being 35% the
ratio between standard deviation and mean over the sample in our protocol.
It must be noted that other standard technologies for blood flow measurement
have a considerable inter-subject variability, but usually lower than what we
found. For example, a recent PET study on four healthy newborns report a
variability of 23% among infants, while a between-subject variability of 27%
is associated to 133Xe clearance method [10]. PET-measured CBF variability
among subjects seems lower in adults, being around 15% [1,86].
Few words must be spent on the fact that a common value for reduced
scattering coefficient was used for all infants in DCS analysis. Chapter 6 re-
ported that a slightly higher inter-animal variability was registered for BFI if
an individual µ′s for each piglet was considered in DCS analysis. Along these
results, the BFI variability among infants increased drastically if an individual
value of µ′s was inserted in DCS analysis, reaching a value higher than 50%.
The error in µ′s is clearly being translated into an error in BFI, as explored in
chapter 5 and in other pieces of literature [100]. For this reason we decided to
consider a common µ′s for all infants, as it is usually currently done for infant
protocols [60, 139]. Surely, it is necessary to improve the accuracy of in vivo
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µ′s estimation for an accurate absolute estimation of BFI.
No statistical difference was detected between BFI and StO2 measured
in the delivery room and on the following day for the replacement protocol.
Nonetheless, the tendency to increase for the former and to decrease for the
latter is comparable to what previously observed in the first weeks of life [187].
To conclude discussion on baseline measurements, DCS measured CBF can
be converted in flow units using the calibration formula found for piglets in
chapter 6. Converting the sample average BFI results in a flow of 27 ml/100g/min,
slightly higher than what is assumed to be the baseline CBF in healthy new-
borns (20 ml/100g/min) [77]. It must be reminded that very few studies have
measured CBF in this population and generally a wide range of values is re-
ported.
7.4.2 Cerebral haemodynamics after birth
The BabyLux device was used to study the cerebral haemodynamics during
the first minutes of life, after an elective cesarean section, in healthy newborns.
Measurement acquisition in this environment is quite complicated and the rate
of valid measurement is a success, being comparable with the commercial pulse
oximetry success rate.
After birth the circulation of the newborn changes from the fetal to the
mature, extra-uterine one. After the first breaths the pulmonary vascular re-
sistance drops, the circulation undergoes a transition from parallel to serial
and the ductus arteriosus shunt started to close [162]. The peripheral arterial
saturation is known to increase from around 60% to the usual 90% [38]. The
increase we see in SpO2 is comparable to the expected and previously mea-
sured behavior. Tissue oxygen saturation increases due to the increase in the
arterial saturation. The StO2 increase is comparable with what reported from
previous studies [3, 11, 62, 102, 172, 213, 214]. It must be considered that all
these works employed commercial cerebral oximeters, measuring higher values
than ours as already noted. The measurement of both SpO2 and StO2 were
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used to estimate the TOE, considering a compartmental model where arterial
to venous fraction is constant [37]. Notably, this may not be true when a dras-
tic change in saturation happens [225]. Nonetheless, most of the already cited
works investigated oxygen extraction. They all measured FTOE = (SpO2-
StO2)/SpO2 instead of TOE and the two cannot be compared in values due to
the high increase in SpO2. In any case, all of them measured a decrease as in
our measurement [3,11,172,214]. None of the previous work measured the CBF
in the transition after birth and this is what our study adds. A decrease in
CBF is measured from minute 3 to minute 10 of life. This decrease is in accor-
dance with a measurement on sheep model with injected radionuclide-labeled
microspheres [103]. In addition CBF velocity (CBFV) was found to decrease
during transition after birth in humans, as measured in the middle cerebral
artery from minute 5 of birth, with a resolution of about 5 minutes [163]. This
is in accordance with our measurement even if they do not coincide temporally
and CBFV is just a surrogate measurement of blood flow. This decreases in
CBF can be motivated by a compensatory response to the increased oxygen
content in the arterial compartment. It has also be related to changes in car-
diac system. In particular the compensatory increase of the left ventricular
output may be inadequate considering the increase of left to right shunt across
the ductus arteriosus.
With the added information on blood flow, we could measure the metabolism.
This is not expected to change especially after a cesarean section, which does
not cause any stress to the baby. In particular, infants born by uncomplicated
cesarean section have low levels of catecholamine, an indirect measure of the
metabolic activity, compared to those vaginally delivered. Therefore they are
not expected to be significantly stressed or asphyxiated and to have developed
an oxygen “debt” during delivery [99, 134, 206]. In any case metabolism has
never been measured before and the 50% decrease during the first ten min-
utes of life we found cannot be compared to other works. We can speculate
that arousal occurring at birth could be associated with higher CMRO2I and
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that we are measuring its descending curve. Our results therefore may suggest
that even an uncomplicated cesarean section involves some physical stress and
strain. It must be noted that, this calculation of CMRO2I can hide different
source of errors, due to the variables that enter the formula. Furthermore er-
rors may be oxygen content-dependent. The main weak point is calculation
of oxygen extraction using all-optical measurements. This assumes a stable
arterial to venous fraction components, which may not be valid in the drastic
change in oxygenation we are measuring. Specifically, there are some evidences
that this ratio is dependent on the saturation level itself [225]. CMRO2I cal-
culation by all-optical measurements has been previously validated in piglets
with good results [215]. Even if they explore a wide range of StO2 by varying
the anesthesia, SaO2 is stable in their experiment, differently from ours.
7.4.3 Variability of BabyLux measurement
To start with, I will focus on the variability during 30 s of continuous mea-
surements that can be directly compared to results on simulated, phantom and
piglet data as reported in chapter 5. Remarkably, precision for StO2 is perfectly
comparable to simulation results at the same count level and StO2 absolute
value. On the other hand, 30 s precision for BFI in infants is higher than the
simulation results. The range over the sampled infant population is quite nar-
row and is comparable to the largest values found for piglets. Different factors
may have increase the variability of the BFI during continuous measurement in
infants compared to piglets. Piglets were anesthetized, therefore, on one side,
those measurements do not suffer from motion artifacts. On the other side,
intrinsic variability is expected to be smaller during anesthesia.
The other aim of this clinical study was to investigate the variability over re-
placement of the BabyLux probe. This was motivated by the fact the standard
deviation for StO2 within probe replacement found with commercial oxime-
ters was considered too high for clinical purpose [78]. Standard deviation over
probe replacement for StO2 was here 3% on average. This is lower than what
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measured in commercial cerebral oximeters [88,95,200], a part from the FORE-
SIGHT device. It must be noted that StO2 as measured by the latter changed
less than expected in the transition after birth [88], giving doubt on the validity
of those measurements. In addition, it should be considered that we measured
lower absolute value of StO2. From the simulation results reported in chapter 5
it is clear that the CV and standard deviation are higher at lower StO2 values.
It has been demonstrated a much lower precision (less than 2%) if SpO2 and
continuous StO2 measurement are concurrently registered and used to account
for physiological and cerebral variation [123]. This was not implemented in
the current protocol, which aimed at assessing the precision the clinical per-
sonnel could expect from a single StO2 measurement of the BabyLux device.
Even if considering this simpler protocol and analysis, our results improved the
variability of StO2 compared to the commercial cerebral oximeters. However,
technological progress should still be focused on improving this result, in order
to set a reliable threshold for normal values of StO2 and act when different
values are measured.
The reproducibility of BFI measurement over probe replacement (22%) is
not easily comparable with other technologies as temporal resolution varies
greatly, from seconds with optical methods to minutes with PET, due to dif-
ferences in protocol for data acquisition and processing. In any case, test
re-test variability with other modalities is not considerably lower than what
we reported for DCS. Specifically, it was estimated to be from 8% to 27%
with Xenon clearance method [80], while it is around 17% if NIRS technnology
with injected tracer is used. It is reported to be lower with PET in adults
(12%) [86], but in our piglets measurement it was actually 20% (chapter 6). In
adults, variability over measurement is lower with ASL-MRI (5%) [86], but in
infants it is expected to be higher with the same technology [220].
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7.5 Conclusions
The BabyLux device could be translated in the clinics for small clinical studies
and gave successful results. It could be employed to measure cerebral oxygena-
tion after birth, in the complicated environment of the delivery room and with
the necessity of starting rapidly the measurement to catch the rise in oxygena-
tion. It proved its feasibility to be used in this protocol, without losing more
measurement than the commercial and simpler pulse oximetry. The rise in tis-
sue oxygenation was as expected and we added measurement on cerebral blood
flow and metabolism. The decrease in CBF was not in contrast with previous
findings, while the decrease in metabolism was not expected but could not be
compared with any other measurement. Reproducibility over probe replace-
ment of StO2 was better than with commercial oximeter, while for BFI was
comparable with other technologies which, however, do not measure perfusion
continuously with such a temporal sampling.
Part III
Hybridization of a commercial
DCS device and a prototype
of a TRS device

Chapter 8
The integration of the two
devices and test in laboratory
settings
The third part of this thesis is focused on the development of an integrated
diffuse optical device using a commercial DCS device and a prototype for a
TRS device and on its application in a neuroscience study.
As a DCS device, the HemoFloMo (HemoPhotonics S.L, Spain) was avail-
able in our laboratory, while a prototype for a TRS device (TRS-20 by Hama-
matsu Photonics K.K., Japan) was loaned to our group by Hamamatsu Pho-
tonics K.K., Japan. The prototype was modified into TRS-20I by the manu-
facturer for the purpose of the integration with the DCS. In this chapter the
two devices are described, as well as the communication protocol between the
two and the development of the integration. Results of laboratory tests are
also presented.
136 The integration of the two devices and test in laboratory settings
(a) (b) )
Figure 8.1: Picture of HemoFloMo (HemoPhotonics S.L., Spain) (a) and TRS-
20 (Hamamatsu Photonics K.K., Japan (b).
8.1 HemoFloMo
HemoFloMo (figure 8.1(a)) is a commercial DCS device developed and com-
mercialized by HemoPhotonics S.L., Spain. It uses a CW long coherence length
laser at 785 nm. Its light can be switched by an optical fiber switch within four
source channels and an OFF position. In addition it has eight parallel detector
channels. The user can select the configuration of the probe used and one or
more detector channels can be associated to any of the source channels. There
are no fibers included with the device, custom fibers from the user must be
used. The device has four input and four output electrical channels, already
integrated in the device. One of the output channels is dedicated to the marker
signal, therefore each time a mark is selected in the device a signal is sent out
from this channel. The others can be used by the user with a certain freedom,
programming the measurement routine of the device.
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8.2 TRS-20I
TRS-20 (figure 8.1(b)) is a prototype of a commercial TRS device by Hama-
matsu Photonics K.K., Japan, based on the TRS-10 system that has been
previously described [167].
It works with three laser sources at 760 nm, 800 nm and 830 nm. The
repetition rate of the lasers is 5 MHz and the IRF has a width of about 300 ps.
It has two source-detector channels. The system includes two complete sets of
fibers for the two channels, either normal straight fibers or prism fibers. The
latter allow for the fiber cable to run perpendicular to the direction of light
injection and are particularly useful for measuring on the fore-head. Cases for
IRF measurement are provided for both the fiber types
Signal Direction Details
Marker IN it marks an event in TRS-20I recording
Trigger IN it triggers TRS-20I measurement
Auto-Zero IN it defines the end of the baseline period
SW1 OUT it switches the state of fiber switch 1
SW2 OUT it switches the state of fiber switch 2
Done OUT voltage pulse after TRS-20I acquisition
Enable OUT high when TRS-20I is in acquisition mode
Busy OUT high when TRS-20I is acquiring data
Table 8.1: Input/Output channel for TRS-20I. Direction refers to whether each
signal is an input or output channel and a short description for each signal is
reported. Only the black font channels have been used in the integration
protocol.
The TRS-20 has been modified to allow for communication with another
device, I will refer to this modified device as TRS-20I. First of all, optical fiber
switches with one input and two output positions (FSM 1x2, piezosystem jena,
Germany) have been added. In this way the light could be deviated from the
source and sent to an OFF position. In addition an external digital input
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output board has been added. This is consist of a NI Compact- DAQ 4-slot
USB Chassis (NI cDAQ-9174, National Instruments) and a two 4-Channel,
LVTTL Digital Input/Output Module (NI 9402, National Instruments). Ta-
ble 8.1 reports the input and output channels configured in the input/output
board. Only the channels reported in black font have been used in the final
integration protocol.
For completeness, I must conclude the section highlighting that TRS-20
has not been introduced to the market, but Hamamatsu Photonics K.K. has
commercialized another TRS device called tNIRS-1 [69]. The pulse width of
the source (1.5 ns) in this system is significantly larger than what is usually
used in TRS devices (few hundreds of ps). Nonetheless, results for optical
properties are comparable to what is measured by TRS-20 in phantoms and
precision of the instrument is better than the CW-NIRS device commercialized
by the same company (NIRO-200NX) [69].
8.3 Integration
In figure 8.2 a picture of the hybrid device composed by HemoFloMo and TRS-
20I is shown. The integration was designed with HemoFloMo as the master.
As explained above, HemoFloMo gives the freedom to the user to select a
routine of events, which defines the behavior of input and output channels
with respect to the DCS curve acquisition. When the start command is given,
the routine will be executed and then iterated until the system is stopped. For
the purpose of the communication with TRS-20I, the sequence of events in the
DCS functioning has been set as:
• DCSscan (DCS acquisition)
• TriggerON (to set trigger output level to high)









Figure 8.2: The hybrid device formed by TRS-20I and HemoFloMo is shown.
Optical fiber switches and input/output module added to TRS-20 for the pur-
pose of the integration are highlighted. The probe that encases fibers for both
devices is also shown.
• TriggerOff (to set trigger output level to low)
• waitTrigger (to wait for a trigger input, “Done” signal of TRS-20I,
before the next step)
Figure 8.3 reports a schematic view of the communication protocol between
the two devices. First device to be started is the TRS-20I, the “Enable” sig-
nal is raised to high level and the device is waiting for a trigger to start the
acquisition. Once HemoFloMo is also started, the procedure explained above




































Figure 8.3: Communication protocol between HemoFloMo and TRS-20I. DCS
acquisition is triggered by the signal “Done” from the TRS, while TRS acqui-
sition by the signal “Trigger” from DCS. In each of the two devices, once a
measurement is acquired, the light is switched from the ON position, corre-
sponding to the probe, to an OFF, unused, position.
in the routine is followed. Therefore, a DCS acquisition is completed and, af-
terwards, a trigger pulse is sent to TRS-20I, through the channel “Trigger”,
and the HemoFloMo is in a waiting state until the next trigger. TRS-20I ac-
quires one measurement and sends a trigger to HemoFloMo through the signal
“Done”. In order to avoid the two devices mutually disturbing the measure-
ment, after each acquisition the optical fiber switches in the two devices turn
the light from the probe into an OFF position. In addition, TRS-20I closes a
shutter in front of its detectors after each measurement and opens them before
each acquisition. This is because the high power HemoFloMo laser light would
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cause saturation of TRS-20I detectors. On contrary, TRS-20I light is weak
enough to not cause any damage to HemoFloMo detectors.
The acquisition time for the two devices can be set by the users, typical
time sampling is reported in figure 8.3. DCS measurements can be usually
acquired with 1 s of averaging time with HemoFloMo. On the other hand,
longer integration time is needed for TRS-20I. According to the device manual,
a ratio of at least three decades is suggested between noise level and the peak
of the DTOF. This is usually achieved with 3-5 s of integration time.
When an event is marked in the HemoFloMo, a signal “Marker” is sent to
TRS-20I and the mark registered in its own acquisition. This property is used
for the synchronization of the two device acquisition.
8.3.1 Probes
Custom probes have been designed in order to host fibers of both devices.
The source detector positions of the two devices must preferably lie in a cross
configuration, in order to probe the same area with the two techniques. In
figure 8.4 example of two probes designed in compliance with this condition
is shown. In those examples two detector positions are foreseen for DCS. The
cross configuration is valid for the long DCS source detector separation. The
probe displayed on the left side of figure 8.4 is designed for TRS-20I prism fibers
and for DCS bent fibers, therefore it would have fibers running parallel to the
probe surface. While the one showed on the right side is used for straight fiber.
The choice between the two probes depends on the application, the former is
useful for measuring on the fore-head, while the latter one is preferable for
phantom measurements or big muscles, e.g. the thigh.













Figure 8.4: Examples of probes that can encase both HemoFloMo and TRS-20I
fibers. The probe on the left side is designed for TRS-20I prism fibers and for
DCS bent fibers, while the one on the right side (bottom and side view) can be
used with TRS-20I and DCS straight fibers. Two detectors are used for DCS
in these probes, one located at 25 mm from the source and the other one at
10 mm. Source-detector distance for TRS is 25 mm.
8.4 Tests in laboratory settings
8.4.1 Methods
Accuracy of optical property estimation by TRS-20I was tested by measur-
ing six different solid phantoms (INO, Canada). The phantom manufacturer
provides results of their optical property estimation by its own TRS system,
claiming an accuracy of 20%. The solid phantoms were not measured at exactly
the same wavelength by the manufacturer. Optical properties were specified
by INO at 785 nm and 830 nm for all the phantoms, therefore the former was
compared to the TRS-20I measurements at 760 nm, being the closest, and the
latter one matches the corresponding TRS-20I measurements. Ten measure-
ment were acquired for each phantom with an integration time of 5 s. Results
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obtained from the ten acquisitions were averaged.
In order to test whether the communication between the two devices was
working smoothly, an over-night measurement on a liquid phantom made with
synthetic scatterers diluted in water and provided by HemoPhotonics S.L,
Spain [169] was performed. Nominal optical properties were 0.1 cm−1 for
µa(785 nm) and 10 cm
−1 for µ′s(785 nm), while nominal BFI amounts to 10
−8
cm2/s. Integration time was set to 5 s for TRS, while averaging time to 2 s for
DCS. 5000 measurements were acquired representing the maximum number to
be stored on TRS-20I. This measurement allowed to investigate:
• the communication signals between the two devices with an oscilloscope.
• the β parameter of DCS curve and the background counts measured by
TRS. These quantities allowed to check whether light levels of the two
devices mutually interfere in their measurements.
• the stability of optical and dynamic property estimation along several
hours of measurement.
8.4.2 Results
Figure 8.5 reports the solid phantom optical properties measured by TRS-20I
and compares them to what has been measured by the manufacturer, consid-
ering an accuracy of ±20%. All points measured by TRS-20I lie inside the
accuracy ranges, it can be observed an over-estimation of the µ′s, especially for
lower µ′s values.
The two signals “Trigger” and “Done” were monitored by an oscilloscope
with the settings used for the over-night measurement on a liquid phantom.
The monitored signals are reported in figure 8.6. The time between receiving
the start trigger and sending the trigger after the measurement is larger than
the sampling time chosen for the two devices. The difference is due to the
actions performed by each device to prepare and to close the measurement
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Figure 8.5: Optical properties of the six solid phantom (INO, Canada) mea-
sured by TRS-20I. Absorption coefficients are reported on the x-axis, while
the scattering coefficients are indicated on the y-axis. The rectangles report
the characterization performed by the manufacturer: the center is the value
measured and the border the 20% accuracy.
before sending the trigger to the other (change of optical switches state and
shutting of the detector for TRS). Over the 5000 measurements the average
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time difference between two consecutive measurements is 9.1 s as registered by
both devices, in accordance to what can be seen in figure 8.6.

























Figure 8.6: The two signals “Trigger” and “Done” measured by an oscilloscope,
when TRS integration time is set to 5 s and DCS averaging time to 2 s. “Trig-
ger” triggers the TRS-20I measurement while “Done” triggers the HemoFloMo
measurement.
From the over-night measurement, β parameter of DCS curve and the back-
ground counts measured by TRS are the first parameters to be checked to assess
the robustness of the integration. Spurious incoherent light would indeed lower
the β parameter, while DCS light shining from the probe during TRS measure-
ment would most probably saturate the TRS detector or at least increase the
background noise. Figure 8.7 reports stability of these parameters over several
hours of measurement therefore it assures stability of communication between
the two. Optical and dynamic properties estimated by the hybrid TRS-20I and
HemoFloMo are reported in figure 8.8. They appear stable over the 12 hours
of measurement.
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(a) β parameter, HemoFloMo































(b) Background counts, TRS-20I
Figure 8.7: Results from an over-night measurement on a liquid phantom. (a)
histogram of β parameter measured from DCS curves acquired by HemoFloMo.
Absence of low values assure that TRS light was not interfering with DCS mea-
surement. (b) Background counts in TRS spectrum. The stability prove that
DCS light did not interfere with TRS measurement and the communication
between the two was stable over-night.
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(b) Reduced scattering coefficient






















Figure 8.8: (a) Absorption, (b) reduced scattering coefficients (at three
wavelengths) and (c) BFI of a liquid phantom by the hybrid TRS-20I and
HemoFloMo.







In this chapter I present a study performed with the hybrid TRS-20I and
HemoFloMo device, described in the previous one. The device was used to
monitor cerebral haemodynamics during transcranial direct current stimula-
tion and, concurrently, electroencephalography was also measured. The aim is
to explore the possibility to use diffuse optical cerebral haemodynamic monitors
to gain online feedback of the stimulation, in order to improve and optimize
protocols of intervention. EEG is the technology commonly used for monitor-
ing the effect of the stimulation and the study purposes included demonstration
that we could concurrently monitor the two aspects of the cerebral response to
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the stimulation, the neuronal and haemodynamic activity. This study has been
published in the paper: Martina Giovannella, David Ibañez, Clara Gregori-Pla,
Michal Kacprzak, Guillem Mitjà, Giulio Ruffini, Turgut Durduran, “Concur-
rent measurement of cerebral haemodynamics and electroencephalography dur-
ing transcranial direct current stimulation”, Neurophoton. 5(1) 015001 (25
January 2018)
9.1 Background
In the introductory chapter of this thesis (chapter 1) I highlighted that diffuse
optical neuro-monitors can be used to investigate the cerebral response to a
stimulation thanks to the principle of neurovascular coupling. Specifically, we
have here investigated the cerebral haemodynamics during and after transcra-
nial direct current stimulation.
Transcranial current stimulation (tCS) is a non-invasive form of brain stim-
ulation that applies weak direct electrical currents to the brain through elec-
trodes placed on the scalp. Different types of stimulation are available based on
how the current delivered to the brain is modulated [191]. The most common
approach is to hold the current constant during the stimulation period, this is
known as transcranial direct current stimulation. This method is commonly re-
ferred to as tDCS, but in order to avoid confusion with the optical method, we
here use DC-tCS. DC-tCS induces bidirectional, polarity dependent, changes
in cerebral excitability of humans [160, 179] and has been shown to modulate
cognition in both healthy subjects (improvement of cognitive function) and
in patients (reversing the effects of cognitive deficits after a stroke) [31, 32].
Positive effects have also been shown in treatment of depression, chronic and
acute pain, Parkinson’s disease, focal epilepsy and for improving recovery after
stroke [27,68,71,131]. A therapeutic application of this technique is appealing
due to its relative low cost, to its demonstrated safety [8] and as a substitute
for pharmacotherapy, especially for patients with poor drug tolerability [27]. In
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order to define protocols of application and to optimize the individual dosage
of stimulation, the effects of the stimulation on the cerebral activity must be
monitored in real time [17, 197]. Availability of a concurrent read-out of the
stimulation effects could improve its effectiveness and, ultimately, a personal-
ized stimulation driven by the neuromonitor feedback can be imagined [117].
For this purpose, due to the complex nature of cerebral activity, multimodal
monitoring is preferable [94, 189], such that different monitors integrated in
a single set-up can allow to record the effects at different levels, from neu-
ronal activity, to haemodynamics to systemic [92]. The neuronal activity is
evaluated by electroencephalography (EEG) which measures the synchronous
activation of a large population of pyramidal neurons oriented perpendicularly
to the scalp. On the other hand, cerebral haemodynamics can be used as a
surrogate measure of the cerebral activation assuming that cerebral blood flow
(CBF) increases in a region of the brain where neurons and synapses are ac-
tivated in order to meet the demand for more energy and that the amount
of local increase of blood flow and the changes in oxygen saturation are re-
lated to the cellular energy consumption [185]. Even if different options are
available as neuro-monitors of haemodynamics, functional near infrared spec-
troscopy (fNIRS) appears to be the best suited for this application [150]. fNIRS
refers to the usage of NIRS technologies to investigate cerebral response to an
evoked or spontaneous brain activation. It allows for continuous non-invasive
measurements, does not require the immobility of the subject and it is not nec-
essary to change the environment preferable for the stimulation to integrate
fNIRS in the protocol [150]. These advantages are fundamental for this kind
of application. CW-NIRS has indeed already been used as a monitor during
DC-tCS, both in animals [82] and on humans at rest [118, 151, 154] and dur-
ing tasks [101, 111, 118]. It has also been used together with EEG to monitor
DC-tCS [109] and a device integrating the two monitors have been developed
and characterized [129, 192]. Despite of the successes of these studies, it must
be reminded that CW-NIRS does not allow a quantification of absolute value
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of HbO2 and HHb concentration, lacks precision and accuracy [93] and does
not give a direct measure of CBF, the primary marker of the neurovascular
coupling.
In this work, we propose to use time resolved NIRS (TRS) and diffuse corre-
lation spectroscopy (DCS), together with EEG, as neuro-monitors of the brain
stimulation. The hybridization of a commercial DCS device, HemoFloMo,
and a prototype of a TRS device, TRS-20, presented in the previous chap-
ter has been used for this purpose. Here HemoFloMo and TRS-20I are used
together with EEG to monitor cerebral activity before, during and after ten
minutes of DC-tCS over the frontal cortex. This area is the most convenient
choice for the diffuse optical monitors because of the lack of hair. Since its
stimulation has been proven effective for the improvement of various cogni-
tive functions [47, 56, 65, 66, 107, 121, 155, 223], for example working memory
enhancement [7, 67, 168, 227], and for treatment of depression [24, 131, 159], it
is also a relevant area to stimulate and study.
9.2 Methods
9.2.1 Transcranial direct current stimulation and EEG device
DC-tCS was delivered using Neuroelectrics Starstimr (Neuroelectrics, Barcelona,
Spain) which is a research-class eight channel transcranial current stimulator
that is also capable of measuring EEG. 12 mm diameter silver chloride elec-
trodes (Ag/AgCl) with conductive saline gel were used both for EEG recording
and for stimulation. Eight electrode (AF7, AF8, FT7, FT8, TP7, TP8, PO7
and PO8) locations were chosen as depicted in figure 9.1(a) according to the
10-10 EEG system [112]. In particular, the active electrodes during stimula-
tion were AF7 (left frontal lobe) and PO8 (right parieto-occipital lobe). From
now on, we will refer to the former (AF7) as the stimulation electrode while to
the latter (PO8) as the return electrode. All the eight electrodes functioned as
EEG recording electrodes for protocol periods that did not involve stimulation.
9.2 Methods 153
EEG spectrum was sampled at 500 Hz.
9.2.2 Hybrid TRS-20I and HemoFloMo
Cerebral haemodynamics was monitored in this study using the device de-
scribed in details in chapter 8. It is a hybridization of a commercial DCS
device, HemoFloMo (HemoPhotonics S.L., Spain), and of a prototype of a
TRS device, TRS-20 (Hamamatsu Photonics K.K., Japan). Therefore it can
measure concurrently the cerebral blood flow in the microvasculature of the
tissue and the blood oxygenation in the microvasculature of the tissue. In
this measurement, the HemoFloMo averaging time was set to 1.5 s, while the
TRS20I integration time was adjusted between 3-4 s depending on the counts
collected in each subject. As explained, the sampling time was the sum of
the two device acquisition times, with some delay due to the details of the
hybridization, resulting in a sampling time of 6-8 s.
The probe 3D-printed in flexible material and used for this protocol is shown
in figure 9.1(b). It can accommodate not only the fibers for DCS (source-
detector separation 2.5 cm) and for TRS (source-detector separation 3.7 cm),
but also an electrode. Two of these probes were placed on the forehead of the
subject, one on the left hemisphere in correspondence with AF7, carrying the
stimulation electrode, while the other on the right hemisphere in AF8 position
with a purely EEG recording electrode. Two of the four sources available for
HemoFloMo were used, one for the left and one for the right hemisphere. For
each hemisphere, only one detection position was implemented using a bundle
of four single-mode fibers probing the same area, i.e. all the eight detector
channels were used. The correlation curves collected by four fibers in the same
area were averaged in order to improve the signal-to-noise ratio. On the other
hand, the two independent source-detector channels of the TRS device (TRS-
20I) were used for the two hemispheres.
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Figure 9.1: (a) A schematic of the optical probes, stimulating and return elec-
trodes and EEG recording electrodes superimposed on a standard 10-10 EEG
system. (b) Image of the integrated probe that could accommodate optical
fibers (both for DCS and TRS) and an electrode. (c) Schematic of the pro-
tocol that lasted a total of fifty minutes divided in five ten minute periods.
Stimulation was delivered during the second period.
9.2.3 Protocol
Healthy, right-handed adult subjects were recruited for three sessions of com-
bined stimulation and measurement: anodal (i.e anode in AF7 (stimulation
electrode) cathode in PO8 (return electrode)), cathodal (i.e. cathode in AF7,
anode in PO8) stimulation sessions and a sham session. Such a montage creates
an electric field that crosses the brain as confirmed by simulation of the electric
field distribution in the brain (data not shown). For half of the subjects, the
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anodal was the first session, while for the other half cathodal was. Sham stim-
ulation was always given during the third session. All sessions were separated
by a wash-out period of at least one week. The studies were approved by the
ethical committee of Hospital Clinic in Barcelona. Each subject signed an in-
formed consent and the study was conducted according to the principles of the
Declaration of Helsinki. Exclusion criteria included the history of neurological
and psychiatric conditions and the current use of psychoactive medications.
A schematic of the protocol is presented in figure 9.1(c). The protocol
consisted of fifty minute measurement sessions divided in five periods. After
ten minutes of baseline (PRE period), ten minutes of stimulation was given
(DURING period), then thirty more minutes were recorded (POST1, POST2
and POST3 periods). During the stimulation, a current of 1 mA (resulting in
a current density of 0.88 mA/cm2) was delivered to the brain with a ramp up
of 30 s at the beginning and a ramp down of 30 s at the end of the stimulation
period. Such a duration for ramp up and down was chosen considering that a
shorter one could cause a itching and disturbing sensation for the subject. In
the sham session, the current was ramped up to 1 mA in 30 s and then brought
back to zero in 30 s. After eight minutes, it was again ramped up and down to
simulate the real stimulation sessions. This design gave the subjects the same
feeling as a real stimulation because the ramp up and down periods are usually
the most noticeable moments. However, the stimulation was too short to have
significant, durable effect on the brain activity.
For each ten minute period, the subject was asked to close the eyes for the
first two minutes (from 0 to 2, from 10 to 12, 20 to 22, 30 to 32 and 40 to 42
minutes). During the eyes-open condition, subjects were requested to stare at
a screen where a cross was shown to change colour or to rotate at random time
(but between every 20 or 30 s) and to press a key when the cross configuration
changed to maintain the subject gaze and attention to a fixed point.
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9.2.4 Data analysis
Optical data
TRS measurement acquired by TRS-20I were analyzed using all the three meth-
ods described in section 3.1.3: the DPF and variance analysis, for which the
first ten minutes of the protocol were used as baseline, and the fitting analysis.
For this, only µa was used as a fitting parameter, while µ
′
s was fixed at baseline
values. This helps improving the stability of the derived absorption coefficient,
used to retrain HbO2 and HHb concentration absolute values. This approx-
imation assumes the metabolic changes to only affect the blood oxygenation
but not the tissue scattering properties, considering the fact that red blood
cells are only a small factor of the total scatterers.
DCS measurements were analysed using the solution for the diffusion equa-
tion of the electric field autocorrelation function for the semi-infinite medium
to derive the blood flow index (BFI) as explained in section 3.2.3. Optical
properties derived from TRS were used in the analysis. Once derived, the
BFI, a measure of CBF, was normalized to the baseline (first ten minutes of
acquisition) to obtain a measure of relative CBF (rCBF).
EEG
Changes in the EEG patterns induced by the brain stimulation were indepen-
dently analysed for eyes open and closed conditions. Pre- and post-stimulation
EEG recordings were filtered using a finite impulse response filter of 500 coeffi-
cients with cut-off frequencies set to 1 Hz and 20 Hz. Filtered recordings were
split into 60 second blocks in which power at delta (2-4 Hz), theta (4-8 Hz), al-
pha (8-13 Hz) and beta (12-18Hz) bands were calculated. Each 60 second block
was further split into two second windows with a 50% overlap. After individual
epoch de-trending, those epochs containing samples larger than 75 µV , consid-
ered high amplitude artifacts, were rejected. Relative power at the previously
defined frequency bands was calculated via trapezoidal power spectral density
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(PSD) integration and were normalized with respect to the full band power
(2-18 Hz). Power at 60 second blocks was calculated as the average power of
artefact-free two second epochs.
Statistical data analysis
Outlier detection was implemented by analysing the functional depth [9, 63],
i.e. the centrality of a given curve within a group of trajectories, with each
curve representing the response of cerebral haemodynamics or EEG power.
The R package [209] fda.usc [64] and the R function Outliergram [9] were used
as tools for this purpose. The outlier detection was run in the two hemispheres
independently for the cerebral haemodynamics and for each electrode and band
for the EEG response. A subject was defined as an outlier if it was detected
by both methods simultaneously and was, thus, removed from the statistical
analysis. If a subject was defined an outlier for HbO2 concentration, it was
removed also for HHb concentration, and vice versa.
A linear mixed effects (LME) analysis was performed to test the effect of
the stimulation session and time on the cerebral haemodynamics and EEG
response using the R package lme4 [15]. For cerebral haemodynamics, we
treated the two hemispheres independently building an LME model for each
of them. To include time, we selected periods of 4 minutes during which we
averaged the response: minute 14 to 19 as DURING DC-tCS period, minute
24 to 29, 34 to 39, 44 to 49 as POST1, POST2 and POST3 DC-tCS periods
respectively. Response was normalized to the last 4 minutes of the PRE-
period, therefore this period was not introduced in the analysis. EEG power
change with respect to initial baseline, each band and electrode was evaluated
separately, as well as eyes opened and eyes closed periods. POST periods were
introduced in the LME by averaging the response in each of them. In all the
models, the period and the stimulation type (and their interaction) entered
as fixed effects. As random effects, the intercepts for subject and the random
slope for period on a subject basis were considered. For EEG only a random
158
Cerebral haemodynamics and electroencephalography measurements during
transcranial direct current stimulation
intercept was used since the model would not converge if the random slope had
also been added. Residuals plots were tested for the inspection of deviations
from homoscedasticity or normality. Models were built with forward steps
following likelihood ratio tests of the model with the effect in question against
the model without the effect in question. The bayesian information criterion
(BIC) parameter was considered to assess whether the effect was improving
the model. Stimulation type was the first to be tested. If found significant, the
period was added and a new model was tested. If this step was also successful,
the interaction between the two was also tested.
Post-hoc analysis was performed with R package lsmeans [133] to quantify
changes in haemodynamics parameters and in EEG power for each stimulation
session and period. To this end, least-square means of the linear model were
calculated and the different sessions were compared using the Tukey correc-
tion for multiple comparisons. For data visualization, a bootstrap sample was
calculated for the time series of cerebral haemodynamics parameter. The boot-
strap method is based on consecutive and random re-sampling of the sample
distribution [36] and was implemented in the R package fda.usc [64].
9.3 Results
A total of twenty healthy subjects (nine female) participated in anodal and
cathodal stimulation sessions. Twelve of them came back for a sham session.
Technical problems resulted in one subject for TRS measurement being dis-
carded for the cathodal session leaving nineteen subjects for HbO2 and HHb
concentration measurements. In addition, one DCS measurement was dis-
carded during the sham session leaving eleven subjects for flow measurement
during sham stimulation. Technical exclusion criteria for EEG, explained in
the data analysis section, resulted in twenty subjects for anodal, sixteen for
cathodal and nine for the sham session. As explained above, outliers were de-
tected and excluded from the statistical analysis. Number of subjects surviving
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the outlier detection for EEG and haemodynamics parameters are presented
in table 9.1 and table 9.2 respectively.
Sham Anodal Cathodal
α β δ θ α β δ θ α β δ θ
AF7 9 8 9 8 20 20 19 19 15 15 16 15
AF8 9 9 9 8 20 19 19 19 15 15 16 15
FT7 9 9 9 9 19 19 18 19 16 15 16 14
FT8 9 9 9 8 20 17 19 20 16 15 14 15
PO7 9 9 9 8 19 19 19 19 16 15 16 15
PO8 8 9 9 7 20 19 18 19 15 15 16 15
TP7 9 9 9 8 19 19 19 19 15 14 16 15
TP8 9 9 9 7 18 19 19 18 15 15 16 15
Table 9.1: Number of subjects for EEG that were used for the statistical
analysis for each electrode and for each band(alpha (α), beta (β), delta (δ)
and theta (θ)), after the technical exclusion criteria and outlier detection.
Sham Anodal Cathodal
Left Right Left Right Left Right
CBF 11 11 18 18 20 18
HbO2 and HHb 12 12 18 19 17 17
Table 9.2: Number of subjects for haemodynamics parameters that were used
for the statistical analysis after the technical exclusion criteria and outlier
detection.
In figure 9.2, the time series of rCBF change, averaged over subjects, is
shown together with the bootstrap sample. Only results from the left hemi-
sphere (ipsilateral side, under the stimulation electrode) are shown from the
three different stimulation sessions.
When building the LME model from the null one, the stimulation type
is found to improve it for blood flow in the left hemisphere, but not in the
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right one. Therefore, blood flow response depends on the stimulation in the
ipsilateral hemisphere, but not in the contralateral one. Period is not an effect
that improves the model for neither of the hemispheres. Accordingly, we can
conclude that blood flow stays constant at the end of the stimulation period
(DURING) and in the POST periods. Post-hoc analysis results are summarized
in figure 9.6. Blood flow increases significantly from the baseline by 10% (C.I.
7%-14%) for anodal (p < 0.001) and 11% (C.I. 7%-15%) for cathodal (p <
0.001) stimulation while no increase is seen in the sham session (p = 0.07).
A comparison between the different sessions revealed a detectable difference
between anodal and sham (p = 0.008) and cathodal and sham (p = 0.003)
sessions while no difference is seen between anodal and cathodal sessions.
In figure 9.3, the results for the time evolution of HbO2 concentration from
TRS measurements using the three different analysis methods are shown for
anodal and sham stimulations for the left (ipsilateral) hemisphere. DPF analy-
sis gives an increase of HbO2 concentration starting during the stimulation and
persisting after it. Notably, this change is seen both in the anodal and sham
sessions. The results obtained with the analysis of variance and by fitting are
comparable and show smaller changes than the DPF analysis both in anodal
(p < 0.001) and sham (p < 0.001) sessions. For this reason, the fit analysis
results are used for building the LME model for the changes in HbO2 and HHb
concentrations. Furthermore, this is what is most commonly used for TRS
analysis [211]. Figure 9.4 and figure 9.5 show the average time evolution and
the bootstrap sample from all the subjects for HbO2 and HHb concentrations
respectively in the left hemisphere during the three stimulation sessions. As
for the blood flow, among the effects considered in the LME model and listed
in the Methods, only the stimulation improves the model. For both variables,
the changes depend on the stimulation session but a recovery is not seen in the
30 minutes of POST periods, because the period is not a significant effect for
the model.
As summarized in figure 9.6, HbO2 concentration increased by 0.5µM (C.I.
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0.1µM -0.8µM) during anodal session (p = 0.002) and by 0.5µM (C.I. 0.2µM -
0.8µM) during cathodal (p = 0.001). As expected, the changes in HHb con-
centration were opposite to HbO2 concentration. HHb concentration decreased
by −0.3µM (C.I. −0.5µM -−0.1µM) during anodal session (p < 0.001) and by
−0.3µM (C.I. −0.5µM -−0.2µM) (p < 0.001) during cathodal session. No
change was seen in the sham session (p = 0.1 for HbO2 and p = 0.07 for
HHb concentration). A difference was detected by our model for HbO2 con-
centration between anodal and sham (p = 0.004) sessions, as well as between
cathodal and sham (p = 0.003) sessions. On the other hand, a pair comparison
for HHb concentration gave a significant difference only between cathodal and
sham sessions (p = 0.03).
Figure 9.2: rCBF change during the three types of stimulation sessions on the
left hemisphere. The thick black line is the average, the grey area represents
the bootstrap sample over all the subjects. The black horizontal bar highlights
the stimulation period.
A frequency range from 1 to 20 Hz was considered for the EEG analysis.
The lower limit was chosen because artifacts derived from movement and sub-
sequent changes in the skin-electrode impedance affect mostly the low EEG
frequencies. Furthermore, a time-frequency analysis of each recording was per-
formed in order to study the signal quality of the data set. In many recordings,
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Figure 9.3: Changes in oxy-haemoglobin (HbO2) concentration during sham
and anodal stimulation, in the left hemisphere, according to the three types of
analysis considered for TRS: orange for DPF analysis, blue for the variance and
red for the fitting analysis. Continuous line is the average of all the subjects, the
lighter coloured region represents the bootstrap sample with the same colour
code. The black horizontal bar highlights the stimulation period.
Figure 9.4: Oxy-haemoglobin (HbO2) concentration during the three types of
stimulation sessions on the left hemisphere from the fit analysis. The thick line
is the average, the lighter coloured region represents the bootstrap sample over
all the subjects. The black horizontal bar highlights the stimulation period.
the EEG spectrum was affected by external interferences in frequencies above
22 Hz. It was then decided to choose an upper cut-off frequency of 20 Hz to
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Figure 9.5: Deoxy-haemoglobin (HHb) concentration during the three types of
stimulation sessions on the left hemisphere from the fit analysis. The thick line
is the average, the lighter coloured region represents the bootstrap sample over
all the subjects. The black horizontal bar highlights the stimulation period.
avoid this noise. As a result, the beta band covers 13 Hz to 20 Hz. In ad-
dition, after the temporal and spectral inspection of the EEG spectrum that
was acquired during the stimulation, we have concluded that the quality was
not sufficient to perform a reliable EEG analysis. Therefore, only recordings
before and after the stimulation were used. Going through results obtained
in EEG power, the changes in resting-state across stimulation modalities were
observed only in the eyes-open condition. Figure 9.7 shows barplots for bands
and electrodes where response was affected by the stimulation session according
to LME model. Post-hoc analysis resulted in a statistically significant power
decrease in delta band in TP8 after every stimulation type. Statistically signif-
icant differences between anodal and cathodal sessions (p < 0.001) and anodal
and sham sessions (p = 0.02) were observed. A statistically significant power
decrease in the theta band after cathodal stimulation in fronto-right region
(AF8, FT8) was observed. Statistically significant differences between catho-
dal and sham sessions (p = 0.002 in both electrodes) and cathodal and anodal
sessions (p = 0.002 in both electrodes) were also observed. A more widespread
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Figure 9.6: Changes of cerebral haemodynamics parameters during and after
the stimulation sessions, as obtained by the LME model with the 95 % confi-
dence interval as the errorbars. N refers to the number of subjects used for the
statistical analysis. Red * highlights statistically significant difference between
stimulation sessions. Dashed vertical line represents the zero level.
effect in the beta band was observed. All electrodes in the tempo-parietal (TP7
and TP8) and parieto-occipital (PO7 and PO8) lobes experienced a statistical
significant increase after sham, but, not after any active stimulation. In all
these electrodes, the difference between anodal and sham sessions (p = 0.004
for TP7,p = 0.01 for TP8, p < 0.001 for PO7, p = 0.002 for PO8) and cathodal
and sham session were significant (p < 0.001 for all electrodes).
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Figure 9.7: Change of electroencephalography (EEG) power in electrode TP8
in the delta band, electrodes AF8 and FT8 in the theta band and electrodes
TP7, PO7, TP8, PO8 in the beta band caused by the three types of stimu-
lation, as obtained by the LME model, with 95 % confidence interval as the
errorbars. N refers to the number of subjects used for the statistical analysis.
Red * highlights the statistical significant difference between stimulation ses-
sions. Dashed vertical line represents the zero level. Only bands and electrodes
with statistical significant changes are shown.
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9.4 Discussion
In this work we have introduced the use of functional diffuse correlation spec-
troscopy (DCS), together with time resolved functional near infrared spec-
troscopy (TRS), as neuro-monitors of cerebral haemodynamics during and af-
ter transcranial direct current stimulation (DC-tCS). The former has allowed
the direct measurement of cerebral blood flow (CBF) primary biomarker of
the neurovascular coupling. The measurement of cerebral haemodynamics was
concurrent to electroencephalography (EEG) which measures electrical activ-
ity. Therefore, information on both haemodynamics and neuronal activity from
the same run of the protocol were available.
I discuss results of linear mixed effect (LME) models for haemodynamics
and EEG. LME models take into account variability within subjects and are
dependent on the numbers of degrees of freedom. The methods section explains
how the LMEs were built and the results section explains in detail the resulting
models and the significant effects on EEG and haemodynamics found through
those models. It must be highlighted that these results valuably describe the
group response to the stimulation, while they do not give information on the
response of each subject. This would be useful if the haemodynamics data must
be used for tailoring the stimulation on each specific subject. This is however
a preliminary work that aims at assessing the feasibility of optical and EEG
recording and the description of the “average” response to the stimulation.
9.4.1 Cerebral haemodynamics
Statistical analysis confirms that CBF increases in the left ipsilateral hemi-
sphere (in the region under the stimulation electrode) during anodal and catho-
dal sessions but not during the sham session. CBF does not recover during the
30 minutes following the stimulation. This is consistent with the fact that if the
stimulation is applied for a period longer than 9 minutes, the effect of the stimu-
lation persists long after the stimulation ends [127]. Specifically, our statistical
9.4 Discussion 167
model results in a 10% increase during anodal session and 11% during cathodal
and gives no difference between the two stimulation conditions. This amount
for CBF change is similar to what was assessed with arterial spin labelling MRI
(ASL-MRI), a magnetic resonance imaging (MRI) technique, [229] but, is much
larger than what measured by positron emission tomography (PET) [128]. In
reference [128], scans taken during the following hour after the stimulation were
averaged, while we have measured only the following 30 minutes, which may
account for some of the difference in our results. The optical probe placed in
the right contralateral hemisphere did not detect any change in CBF in this
region. The work done with PET [128] allowed for whole brain imaging and
detected regional increases in different areas of the brain, even far away from
the stimulation electrodes, after both anodal and cathodal sessions compared
to sham. Although anodal stimulation proved to cause a more widespread in-
crease of regional CBF than cathodal stimulation, the same effect was seen for
both stimulation types in the region under the electrode, which is consistent
with our results.
As far as TRS measurement are concerned, I will here discuss results of
the fit analysis. In this protocol, HbO2 concentration increases and HHb con-
centration decreases in the left hemisphere during both anodal and cathodal
stimulations, but not during sham. The right frontal lobe (contralateral to
the stimulation) does not present changes in the oxygenation as is also true
for CBF. Even if changes retrieved were very small, less than 1µM , HbO2
and HHb concentrations can mark the status of the ongoing stimulation. As
a matter of fact, the changes are statistically significant during both anodal
and cathodal sessions but not during the sham session. HbO2 concentration
is a more robust marker, since response to anodal and to sham sessions are
statistically significantly different, as well as the response to the cathodal and
to sham sessions. On the other hand, for HHb concentration, the contrast-to-
noise ratio is not enough to give a statistically significant difference between
anodal and sham sessions, but a decrease is not seen in the sham session. The
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directions of HHb and HbO2 concentration changes are consistent with what
is expected in case of a cerebral activation and what was previously found in
the literature [118, 151]. Specifically, due to the neurovascular coupling, when
a cerebral region is activated, CBF is recruited to meet the additional demand
of oxygen and it increases [185]. Concurrent to this, an increase of HbO2 con-
centration and a decrease of HHb concentration is usually detected [199]. This
suggests that the brain is over supplied by oxygen by the increase of CBF com-
pared to the oxygen consumption. The details of this process is, in fact, more
complex [185]. The time series of the haemodynamics parameters in figure 9.2,
9.4 and 9.5 suggest a more steep increase of CBF than the HbO2 and HHb con-
centrations. The above mentioned mechanism of neurovascular coupling can
explain this [199]. Right after the stimulus, the supply of CBF does not over-
come the need immediately. Only after this happens, a HbO2 concentration
increase and a HHb decrease is detected. This process was previously verified
during in vivo protocols [188]. Nonetheless, to make quantitative inferences on
the time lag, we should have had a better time resolution than what we have
here.
Different source detector separation for TRS and DCS
Explaining DCS data analysis, it was highlighted that optical properties mea-
sured by TRS are used for DCS analysis. It must be noted that source detector
separation for the two was different (2.5 cm for DCS and 3.7 cm for TRS). Since
our analysis assumes that the underlying tissue is homogeneous, we can tol-
erate this difference. In addition our results are relatively insensitive to small
inaccuracies of the bulk optical properties, since we focus on the measurement
of relative CBF [53].
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Possible influence on skin perfusion
It is known that diffuse optical techniques measure a mixture of extra- and
intra-cerebral perfusion [13]. This could be a confounding factor since DC-tCS
causes a “skin redness” (erythema), that may lead to changes in the skin perfu-
sion of different amounts between active and sham stimulations [8]. However,
the properties of photon diffusion into the tissue help us in explaining that
response detected in this protocol is not mainly due to changes in skin perfu-
sion due to the stimulation induced skin redness. The visitation probability of
photons traveling into the tissue has a so-called “banana-shaped” pattern and
touches the skin mainly in the region corresponding to the source and detector
fibers [171]. In our case, the fibers are separated by a distance of 25 mm while
the electrode, placed in the middle has a diameter of 12 mm. If we consider
that various works [58, 212] have shown that the erythema is concentrated in
the area under the electrode, our optical monitors are not particularly sensitive
to this redness. Furthermore, a recent study [116] measured the temperature
under the electrode during the stimulation, detecting a non-significant change
after 10 minutes of stimulation (our total time of stimulation). Only after 20
minutes of application a significant increase of 1.36◦ was detected. However,
we should account for the fact that this work used a larger electrode result-
ing in a lower current density than ours (0.06 mA/cm2 versus 0.88 mA/cm2).
Interestingly, there is evidence suggesting that the current intensity and the
electrode area are more important parameters leading to increased redness and
discomfort due to the stimulation of more cutaneous receptors [212]. In the
above mentioned reference [116], temperature was measured using a current
intensity of 2 mA, larger that what was used in our experiment. Therefore, we
expect a minimal, non-significant temperature increase in our case. Another
indication that the observed, long-term changes are not purely due to skin red-
ness is that it is known that erythema disappears within thirty minutes after
the stimulation [81]. In our case, the stimulation response did not decrease
after thirty minutes.
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Results from different type of TRS analysis
Even if fit analysis is the most used methods for TRS curve analysis, I also
explored other methods. DPF analysis was considered to understand which re-
sults would have been obtained using a typical one distance CW-NIRS setup.
While the variance method was meant to compare the fit results with a method
that has proven to be more sensitive to deeper layers. DPF analysis shows an
increase of about 2 µM in HbO2 concentration in the left hemisphere compati-
ble with what was previously found in the literature [118,151]. This increase is
seen in active and sham stimulations where the brain is not actually stimulated
which questions its validity. Focusing on the results given by the analysis of
variance, the second moment of the DTOF, we retrieve smaller changes both
in anodal and sham session respect to DPF analysis. Notably, the variance
of TRS curves is more sensitive to the deeper layers respect to the intensity,
the parameter used in the DPF analysis [137]. This may suggest that results
in DPF analysis are contaminated by superficial effects present both during
anodal and sham stimulations. Moreover, these results are in accordance with
a previous single subject experiment where TRS was used during anodal stim-
ulation [154]. In this work TRS measurements were analyzed with a gated
analysis [232]. This method exploits the depth information encoded in time
in the broadened pulse collected after propagation into the tissue, and allows
to decouple changes in the extra-cerebral and cerebral layers. Measurements
performed on a single subject during anodal stimulation retrieved a larger
HbO2 concentration change in the superficial than in the deeper layer, which
would be heavily reflected in the DPF analysis. We would like to point out
that the time gating analysis of TRS was not implemented here because the
lack of knowledge of the extra-cerebral layer thickness on an individual basis
compromises the validity of this method [183].
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Cerebral haemodynamics response not dependent on stimulation po-
larity
It is interesting to observe that both the anodal and cathodal stimulation ses-
sions have created similar changes in the haemodynamics parameters. All the
reviewed and cited published works [128,229] that measure cerebral haemody-
namics during DC-tCS show the same pattern for both cathodal and anodal
stimulations in the region under the electrode. Our results confirm these find-
ings. In addition, positron emission tomography (PET) studies concurrent to
transcranial magnetic stimulation (TMS) also demonstrate an increase in CBF
in the region under the stimulation for both excitatory and inhibitory proto-
cols [190]. These results suggest that CBF is not a marker of the polarity of
the stimulation, at least in the directly stimulated area, and that regardless
of whether the stimulation results in an activation of inhibitory or excitatory
synapses, it leads to an increase in blood flow. It has been highlighted that
this behavior of CBF reflects the local levels of synaptic activity in intracortical
neurons and inputs to those areas rather than the activity of output neurons
which is opposite when the stimulation is excitatory or inhibitory [128,143].
9.4.2 EEG
The stimulation protocol used in this study influenced EEG rhythmic activity
at different bands and electrodes. Comparing the results from previously pub-
lished studies about DC-tCS on the frontal cortex is not a trivial task since
EEG response depends heavily on the electrode montage [2]. All of the pre-
vious studies used F3 as the stimulation electrode while the return electrode,
here referring to the electrode not placed in the frontal cortex with opposite
polarity, was placed either on the supra-orbital region or on extra-cerebral re-
gions. In contrast, we have decided to use the AF7 electrode as stimulation
electrode because the optical measurement series on the frontal brain region
are more reliable due to the absence of hair. The return electrode was chosen
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to be spatially and functionally distant from the stimulation electrode in order
to minimize the interactions and to stimulate the frontal region unilaterally.
Moreover, few studies measured the EEG spectrum at rest while most of them
assessed the response to a task and how this can be influenced by the stimula-
tion. It must be noted that a recent systematic review highlighted that results
in the EEG spectrum of the same protocol were not consistent within different
works [91]. They concluded that there is no evidence that EEG spectrum is
affected by the stimulation. It may also be hypothesized that, since it is not
trivial to maintain subjects in a well controlled condition, the variability of the
effects is increased. We note that the protocol is fifty minutes long which may
have led to a sense of drowsiness and/or fatigue in the subjects which could
alter the cerebral electrophysiology and metabolism. The staring and attention
tasks were implemented to minimize this effect. Furthermore, the transition
from eyes open and closed and vice versa also helped with this issue. In spite
of this, we cannot exclude that some of the subjects may have been affected
and we do not have any control over this.
In order to define EEG spectrum results, effects in different frequency bands
have been studied since different bands are traditionally related to different
brain functions. It is however controversial whether the activity at a certain
frequency band is related to a single brain function or that complex stimuli are
reflected on a single oscillatory activity [14]. This may explain the multiplicity
of bands affected by our protocol.
The protocol applied in this study influenced brain activity in the delta, theta
and beta bands. No effect was detected in the alpha band which is consistent
with previous works [91]. We will focus from now on on the bands where the
stimulation has proven to be effective. The changes in the delta band were
observed in the right tempo-parietal region after all stimulation sessions but
were significantly smaller in the anodal session compared to the other two.
On the other hand, changes in the theta band occurred in the right fronto-
temporal area exclusively after cathodal stimulation. Interestingly, delta and
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theta bands are associated to functions linked to the frontal cortex which was
stimulated in our protocol. It is an indication of activity in cognitive and mem-
ory performances [124], attention [83] and working memory [194]. A response
in these bands is consistent with previous work. Specifically, a lower power in
delta and beta bands after the stimulation compared to sham has been previ-
ously observed [113,223], where pre- and post-stimulation spectral power were
not calculated but the comparison between stimulation sessions was done in
absolute values. This effect has only been found in the frontal cortex, in con-
trast to our findings, but both stimulation and return electrodes were placed
on the anterior part of the head, while we have an electric field crossing all the
brain. A significant and selective decrease of the power of theta band in the
right inferior frontal gyrus area has been reported after DC-tCS stimulation
along with an improvement in behavioural inhibition [104].
Differences in EEG power across different stimulation sessions were also seen
in the beta band. Power increased after sham session in temporal and parietal
region, but not after active stimulation sessions. An unchanged or a decreased
level of beta activity is usually observed in tasks where behaviour is driven
by bottom-up signals, while enhancement occurs if the system has to actively
maintain endogenous attention [57]. It may be hypothesized that the detected
increase in beta activity is linked to a active effort to maintain the cognitive
concentration state required for the sustained attentional task along the exper-
imental protocol. This activity was present during sham but not during active
stimulation sessions. Several references highlight an influence of DC-tCS when
applied on the frontal cortex, on sustained attention [73]. In our protocols,
same effects for anodal and cathodal session was found in the EEG beta band
in the posterior part of the brain, without a differentiation due to the po-
larity. Intuitively this is not expected because opposite polarity stimulation
should produce an opposite electric field in the brain, i.e. either excitatory or
inhibitory. Nonetheless, it must be mentioned that the predominance of exci-
tatory or inhibitory electric field in an area of the brain does not exclude that
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some “pockets” of the opposite direction are present [126]. We can speculate
that only excitatory areas influenced the power in the beta band in the poste-
rior area of the brain in our protocol. Unfortunately, this is prohibitively hard
to confirm since not only the electrode montage but also the concurrent tasks
alter the response to a certain polarity of stimulation [201, 204], i.e. it would
require a special protocol to address this. For our protocol, the attention task
was not the primary goal.
9.4.3 Correlation between cerebral haemodynamics and neu-
ronal activity
Lastly, it was verified whether the change in CBF in the left frontal cortex due
to stimulation has any correlation with the power change respect to baseline
in any of the EEG bands and electrodes. This was done even for the elec-
trodes far away from the optical probes since the source of the EEG signal
can lay far from the scalp point where it is registered and its exact location
cannot be determined well due to the inverse problem [75]. The Pearson cor-
relation coefficient was calculated and a correlation was defined significant if,
by bootstrapping the sample (i.e. repeating the analysis removing one subject
at time), the correlation stays significant. After this analysis, we have found
a negative correlation in the delta band for electrode FT8 with a Pearson cor-
relation coefficient of R=-0.6. This is consistent with a predicted and verified
decrease in lower frequency band during activation [119,144]. The study of the
correlation between the haemodynamics and neuronal activity is a very ap-
pealing topic due to the important information on the neurovascular coupling
it could provide. It is also a very complicated process since several factor can
contribute to the failure of the correlation between EEG activity and haemo-
dynamics [186]. A detailed characterization of this is beyond the scope of this
work, which aimed at the introduction of hybrid diffuse optical devices for
monitoring the response to the stimulation, and requires a dedicated protocol
with more regions probed for haemodynamics.
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9.5 Conclusion
We have shown that DCS and TRS are suitable tools to monitor cerebral
haemodynamics during and after DC-tCS and they can be integrated with
EEG which monitors the neuronal activity. We have found CBF to be a good
indicator of the ongoing stimulation since it shows an increase during and after
anodal and cathodal stimulation in the region under the stimulation electrode.
Results obtained with TRS show small changes of HbO2 and HHb concentra-
tions but the effect of the stimulation was still detectable. By concurrent EEG
recordings, we could follow the modulation of the underlying neural oscillations.
DC-tCS over the frontal cortex induced statistically significant power changes
across different stimulation sessions in delta, theta and beta EEG rhythms.
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Two hybrid devices integrating time resolved near-infrared spectroscopy (TRS)
and diffuse correlation spectroscopy (DCS) have been developed, tested and
exploited for monitoring cerebral haemodynamics in both adult and infant
populations. Such devices allow for the simultaneous and independent mea-
surement of microvascular cerebral blood flow and of the blood oxygen content
in the microvasculature of the tissue. They make possible to measure non-
invasively and continuously cerebral haemodynamics and metabolism at the
bed- or cot-side.
The core of this thesis is the work developed within the BabyLux project.
Together with the consortium involved in the project, I have developed a hybrid
DCS and TRS device that could be used as a neuro-monitor for the premature
newborn infants. The device has been built targeting this population and it
had to be robust, portable and user-friendly to be used by the clinical personnel
in the neonatology units.
Apart from describing the device and the protocol applied to test it in
laboratory settings, other important technological aspects have been described
in this thesis, whose importance goes beyond the BabyLux device.
First of all, through realistic simulated data, I have described the lower
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limits to be expected from such a device in terms of precision and accuracy.
This was tailored to measurement of the neonatal head but it can be extended
to other DCS and TRS devices and to other populations.
Furthermore, I have validated DCS-measured cerebral blood flow (CBF),
the BFI, against the gold standard positron emission tomography on a piglet
model. I have obtained a calibration formula to turn BFI in flow units which
gave satisfactory results in piglets and infants.
Two equivalent BabyLux devices were built and successfully validated in
clinical settings by the end-users, i.e. neonatologists. In particular, we have
demonstrated that the BabyLux device could measure in a complicated en-
vironment such as the delivery room, following the transition after birth, not
losing more data than the commercial pulse oximetry and providing results not
in contrast with previous findings.
Clinical testing focused, in addition, on the reproducibility of the measure-
ment over probe replacement. Performance for StO2 were improved compared
to the cerebral oximeters, while variability of BFI was comparable to other
technologies, which, in any case, measure with different time and space resolu-
tion.
Therefore the BabyLux device improves the state of the art, i.e. commercial
cerebral oximeters, because it adds information on blood flow and provides
better precision in oxygen saturation estimation.
The feedback received and the experience gained during the clinical studies
with the BabyLux device can help with the first upgrade of the device. Updates
can be, for example, providing more power from the TRS lasers, to lower the
test-re-test variability of oxygen saturation, or improving the software, to reach
an even more user-friendly graphical user interface. Inter-subject variability
of BFI is a further point to improve, for example by increasing the signal-to-
noise-ratio of DCS. Adding more detectors, or improving the engineering of the
probe, to be less sensitive to pressure, movement, head curvature, are some of
the first actions to initiate. Furthermore, the upgrade should be focused on
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the safety features in order to be able to start the process of CE approval for
medical devices and to make it easier to start clinical research on a larger scale.
Meanwhile, more clinical studies are ongoing with the device and further are
planned. New studies focus mainly on preterm infants, the target population
which was not measured during this thesis’ work. First results on preterm
newborns confirm the usability of the device and its probe on smaller heads.
The importance of the BabyLux project results lays in contributing to
bridge the gap between research and clinical market. Hybrid DCS and TRS
devices had been previously used for small studies on term and preterm in-
fants, however the BabyLux device is the first device specifically designed for
this purpose. Its user-friendliness allowed the clinicians to acquire data with
minimal technical support and no adverse effects have been registered during
data acquisition, even in extreme conditions such as the delivery room. This
work lays the ground for a new generation of neuro-monitors for the infants
brain and paves the way of more extensive clinical studies, involving more
clinical centers.
In the last part of this thesis I have presented the hybridization of a com-
mercial DCS and a prototype for a TRS. A detailed explanation of the robust
integration of the two devices is of interest to eventually reproduce it. Having
such hybrid devices available in non-technical research groups could expand
and push forward research on various applications.
In this thesis the integrated device has been employed to measure cerebral
haemodynamics of healthy adult volunteers. Specifically I have monitored
the local CBF before during and after transcranial direct current stimulation
for the first time. Such a neuro-monitor can be used for basic research on the
effect of the stimulation but also to ultimately tailor the protocol to the subject
necessity. Next steps will require to investigate the cerebral haemodynamics
in specific interventions, including tasks, and to correlate the haemodynamic
response, during or after the stimulation, to patient or subject outcome.
Results discussed throughout the thesis are positive and appealing, however
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it must be reminded that several challenges are still to be solved for ultimately
pushing diffuse optics towards clinical application. Some of the limitations of
these technologies require to push physics research instead of a purely engi-
neering efforts. One example is the fact that BFI absolute measurement is still
not reliable enough for clinical purpose. One weak point, leading to high BFI
variability, is the inaccurate determination of reduced scattering coefficient µ′s.
To tackle this point, work must be done on the model used for analysis, since
the diffusion approximation already theoretically estimates µ′s with an error of
about 10%. Model based on the radiation transport equation have been pub-
lished over the years, but they are still too complex to be employed for in-vivo
data. Another improvement could focus on narrowing the pulse width of the
instrument response function to increase the sensitivity of TRS measurement
to µ′s. Work is being carried on mainly on the detector side, focusing for ex-
ample on silicon photomultipliers, lowering the noise and improving the timing
resolution of this electronics.
A further unresolved problem regards the physical origin of the quantity
measured by DCS. Specifically, BFI is surely proportional to blood flow but
it depends on a variety of other parameters, the haematocrit and the vessel
diameter and dimension in the probed tissue, among others. The fact that we
do not have control of all the sources of the signal increases the variability of
the measurement. A deeper insight on the origin of the BFI value would be
useful for fundamentally understanding its relationship with the tissue blood
flow and to make the BFI absolute value a measure of absolute blood flow useful
and reliable for clinical application. Currently, DCS community is focused on
theoretical and numerical studies, that will have to ultimately be translated in
experimental measurement.
A common problem for all diffuse optical technologies used as brain mon-
itors is the extra-cerebral contribution to the signal detected. This is not a
major issue for the infant application, due to the thin skull and scalp of the
newborns and infants, but it is for adult brain monitoring, as discussed in Part
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3 of this thesis. To this purpose, research has been focused on theoretically
studying the depth sensitivity and selectivity of diffuse optical technologies.
Interestingly, previous studies have shown a larger sensitivity to the brain for
both DCS and TRS compared to CW-NIRS. On the other side, data analy-
sis and experimental protocols have been developed in order to improve the
sensitivity to the brain haemodynamics. These new methods have not been
fully introduced in in-vivo measurements yet. First of all because they usually
require an accurate knowledge of the superficial layer thickness on an individ-
ual basis to actually improve the results and this is not an information easily
obtained. In addition, some of them require multi-distance measurements,
increasing the complexity of the instruments and probes.
The list of issues provided above has been keeping (and will keep) the
diffuse optical community busy enough to improve precision and accuracy of
brain haemodynamics measured by diffuse optics to reach the degree of relia-
bility needed for clinical application. However we must remind that the small
and medium sized clinical studies running all over the world employing the
cutting-edge diffuse optical neuro-monitor are providing positive and valuable
results. These technologies are (currently) the only and best option to provide
continuous and non-invasive monitoring of the brain supply and consumption
of oxygen at the cot- or bed-side. For this reason, clinical research should run
in parallel with technological progress, with the design of more clinical studies
in more clinical centers. These should have the objectives to, first, define refer-
ence clinical values and, hence, guidelines for maintaining those in each patient.
This is specifically true for application in neonatal intensive care. Once more
information on each preterm or critically-ill infant brain is given by shedding
light on the head of each of them, a new path for clinical intervention can be
laid. We could therefore discover whether clinical care guided by near-infrared
photons traveling in neonatal brain could significantly improve the outcome of
infants born preterm or critically-ill.
184 Conclusions
Bibliography
[1] Aanerud, J., Borghammer, P., Mallar Chakravarty, M., Vang,
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rich, J., Flöel, A., Fregni, F., George, M. S., Hamilton, R.,
Haueisen, J., Herrmann, C. S., Hummel, F. C., Lefaucheur,
J. P., Liebetanz, D., Loo, C. K., McCaig, C. D., Miniussi, C.,
Miranda, P. C., Moliadze, V., Nitsche, M. A., Nowak, R.,
Padberg, F., Pascual-Leone, A., Poppendieck, W., Priori, A.,
Rossi, S., Rossini, P. M., Rothwell, J., Rueger, M. A., Ruffini,
G., Schellhorn, K., Siebner, H. R., Ugawa, Y., Wexler, A.,
Ziemann, U., Hallett, M., and Paulus, W. Low intensity transcra-
nial electric stimulation: Safety, ethical, legal regulatory and application
guidelines. Clin. Neurophysiol. 128, 9 (2017), 1774–1809.
[9] Arribas-Gil, A., and Romo, J. Shape outlier detection and visual-
ization for functional data: the outliergram. Biostatistics 15, 4 (2014),
603–619.
Bibliography 187
[10] Baenziger, O., Jaggi, J. L., Mueller, A. C., Morales, C. G.,
Lipp, A. E., Duc, G., and Bucher, H. U. Regional differences of
cerebral blood flow in the preterm infant. Eur. J. Pediatr. 154 (1995),
919–924.
[11] Baik, N., Urlesberger, B., Schwaberger, B., Schmölzer, G. M.,
Mileder, L., Avian, A., and Pichler, G. Reference Ranges for Cere-
bral Tissue Oxygen Saturation Index in Term Neonates during Immedi-
ate Neonatal Transition after Birth. Neonatology 108, 4 (2015), 283–286.
[12] Bailey, S. M., Hendricks-Munoz, K. D., and Mally, P. Cerebral,
renal, and splanchnic tissue oxygen saturation values in healthy term
newborns. Am. J. Perinatol. 31, 4 (2014), 339–344.
[13] Baker, W. B., Parthasarathy, A. B., Ko, T. S., Busch, D. R.,
Abramson, K., Tzeng, S.-y., Mesquita, R. C., Durduran, T.,
Greenberg, J. H., Kung, D. K., and Yodh, A. G. Pressure modu-
lation algorithm to separate cerebral hemodynamic signals from extrac-
erebral artifacts. Neurophotonics 2, 3 (2015), 035004.
[14] Basar, E., Basar-Eroglu, C., Karakas, S., and Schuermann,
M. Are cognitive processes manifested in event-related gamma, alpha,
theta and delta oscillations in the EEG? Neurosci. Lett. 259, 3 (1999),
165–168.
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